[
  {
    "title": "Danaher  ( DHR )  Increases Despite Market Slip: Here's What You Need to Know",
    "url": "https://www.zacks.com/stock/news/2204707/danaher-dhr-increases-despite-market-slip-heres-what-you-need-to-know",
    "time_published": "20240102T231520",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Danaher (DHR) concluded the recent trading session at $234.79, signifying a +1.49% move from its prior day's close.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default85.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.95493"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.192958,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.554916",
        "ticker_sentiment_score": "0.205727",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Gastrointestinal Pathogen Testing Market Size to be Worth USD 5.2 billion by 2031, with Notable CAGR of 3.2%| Transparency Market Research, Inc.",
    "url": "https://www.benzinga.com/pressreleases/24/01/g36450979/gastrointestinal-pathogen-testing-market-size-to-be-worth-usd-5-2-billion-by-2031-with-notable-cag",
    "time_published": "20240102T140000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, Jan. 02, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The gastrointestinal pathogen testing industry was worth US$ 4.0 billion in 2022. A CAGR of 3.2% is projected from 2023 to 2031. The market is expected to reach US$ 5.2 billion by the end ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.360215"
      }
    ],
    "overall_sentiment_score": 0.190534,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BMXMF",
        "relevance_score": "0.152741",
        "ticker_sentiment_score": "0.083224",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.038407",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.038407",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BIO",
        "relevance_score": "0.038407",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ONTTF",
        "relevance_score": "0.038407",
        "ticker_sentiment_score": "0.062423",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LH",
        "relevance_score": "0.038407",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.114865",
        "ticker_sentiment_score": "0.07602",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.038407",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Here's Why Danaher  ( DHR )  Fell More Than Broader Market",
    "url": "https://www.zacks.com/stock/news/2205307/heres-why-danaher-dhr-fell-more-than-broader-market",
    "time_published": "20240103T230020",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "The latest trading day saw Danaher (DHR) settling at $230.81, representing a -1.7% change from its previous close.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default283.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.947132"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      }
    ],
    "overall_sentiment_score": 0.225255,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.666827",
        "ticker_sentiment_score": "0.240668",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Should You Invest in the Invesco Global Water ETF  ( PIO ) ?",
    "url": "https://www.zacks.com/stock/news/2204771/should-you-invest-in-the-invesco-global-water-etf-pio",
    "time_published": "20240103T112006",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Sector ETF report for PIO ...",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default259.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "1.0"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.180544,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ROP",
        "relevance_score": "0.135347",
        "ticker_sentiment_score": "0.071708",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "IVZ",
        "relevance_score": "0.329992",
        "ticker_sentiment_score": "0.158874",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PNR",
        "relevance_score": "0.135347",
        "ticker_sentiment_score": "0.071708",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.135347",
        "ticker_sentiment_score": "0.071708",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Here's How Much $100 Invested In Danaher 5 Years Ago Would Be Worth Today - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/news/24/01/36490823/heres-how-much-100-invested-in-danaher-5-years-ago-would-be-worth-today",
    "time_published": "20240104T143028",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Danaher DHR has outperformed the market over the past 5 years by 7.43% on an annualized basis producing an average annual return of 20.23%. Currently, Danaher has a market capitalization of $170.55 billion.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_3.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.160819,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.983605",
        "ticker_sentiment_score": "0.387251",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Peering Into Danaher's Recent Short Interest - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/short-sellers/24/01/36510443/peering-into-danahers-recent-short-interest",
    "time_published": "20240105T144524",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Danaher's DHR short percent of float has fallen 13.79% since its last report. The company recently reported that it has 6.59 million shares sold short, which is 1.0% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.89 days to cover their ...",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.241618,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.224903",
        "ticker_sentiment_score": "0.085754",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Danaher  ( DHR )  Suffers a Larger Drop Than the General Market: Key Insights",
    "url": "https://www.zacks.com/stock/news/2207860/danaher-dhr-suffers-a-larger-drop-than-the-general-market-key-insights",
    "time_published": "20240109T231523",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Danaher (DHR) concluded the recent trading session at $230.87, signifying a -1.7% move from its prior day's close.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default208.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.95493"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.170098,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.565003",
        "ticker_sentiment_score": "0.165417",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "What the Options Market Tells Us About Danaher - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/markets/options/24/01/36564753/what-the-options-market-tells-us-about-danaher",
    "time_published": "20240109T201539",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Financial giants have made a conspicuous bullish move on Danaher. Our analysis of options history for Danaher DHR revealed 10 unusual trades. Delving into the details, we found 70% of traders were bullish, while 30% showed bearish tendencies.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Markets",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.208417,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "VLTO",
        "relevance_score": "0.124164",
        "ticker_sentiment_score": "0.038895",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.7887",
        "ticker_sentiment_score": "0.235373",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Danaher  ( DHR )  Stock Declines While Market Improves: Some Information for Investors",
    "url": "https://www.zacks.com/stock/news/2208554/danaher-dhr-stock-declines-while-market-improves-some-information-for-investors",
    "time_published": "20240110T230016",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Danaher (DHR) closed the most recent trading day at $229.64, moving -0.53% from the previous trading session.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default102.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.917436"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      }
    ],
    "overall_sentiment_score": 0.223916,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.622414",
        "ticker_sentiment_score": "0.301717",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "How Good Is Your Market Cap Knowledge?",
    "url": "https://www.fool.com/investing/2024/01/11/how-good-is-your-market-cap-knowledge/",
    "time_published": "20240111T092600",
    "authors": [
      "Motley Fool Staff"
    ],
    "summary": "A company with a $50 price per share might have a million shares outstanding or a billion shares outstanding. And unless you know, you don't know the price tag of the stock you're about to buy.",
    "banner_image": "https://g.foolcdn.com/editorial/images/759369/market-gap.jpeg",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "1.0"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.166667"
      }
    ],
    "overall_sentiment_score": 0.179873,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "NFLX",
        "relevance_score": "0.044427",
        "ticker_sentiment_score": "0.069744",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "INTU",
        "relevance_score": "0.040728",
        "ticker_sentiment_score": "0.034321",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "VRNS",
        "relevance_score": "0.003704",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GLP",
        "relevance_score": "0.003704",
        "ticker_sentiment_score": "0.005109",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ALGN",
        "relevance_score": "0.040728",
        "ticker_sentiment_score": "0.107208",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.029627",
        "ticker_sentiment_score": "0.070037",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DPZ",
        "relevance_score": "0.022222",
        "ticker_sentiment_score": "0.122039",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BR",
        "relevance_score": "0.022222",
        "ticker_sentiment_score": "0.02157",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SHOP",
        "relevance_score": "0.055518",
        "ticker_sentiment_score": "0.108",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DMPZF",
        "relevance_score": "0.014816",
        "ticker_sentiment_score": "0.116641",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LMT",
        "relevance_score": "0.003704",
        "ticker_sentiment_score": "0.065951",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RGEN",
        "relevance_score": "0.037029",
        "ticker_sentiment_score": "0.08603",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WBD",
        "relevance_score": "0.003704",
        "ticker_sentiment_score": "-0.042186",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CLNE",
        "relevance_score": "0.011112",
        "ticker_sentiment_score": "0.06377",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MAR",
        "relevance_score": "0.003704",
        "ticker_sentiment_score": "0.065951",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Dental Implants and Prosthetics Market Worth $16.0 Billion | MarketsandMarkets\u2122",
    "url": "https://www.prnewswire.com/news-releases/dental-implants-and-prosthetics-market-worth-16-0-billion--marketsandmarkets-302033431.html",
    "time_published": "20240112T153000",
    "authors": [
      "MarketsandMarkets"
    ],
    "summary": "CHICAGO, Jan. 12, 2024 /PRNewswire/ -- Dental Implants and Prosthetics Market in terms of revenue was estimated to be worth $10.4 billion in 2023 and is poised to reach $16.0 billion by 2029, growing at a CAGR of 7.5% from 2023 to 2029 according to a new report by MarketsandMarkets\u2122.",
    "banner_image": "https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg?p=facebook",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.266143"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.269961,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "META",
        "relevance_score": "0.02677",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HSIC",
        "relevance_score": "0.02677",
        "ticker_sentiment_score": "0.049838",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "KURRF",
        "relevance_score": "0.02677",
        "ticker_sentiment_score": "0.049838",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MITSF",
        "relevance_score": "0.02677",
        "ticker_sentiment_score": "0.049838",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SAUHF",
        "relevance_score": "0.02677",
        "ticker_sentiment_score": "0.049838",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MITUF",
        "relevance_score": "0.02677",
        "ticker_sentiment_score": "0.049838",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "XRAY",
        "relevance_score": "0.02677",
        "ticker_sentiment_score": "0.049838",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MMM",
        "relevance_score": "0.02677",
        "ticker_sentiment_score": "0.049838",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVST",
        "relevance_score": "0.02677",
        "ticker_sentiment_score": "0.049838",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.02677",
        "ticker_sentiment_score": "0.049838",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "X-Ray Equipment Market to grow by USD 14.97 billion by 2027 with a CAGR of 6.2% between 2022 to 2027; Market ... - PR Newswire",
    "url": "https://www.prnewswire.com/news-releases/x-ray-equipment-market-to-grow-by-usd-14-97-billion-by-2027-with-a-cagr-of-6-2-between-2022-to-2027-market-size-share--trends-analysis-report--technavio-302032924.html",
    "time_published": "20240112T013000",
    "authors": [],
    "summary": "X-Ray Equipment Market to grow by USD 14.97 billion by 2027 with a CAGR of 6.2% between 2022 to 2027. Market ... PR ...",
    "banner_image": null,
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.221898,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "KNCAF",
        "relevance_score": "0.049732",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CAJFF",
        "relevance_score": "0.049732",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HTHIF",
        "relevance_score": "0.049732",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "VREX",
        "relevance_score": "0.049732",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SEMHF",
        "relevance_score": "0.049732",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.049732",
        "ticker_sentiment_score": "0.230267",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SSNLF",
        "relevance_score": "0.049732",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AFGVY",
        "relevance_score": "0.099271",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HOLX",
        "relevance_score": "0.049732",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SHMZF",
        "relevance_score": "0.049732",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GEHC",
        "relevance_score": "0.049732",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FUJIF",
        "relevance_score": "0.049732",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TOSYY",
        "relevance_score": "0.049732",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Danaher  ( DHR )  Rises As Market Takes a Dip: Key Facts",
    "url": "https://www.zacks.com/stock/news/2211138/danaher-dhr-rises-as-market-takes-a-dip-key-facts",
    "time_published": "20240116T231517",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Danaher (DHR) reachead $226.75 at the closing of the latest trading day, reflecting a +0.67% change compared to its last close.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default165.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.95493"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.11771,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.625937",
        "ticker_sentiment_score": "0.160845",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Charts turn bullish on health-care stocks as sector takes early lead in 2024",
    "url": "https://www.marketwatch.com/story/charts-turn-bullish-on-health-care-stocks-as-sector-takes-early-lead-in-2024-12272495",
    "time_published": "20240116T162900",
    "authors": [
      "Joseph Adinolfi"
    ],
    "summary": "Health-care stocks are off to a strong start in 2024, and Wall Street analysts are taking notice.",
    "banner_image": "https://images.mktw.net/im-735118/social",
    "source": "MarketWatch",
    "category_within_source": "Top Stories",
    "source_domain": "www.marketwatch.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.744043"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.342773,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MCK",
        "relevance_score": "0.15697",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "VTRS",
        "relevance_score": "0.15697",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LLY",
        "relevance_score": "0.15697",
        "ticker_sentiment_score": "0.294849",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ABBV",
        "relevance_score": "0.15697",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DXCM",
        "relevance_score": "0.15697",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "UNH",
        "relevance_score": "0.15697",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.15697",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Molecular Diagnostics Market Hits US$ 39.5 Billion in 2022, Expected to Reach US$ 59.4 Billion by 2033 with a 4.2% CAGR, Persistence Market Research",
    "url": "https://www.benzinga.com/pressreleases/24/01/g36643857/molecular-diagnostics-market-hits-us-39-5-billion-in-2022-expected-to-reach-us-59-4-billion-by-203",
    "time_published": "20240116T153000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "New York, Jan. 16, 2024 ( GLOBE NEWSWIRE ) -- The Molecular Diagnostics Market is experiencing robust growth due to technological advancements and increasing demand for personalized medicine. Key applications include oncology, infectious diseases, genetic testing, and cardiovascular diseases.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.263389,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "A",
        "relevance_score": "0.019797",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HOLX",
        "relevance_score": "0.019797",
        "ticker_sentiment_score": "-0.14516",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.019797",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.019797",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.019797",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BIO",
        "relevance_score": "0.019797",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GRFS",
        "relevance_score": "0.019797",
        "ticker_sentiment_score": "0.089741",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "QGEN",
        "relevance_score": "0.019797",
        "ticker_sentiment_score": "0.071657",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.019797",
        "ticker_sentiment_score": "0.132145",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Electron Microscope Market size to grow by USD 1.68 billion from 2022 to 2027; APAC to account for 55% of market ... - PR Newswire",
    "url": "https://www.prnewswire.com/news-releases/electron-microscope-market-size-to-grow-by-usd-1-68-billion-from-2022-to-2027-apac-to-account-for-55-of-market-growth--technavio-302034482.html",
    "time_published": "20240116T083500",
    "authors": [],
    "summary": "Electron Microscope Market size to grow by USD 1.68 billion from 2022 to 2027. APAC to account for 55% of market ... PR ...",
    "banner_image": null,
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.191608,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "A",
        "relevance_score": "0.051111",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HTHIF",
        "relevance_score": "0.051111",
        "ticker_sentiment_score": "0.107415",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NINOF",
        "relevance_score": "0.051111",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BRKR",
        "relevance_score": "0.051111",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVS",
        "relevance_score": "0.051111",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "OCPNF",
        "relevance_score": "0.051111",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.051111",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SNEJF",
        "relevance_score": "0.051111",
        "ticker_sentiment_score": "0.083468",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SSNLF",
        "relevance_score": "0.051111",
        "ticker_sentiment_score": "0.083468",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ADTTF",
        "relevance_score": "0.051111",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "KEYS",
        "relevance_score": "0.102013",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.102013",
        "ticker_sentiment_score": "0.092927",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TOPCF",
        "relevance_score": "0.051111",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TOSYY",
        "relevance_score": "0.051111",
        "ticker_sentiment_score": "0.083468",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Why Danaher  ( DHR )  is Poised to Beat Earnings Estimates Again",
    "url": "https://www.zacks.com/stock/news/2211645/why-danaher-dhr-is-poised-to-beat-earnings-estimates-again",
    "time_published": "20240117T171010",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Danaher (DHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default140.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.99998"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.310113,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.405215",
        "ticker_sentiment_score": "0.465736",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "$1000 Invested In Danaher 10 Years Ago Would Be Worth This Much Today - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/news/24/01/36697330/1000-invested-in-danaher-10-years-ago-would-be-worth-this-much-today",
    "time_published": "20240119T160040",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Danaher DHR has outperformed the market over the past 10 years by 5.9% on an annualized basis producing an average annual return of 15.99%. Currently, Danaher has a market capitalization of $168.79 billion.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_0.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.160819,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.983605",
        "ticker_sentiment_score": "0.387251",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "3M  ( MMM )  Gears Up to Post Q4 Earnings: Is a Beat in Store?",
    "url": "https://www.zacks.com/stock/news/2212826/3m-mmm-gears-up-to-post-q4-earnings-is-a-beat-in-store",
    "time_published": "20240119T144900",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "3M's (MMM) fourth-quarter 2023 results are likely to have gained from strength across its automotive OEM and medical solutions businesses. However, weak commercial solutions and transportation safety markets might have hurt its results.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/d9/573.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.99989"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.221833,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ITT",
        "relevance_score": "0.172097",
        "ticker_sentiment_score": "0.05804",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MMM",
        "relevance_score": "0.228073",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GE",
        "relevance_score": "0.172097",
        "ticker_sentiment_score": "0.096919",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.172097",
        "ticker_sentiment_score": "0.05804",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Can General Electric  ( GE )  Q4 Earnings Beat on Aerospace Boost?",
    "url": "https://www.zacks.com/stock/news/2213135/can-general-electric-ge-q4-earnings-beat-on-aerospace-boost",
    "time_published": "20240120T011800",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Strength in the Aerospace segment and accretive acquisitions are likely to aid General Electric's (GE) fourth-quarter 2023 results.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/fb/468.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.999973"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.157188,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ITT",
        "relevance_score": "0.104911",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MMM",
        "relevance_score": "0.104911",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GE",
        "relevance_score": "0.447091",
        "ticker_sentiment_score": "0.336135",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.104911",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Danaher  ( DHR )  Outpaces Stock Market Gains: What You Should Know",
    "url": "https://www.zacks.com/stock/news/2213810/danaher-dhr-outpaces-stock-market-gains-what-you-should-know",
    "time_published": "20240122T230017",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Danaher (DHR) reachead $231.97 at the closing of the latest trading day, reflecting a +0.4% change compared to its last close.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default36.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.95493"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.188592,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.570165",
        "ticker_sentiment_score": "0.256439",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Breast Biopsy Devices Market size to grow by USD 721.64 million from 2022 to 2027; North America accounts for 39 ... - PR Newswire",
    "url": "https://www.prnewswire.com/news-releases/breast-biopsy-devices-market-size-to-grow-by-usd-721-64-million-from-2022-to-2027-north-america-accounts-for-39-of-market-growth--technavio-302039676.html",
    "time_published": "20240122T103500",
    "authors": [],
    "summary": "Breast Biopsy Devices Market size to grow by USD 721.64 million from 2022 to 2027. North America accounts for 39 ... PR ...",
    "banner_image": null,
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.211322,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "HOLX",
        "relevance_score": "0.056674",
        "ticker_sentiment_score": "0.124941",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MMSI",
        "relevance_score": "0.056674",
        "ticker_sentiment_score": "0.124941",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.056674",
        "ticker_sentiment_score": "0.124941",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FUJIF",
        "relevance_score": "0.056674",
        "ticker_sentiment_score": "0.124941",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SEMHF",
        "relevance_score": "0.056674",
        "ticker_sentiment_score": "0.124941",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GE",
        "relevance_score": "0.056674",
        "ticker_sentiment_score": "0.124941",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.056674",
        "ticker_sentiment_score": "0.124941",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Danaher  ( DHR )  Expected to Beat Earnings Estimates: Can the Stock Move Higher?",
    "url": "https://www.zacks.com/stock/news/2214255/danaher-dhr-expected-to-beat-earnings-estimates-can-the-stock-move-higher",
    "time_published": "20240123T150030",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Danaher (DHR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default99.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.316726"
      }
    ],
    "overall_sentiment_score": 0.180143,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.299478",
        "ticker_sentiment_score": "0.15265",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Thermo Fisher Scientific appoints Srinath Venkatesh as MD for India and South Asia",
    "url": "https://www.financialexpress.com/healthcare/news-healthcare/thermo-fisher-scientific-appoints-srinath-venkatesh-as-md-for-india-and-south-asia/3372907/",
    "time_published": "20240123T104721",
    "authors": [
      "Health Desk"
    ],
    "summary": "Thermo Fisher Scientific on Tuesday announced the appointment of Srinath Venkatesh as Managing Director, India and South Asia, for the company. Srinath Venkatesh steps into this pivotal role with a vision to advance Thermo Fisher's growth and operations in India, while enhancing customer value ...",
    "banner_image": "https://www.financialexpress.com/wp-content/uploads/2024/01/Srinath-Venkatesh.jpg",
    "source": "The Financial Express",
    "category_within_source": "n/a",
    "source_domain": "www.financialexpress.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.482696,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.082111",
        "ticker_sentiment_score": "0.154358",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.319933",
        "ticker_sentiment_score": "0.518623",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Jim Cramer: Stay Away From This Major Airline Stock, 'People Should Understand Airlines Are Trades' - Delta Air Lines  ( NYSE:DAL ) , Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/trading-ideas/long-ideas/24/01/36752745/jim-cramer-stay-away-from-this-major-airline-stock-people-should-understand-airlines-are",
    "time_published": "20240124T135229",
    "authors": [
      "Avi Kapoor"
    ],
    "summary": "On CNBC's \"Mad Money Lightning Round,\" Jim Cramer recommended to stay away from Delta Air Lines, Inc. DAL. \"People should understand airlines are trades,\" he noted.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/01/24/jim-cramer2.jpg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.938793"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.097495,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "FLR",
        "relevance_score": "0.558244",
        "ticker_sentiment_score": "0.213605",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DAL",
        "relevance_score": "0.299478",
        "ticker_sentiment_score": "-0.124916",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ILMN",
        "relevance_score": "0.436009",
        "ticker_sentiment_score": "0.326787",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.436009",
        "ticker_sentiment_score": "0.326787",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Is Invesco Global Water ETF  ( PIO )  a Strong ETF Right Now?",
    "url": "https://www.zacks.com/stock/news/2214735/is-invesco-global-water-etf-pio-a-strong-etf-right-now",
    "time_published": "20240124T112006",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Smart Beta ETF report for PIO ...",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default180.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.999953"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.223024,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "VLTO",
        "relevance_score": "0.121037",
        "ticker_sentiment_score": "0.068013",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "IVZ",
        "relevance_score": "0.296582",
        "ticker_sentiment_score": "0.205886",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PNR",
        "relevance_score": "0.121037",
        "ticker_sentiment_score": "0.068013",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.121037",
        "ticker_sentiment_score": "0.068013",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Check Out What Whales Are Doing With DHR - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/options/24/01/36787076/check-out-what-whales-are-doing-with-dhr",
    "time_published": "20240125T183043",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Whales with a lot of money to spend have taken a noticeably bullish stance on Danaher. Looking at options history for Danaher DHR we detected 16 trades. If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with bullish expectations and 50% ...",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Markets",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.131167,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "VLTO",
        "relevance_score": "0.108958",
        "ticker_sentiment_score": "0.036952",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BCS",
        "relevance_score": "0.108958",
        "ticker_sentiment_score": "-0.121229",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.662393",
        "ticker_sentiment_score": "0.25558",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Seeking Clues to Danaher  ( DHR )  Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics",
    "url": "https://www.zacks.com/stock/news/2215696/seeking-clues-to-danaher-dhr-q4-earnings-a-peek-into-wall-street-projections-for-key-metrics",
    "time_published": "20240125T141524",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Beyond analysts' top -and-bottom-line estimates for Danaher (DHR), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default78.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.967321"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      }
    ],
    "overall_sentiment_score": 0.123065,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.487546",
        "ticker_sentiment_score": "0.031172",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Stocks Ease Despite Benign Inflation Data, Bitcoin Stages Comeback: What's Driving Markets Friday? - Broadcom  ( NASDAQ:AVGO ) , Advanced Micro Devices  ( NASDAQ:AMD ) ",
    "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/01/36806683/stocks-ease-despite-benign-inflation-data-bitcoin-stages-comeback-whats-driving-mar",
    "time_published": "20240126T181837",
    "authors": [
      "Piero Cingari"
    ],
    "summary": "Major stock indices were poised for a mixed session during midday trading in New York, with investors assessing another mild inflation report while taking note of personal spending growth that exceeded expectations.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/Wall-Street-sign_3.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Markets",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.2"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.2"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.2"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.2"
      },
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.918141"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.2"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.947132"
      },
      {
        "topic": "Economy - Macro",
        "relevance_score": "0.158519"
      }
    ],
    "overall_sentiment_score": 0.142978,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "AVGO",
        "relevance_score": "0.158519",
        "ticker_sentiment_score": "-0.178767",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "TXN",
        "relevance_score": "0.158519",
        "ticker_sentiment_score": "-0.178767",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "IVZ",
        "relevance_score": "0.079656",
        "ticker_sentiment_score": "0.168798",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.158519",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NEE",
        "relevance_score": "0.158519",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMUS",
        "relevance_score": "0.158519",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "QCOM",
        "relevance_score": "0.158519",
        "ticker_sentiment_score": "-0.178767",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "BX",
        "relevance_score": "0.158519",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "INTC",
        "relevance_score": "0.158519",
        "ticker_sentiment_score": "-0.347986",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "V",
        "relevance_score": "0.158519",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AMD",
        "relevance_score": "0.158519",
        "ticker_sentiment_score": "-0.178767",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "AXP",
        "relevance_score": "0.158519",
        "ticker_sentiment_score": "0.2248",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "CCZ",
        "relevance_score": "0.079656",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CRYPTO:BTC",
        "relevance_score": "0.235823",
        "ticker_sentiment_score": "0.345848",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Our life sciences name jumps on a rival's good fortune. What to expect from next week's earnings",
    "url": "https://www.cnbc.com/2024/01/26/danaher-jumps-on-a-rivals-good-fortune-what-to-expect-from-next-week-earnings.html",
    "time_published": "20240126T164922",
    "authors": [
      "Morgan Chittum"
    ],
    "summary": "The Investing Club holds its \"Morning Meeting\" every weekday at 10:20 a.m. ET.",
    "banner_image": "https://image.cnbcfm.com/api/v1/image/107365108-17062831101706283105-33064902205-1080pnbcnews.jpg?v=1706283109&w=600&h=300&vtcrop=y",
    "source": "CNBC",
    "category_within_source": "Top News",
    "source_domain": "www.cnbc.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.938793"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.495866"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.277537,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "EVR",
        "relevance_score": "0.183895",
        "ticker_sentiment_score": "0.178792",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.272788",
        "ticker_sentiment_score": "0.241103",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PANW",
        "relevance_score": "0.183895",
        "ticker_sentiment_score": "0.178792",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Danaher  ( DHR )  Gears Up to Post Q4 Earnings: Is a Beat in Store?",
    "url": "https://www.zacks.com/stock/news/2216359/danaher-dhr-gears-up-to-post-q4-earnings-is-a-beat-in-store",
    "time_published": "20240126T131000",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Danaher's (DHR) Q4 earnings are likely to have been hurt by weakness in the Biotechnology and Diagnostics units owing to lower sales of COVID-related products. Improving supply chains and strong price realization are expected to have been positives.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/58/4678.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.999999"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.120773,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ETN",
        "relevance_score": "0.107495",
        "ticker_sentiment_score": "0.151341",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "GFF",
        "relevance_score": "0.107495",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.500753",
        "ticker_sentiment_score": "0.114467",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Thyroid Function Test Market Expansion at 4.2% CAGR to US$ 2.5 Billion, Persistence Market Research",
    "url": "https://www.benzinga.com/pressreleases/24/01/g36796407/thyroid-function-test-market-expansion-at-4-2-cagr-to-us-2-5-billion-persistence-market-research",
    "time_published": "20240126T083519",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "New York, Jan. 26, 2024 ( GLOBE NEWSWIRE ) -- Thyroid Function Tests ( TFTs ) serve as diagnostic tools to assess the health and functionality of the thyroid gland, a crucial regulator of metabolism through hormone production.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.360656,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "HCSG",
        "relevance_score": "0.026562",
        "ticker_sentiment_score": "0.139962",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.053094",
        "ticker_sentiment_score": "0.321943",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.026562",
        "ticker_sentiment_score": "0.328355",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Specialty Medical Chairs Market Poised For Significant Growth In The Forecast Period - CAGR Is Expected To Be More Than 5% Through 2024-2028 As Per The Business Research Company's Specialty Medical Chairs Global Market Report 2024",
    "url": "https://www.benzinga.com/pressreleases/24/01/g36828228/specialty-medical-chairs-market-poised-for-significant-growth-in-the-forecast-period-cagr-is-expec",
    "time_published": "20240129T163000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "LONDON, Jan. 29, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Specialty Medical Chairs Global Market Report 2024, the specialty medical chairs market has witnessed substantial growth in recent years, with the market size set to reach $4.88 billion in 2024, marking a robust ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.332222,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "SYK",
        "relevance_score": "0.060236",
        "ticker_sentiment_score": "0.273198",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PBHDF",
        "relevance_score": "0.060236",
        "ticker_sentiment_score": "0.273198",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.060236",
        "ticker_sentiment_score": "0.273198",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Griffon  ( GFF )  to Report Q1 Earnings: Is a Beat in Store?",
    "url": "https://www.zacks.com/stock/news/2216964/griffon-gff-to-report-q1-earnings-is-a-beat-in-store",
    "time_published": "20240129T135600",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Griffon's (GFF) Q1 results are likely to gain from strength in the HBP segment. However, weakness in the CPP segment, along with higher marketing costs, is expected to have hurt its performance.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/d9/554.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.999756"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.174893,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "XYL",
        "relevance_score": "0.201803",
        "ticker_sentiment_score": "0.062135",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ETN",
        "relevance_score": "0.201803",
        "ticker_sentiment_score": "0.062135",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GFF",
        "relevance_score": "0.390904",
        "ticker_sentiment_score": "0.288443",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.201803",
        "ticker_sentiment_score": "0.049679",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Honeywell  ( HON )  Gears Up to Post Q4 Earnings: What to Expect?",
    "url": "https://www.zacks.com/stock/news/2216933/honeywell-hon-gears-up-to-post-q4-earnings-what-to-expect",
    "time_published": "20240129T133800",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Honeywell's (HON) fourth-quarter results are likely to have benefited from strength across its businesses. Weakness in the warehouse automation market and high costs and expenses might have been spoilsports.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/b6/1336.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.99989"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.263591,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "XYL",
        "relevance_score": "0.144853",
        "ticker_sentiment_score": "0.052017",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GFF",
        "relevance_score": "0.144853",
        "ticker_sentiment_score": "0.040839",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HON",
        "relevance_score": "0.329866",
        "ticker_sentiment_score": "0.230322",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.096866",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Why Danaher  ( DHR )  Might Surprise This Earnings Season",
    "url": "https://www.zacks.com/stock/news/2216930/why-danaher-dhr-might-surprise-this-earnings-season",
    "time_published": "20240129T133600",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Danaher (DHR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/58/4678.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.99237"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.463457,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.906257",
        "ticker_sentiment_score": "0.605993",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "DANAHER ALERT: Bragar Eagel & Squire, P.C. is Investigating Danaher Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/pressreleases/24/01/g36819193/danaher-alert-bragar-eagel-squire-p-c-is-investigating-danaher-corporation-on-behalf-of-long-term-",
    "time_published": "20240129T070000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "NEW YORK, Jan. 29, 2024 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Danaher Corporation DHR on behalf of long-term stockholders following a class action complaint that was filed against Danaher ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999499"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.538269"
      }
    ],
    "overall_sentiment_score": -0.050487,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.617346",
        "ticker_sentiment_score": "-0.09377",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "US Stocks Ease Ahead Of Key Tech Earnings, UPS Sinks, General Motors Rallies: What's Driving Markets Tuesday? - Advanced Micro Devices  ( NASDAQ:AMD ) , Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/01/36851993/us-stocks-ease-ahead-of-key-tech-earnings-ups-sinks-general-motors-rallies-whats-dr",
    "time_published": "20240130T183153",
    "authors": [
      "Piero Cingari"
    ],
    "summary": "Traders are adopting a more cautious stance toward the stock market on Tuesday as they await the earnings reports of major tech companies and the Federal Reserve Open Market Committee meeting scheduled for Wednesday.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/Wall-Street-sign_4.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Markets",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.77141"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.795202"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.166667"
      }
    ],
    "overall_sentiment_score": 0.01695,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MSFT",
        "relevance_score": "0.186738",
        "ticker_sentiment_score": "0.118924",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GOOG",
        "relevance_score": "0.09402",
        "ticker_sentiment_score": "0.084677",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LCID",
        "relevance_score": "0.186738",
        "ticker_sentiment_score": "0.217219",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "GM",
        "relevance_score": "0.09402",
        "ticker_sentiment_score": "0.3672",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "AMD",
        "relevance_score": "0.186738",
        "ticker_sentiment_score": "0.118924",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MSCI",
        "relevance_score": "0.186738",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SLB",
        "relevance_score": "0.09402",
        "ticker_sentiment_score": "-0.239865",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "UPS",
        "relevance_score": "0.186738",
        "ticker_sentiment_score": "-0.312421",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "IVZ",
        "relevance_score": "0.09402",
        "ticker_sentiment_score": "0.075287",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.186738",
        "ticker_sentiment_score": "-0.340731",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "FOREX:USD",
        "relevance_score": "0.09402",
        "ticker_sentiment_score": "0.100208",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Wall Street issues a bullish call on big banks. Here's what it says about our financial stocks",
    "url": "https://www.cnbc.com/2024/01/30/wall-street-issues-a-bullish-bank-call-what-it-says-about-our-financial-stocks.html",
    "time_published": "20240130T165432",
    "authors": [
      "Morgan Chittum"
    ],
    "summary": "The Investing Club holds its \"Morning Meeting\" every weekday at 10:20 a.m. ET.",
    "banner_image": "https://image.cnbcfm.com/api/v1/image/107366375-17066287631706628758-33120377042-1080pnbcnews.jpg?v=1706628762&w=600&h=300&vtcrop=y",
    "source": "CNBC",
    "category_within_source": "Top News",
    "source_domain": "www.cnbc.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.25"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.25"
      },
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.25"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.967645"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.714479"
      }
    ],
    "overall_sentiment_score": 0.189913,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MSFT",
        "relevance_score": "0.241284",
        "ticker_sentiment_score": "0.14884",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SBUX",
        "relevance_score": "0.162255",
        "ticker_sentiment_score": "0.110697",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WFC",
        "relevance_score": "0.162255",
        "ticker_sentiment_score": "0.110697",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MS",
        "relevance_score": "0.241284",
        "ticker_sentiment_score": "0.14884",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.317869",
        "ticker_sentiment_score": "0.184845",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Life Science Giant Danaher Warns Of Sales Decline In 2024; Says 'Pandemic Has Transitioned To An Endemic State' Life Science Giant Danaher Stock Is Trading Higher Today - What's Going On? - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/news/earnings/24/01/36849423/life-science-giant-danaher-warns-of-sales-decline-in-2024-says-pandemic-has-transitioned-to-an-ende",
    "time_published": "20240130T162615",
    "authors": [
      "Vandana Singh"
    ],
    "summary": "Tuesday, Danaher Corp DHR reported a fourth-quarter 2023 adjusted EPS of $2.09, down from $2.54 a year ago, surpassing the consensus of $1.89. Sales decreased 10% Y/Y to $6.4 billion, beating the consensus of $6.09 billion. Non-GAAP core revenue decreased 11.5%, including a 4.5% non-GAAP base ...",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/Danaher.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999967"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": -0.033421,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.491878",
        "ticker_sentiment_score": "0.180061",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Danaher  ( DHR )  Q4 Earnings Beat, Biotechnology Sales Dip Y/Y",
    "url": "https://www.zacks.com/stock/news/2218073/danaher-dhr-q4-earnings-beat-biotechnology-sales-dip-yy",
    "time_published": "20240130T160800",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "While Danaher (DHR) surpasses Q4 earnings and revenue estimates, its performance is hurt by a decrease in the sale of COVID-related products and weak demand in the Biotechnology segment.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/58/4678.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.976671"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.044859,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ITT",
        "relevance_score": "0.162802",
        "ticker_sentiment_score": "0.130894",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FLS",
        "relevance_score": "0.162802",
        "ticker_sentiment_score": "0.116144",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CR",
        "relevance_score": "0.108958",
        "ticker_sentiment_score": "0.091595",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.548805",
        "ticker_sentiment_score": "-0.072999",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Danaher  ( DHR )  Surpasses Q4 Earnings and Revenue Estimates",
    "url": "https://www.zacks.com/stock/news/2217649/danaher-dhr-surpasses-q4-earnings-and-revenue-estimates",
    "time_published": "20240130T121004",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Danaher (DHR) delivered earnings and revenue surprises of 10% and 6.93%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default355.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.999997"
      }
    ],
    "overall_sentiment_score": 0.179756,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "HON",
        "relevance_score": "0.206392",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.399204",
        "ticker_sentiment_score": "0.197229",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Director Declaration",
    "url": "https://www.globenewswire.com/news-release/2024/01/30/2819739/0/en/Director-Declaration.html",
    "time_published": "20240130T112200",
    "authors": [
      "PayPoint plc"
    ],
    "summary": "30 January ...",
    "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/01c8cd71-2417-44ba-b4a3-462b7db307c0",
    "source": "GlobeNewswire",
    "category_within_source": "n/a",
    "source_domain": "www.globenewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.061378,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ABCZF",
        "relevance_score": "0.407844",
        "ticker_sentiment_score": "0.126308",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HLMAF",
        "relevance_score": "0.716023",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SNIRF",
        "relevance_score": "0.407844",
        "ticker_sentiment_score": "0.126308",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.407844",
        "ticker_sentiment_score": "0.126308",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Danaher Analysts Increase Their Forecasts After Upbeat Earnings - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/news/earnings/24/01/36870765/danaher-analysts-increase-their-forecasts-after-upbeat-earnings",
    "time_published": "20240131T163955",
    "authors": [
      "Avi Kapoor"
    ],
    "summary": "Danaher Corporation DHR posted better-than-expected fourth-quarter financial results on Tuesday. Danaher reported a fourth-quarter 2023 adjusted EPS of $2.09, down from $2.54 a year ago, surpassing the consensus of $1.89, according to data from Benzinga Pro.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/01/31/danaher_-_logo.jpg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999956"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.155715,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.827318",
        "ticker_sentiment_score": "0.268308",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Stocks With Rising Relative Strength: Danaher",
    "url": "https://www.investors.com/ibd-data-stories/stocks-with-rising-relative-strength-danaher-3/",
    "time_published": "20240131T080000",
    "authors": [
      "INVESTOR'S BUSINESS DAILY",
      "Investor's Business Daily"
    ],
    "summary": "In a welcome move, Danaher ( DHR ) saw its Relative Strength Rating rise from 70 to 78 on Wednesday. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength. IBD's unique rating identifies market leadership with a 1 ( worst ) to 99 ( best ) ...",
    "banner_image": "https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg",
    "source": "Investors Business Daily",
    "category_within_source": "n/a",
    "source_domain": "www.investors.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.374197,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.89979",
        "ticker_sentiment_score": "0.547939",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Markel's  ( MKL )  Q4 Earnings Beat, Revenues Lag Estimates",
    "url": "https://www.zacks.com/stock/news/2219806/markels-mkl-q4-earnings-beat-revenues-lag-estimates",
    "time_published": "20240201T182800",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Markel's (MKL) fourth-quarter results reflect improved earned premiums and increased net investment income.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/5d/41051.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.905476"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.988787"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.112809,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "GE",
        "relevance_score": "0.147818",
        "ticker_sentiment_score": "0.119494",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HON",
        "relevance_score": "0.098862",
        "ticker_sentiment_score": "0.194663",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.098862",
        "ticker_sentiment_score": "-0.020469",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MKL",
        "relevance_score": "0.423843",
        "ticker_sentiment_score": "0.41828",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "AT&T To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday - Boston Scientific  ( NYSE:BSX ) , Cigna Group  ( NYSE:CI ) ",
    "url": "https://www.benzinga.com/news/24/02/36886194/at-t-to-rally-around-19-here-are-10-top-analyst-forecasts-for-thursday",
    "time_published": "20240201T124820",
    "authors": [
      "Avi Kapoor"
    ],
    "summary": "Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Needham raised the price target for Boston Scientific Corporation BSX from $60 to $71.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/02/01/att_-_logo.jpg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.752319"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.25"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.25"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.25"
      }
    ],
    "overall_sentiment_score": 0.172357,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "EXTR",
        "relevance_score": "0.242084",
        "ticker_sentiment_score": "-0.113337",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PSX",
        "relevance_score": "0.242084",
        "ticker_sentiment_score": "0.312106",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "T",
        "relevance_score": "0.162802",
        "ticker_sentiment_score": "0.27572",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.242084",
        "ticker_sentiment_score": "0.216608",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "CI",
        "relevance_score": "0.162802",
        "ticker_sentiment_score": "0.229926",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PAGS",
        "relevance_score": "0.242084",
        "ticker_sentiment_score": "-0.031516",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CNMD",
        "relevance_score": "0.242084",
        "ticker_sentiment_score": "0.109592",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NYCB",
        "relevance_score": "0.242084",
        "ticker_sentiment_score": "0.014804",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.242084",
        "ticker_sentiment_score": "-0.156489",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "ROK",
        "relevance_score": "0.242084",
        "ticker_sentiment_score": "0.123366",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Danaher  ( NYSE:DHR )  Downgraded by StockNews.com to Hold",
    "url": "https://www.defenseworld.net/2024/02/01/danaher-nysedhr-downgraded-by-stocknews-com-to-hold.html",
    "time_published": "20240201T103842",
    "authors": [
      "Defense World Staff"
    ],
    "summary": "StockNews.com lowered shares of Danaher ( NYSE:DHR - Free Report ) from a buy rating to a hold rating in a research report sent to investors on Wednesday.",
    "banner_image": "https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&Symbol=DHR",
    "source": "Stocknews.com",
    "category_within_source": "n/a",
    "source_domain": "www.defenseworld.net",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.723405"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.94762"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.195464,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "STT",
        "relevance_score": "0.110462",
        "ticker_sentiment_score": "0.196359",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BCS",
        "relevance_score": "0.055364",
        "ticker_sentiment_score": "-0.008996",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RBCPF",
        "relevance_score": "0.055364",
        "ticker_sentiment_score": "-0.008996",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GS",
        "relevance_score": "0.055364",
        "ticker_sentiment_score": "-0.008996",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WFC",
        "relevance_score": "0.055364",
        "ticker_sentiment_score": "-0.008996",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.835133",
        "ticker_sentiment_score": "0.340278",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Top Stock Reports for Eli Lilly, Danaher & Citigroup",
    "url": "https://www.zacks.com/research-daily/2220146/top-stock-reports-for-eli-lilly-danaher-citigroup",
    "time_published": "20240202T215900",
    "authors": [
      "Mark Vickery"
    ],
    "summary": "Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Danaher Corporation (DHR) and Citigroup Inc. (C).",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/af/51929.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.260398,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "LLY",
        "relevance_score": "0.298264",
        "ticker_sentiment_score": "0.202381",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "C",
        "relevance_score": "0.101582",
        "ticker_sentiment_score": "0.158795",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ABCZF",
        "relevance_score": "0.101582",
        "ticker_sentiment_score": "0.183981",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.298264",
        "ticker_sentiment_score": "0.097043",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Novo Nordisk buys three plants for $11 billion to boost Wegovy output",
    "url": "https://www.business-standard.com/world-news/novo-nordisk-buys-three-plants-for-11-billion-to-boost-wegovy-output-124020600004_1.html",
    "time_published": "20240205T183134",
    "authors": [
      "Bloomberg"
    ],
    "summary": "Novo Nordisk A/S struck a deal that will allow the Danish drugmaker to respond to surging demand for its weight-loss drug Wegovy and diabetes treatment Ozempic. Novo's biggest shareholder is buying Catalent Inc., one of the world's biggest drug-manufacturing companies, for $16.5 billion, ...",
    "banner_image": "https://bsmedia.business-standard.com/_media/bs/img/article/2024-02/05/full/1707157742-4299.jpg?im=FeatureCrop,size=(826,465)",
    "source": "Business Standard",
    "category_within_source": "GoogleRSS",
    "source_domain": "www.business-standard.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      }
    ],
    "overall_sentiment_score": 0.162009,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MRNA",
        "relevance_score": "0.06623",
        "ticker_sentiment_score": "0.130555",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CTLT",
        "relevance_score": "0.381949",
        "ticker_sentiment_score": "0.157111",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DNSKF",
        "relevance_score": "0.06623",
        "ticker_sentiment_score": "0.120242",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVO",
        "relevance_score": "0.132004",
        "ticker_sentiment_score": "0.061966",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.06623",
        "ticker_sentiment_score": "0.140995",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Bioprocess Technology Market Size to Hit USD 53.7 billion by 2031, at a 8.3% CAGR - Report Transparency Market Research, Inc.",
    "url": "https://www.benzinga.com/pressreleases/24/02/g36936562/bioprocess-technology-market-size-to-hit-usd-53-7-billion-by-2031-at-a-8-3-cagr-report-transparenc",
    "time_published": "20240205T165000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, Feb. 05, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global bioprocess technology market is estimated to flourish at a CAGR of 8.3% from 2021 to 2031.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.929393"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.37305,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GOOG",
        "relevance_score": "0.03478",
        "ticker_sentiment_score": "0.05005",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AHKSF",
        "relevance_score": "0.03478",
        "ticker_sentiment_score": "0.069473",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SUVPF",
        "relevance_score": "0.069495",
        "ticker_sentiment_score": "0.235549",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.104078",
        "ticker_sentiment_score": "0.195664",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.104078",
        "ticker_sentiment_score": "0.264462",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BIO",
        "relevance_score": "0.03478",
        "ticker_sentiment_score": "0.069473",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.104078",
        "ticker_sentiment_score": "0.079878",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ASBRF",
        "relevance_score": "0.03478",
        "ticker_sentiment_score": "0.069473",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GE",
        "relevance_score": "0.138464",
        "ticker_sentiment_score": "0.297897",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.069495",
        "ticker_sentiment_score": "0.240753",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SIELY",
        "relevance_score": "0.03478",
        "ticker_sentiment_score": "0.069473",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "3D Optical Microscope Market to grow by USD 113.04 million from 2022 to 2027, Increasing funding for RandD to drive ... - PR Newswire",
    "url": "https://www.prnewswire.com/news-releases/3d-optical-microscope-market-to-grow-by--usd-113-04-million-from-2022-to-2027--increasing-funding-for-randd-to-drive-growth--technavio-302052797.html",
    "time_published": "20240205T142400",
    "authors": [],
    "summary": "3D Optical Microscope Market to grow by USD 113.04 million from 2022 to 2027, Increasing funding for RandD to drive ... PR ...",
    "banner_image": null,
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.129783,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "KLAC",
        "relevance_score": "0.088799",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "A",
        "relevance_score": "0.088799",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "KYCCF",
        "relevance_score": "0.088799",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HTHIF",
        "relevance_score": "0.088799",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NINOF",
        "relevance_score": "0.088799",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BRKR",
        "relevance_score": "0.088799",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AME",
        "relevance_score": "0.088799",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "OCPNF",
        "relevance_score": "0.088799",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.088799",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "The Zacks Analyst Blog Highlights Eli Lilly, Danaher, Citigroup, Shopify and Canadian Pacific Kansas",
    "url": "https://www.zacks.com/stock/news/2220682/the-zacks-analyst-blog-highlights-eli-lilly-danaher-citigroup-shopify-and-canadian-pacific-kansas",
    "time_published": "20240205T095000",
    "authors": [
      "Zacks Investment Research"
    ],
    "summary": "Eli Lilly, Danaher, Citigroup, Shopify and Canadian Pacific Kansas are included in this Analyst Blog.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/33/496.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.25"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.25"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.25"
      }
    ],
    "overall_sentiment_score": 0.221674,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "LLY",
        "relevance_score": "0.423843",
        "ticker_sentiment_score": "0.162899",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SHOP",
        "relevance_score": "0.147818",
        "ticker_sentiment_score": "0.038811",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "C",
        "relevance_score": "0.220141",
        "ticker_sentiment_score": "0.051533",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABCZF",
        "relevance_score": "0.07423",
        "ticker_sentiment_score": "0.169296",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "CP",
        "relevance_score": "0.147818",
        "ticker_sentiment_score": "0.038811",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.423843",
        "ticker_sentiment_score": "0.105431",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Passenger Vehicle Telematics Market to grow by USD 24.78 billion from 2022 to 2027, OEM push for embedded ... - PR Newswire",
    "url": "https://www.prnewswire.com/news-releases/passenger-vehicle-telematics-market-to-grow-by-usd-24-78-billion-from-2022-to-2027--oem-push-for-embedded-telematics-systems-in-bric-nations-to-boost-the-growth---technavio-302052732.html",
    "time_published": "20240205T080000",
    "authors": [],
    "summary": "Passenger Vehicle Telematics Market to grow by USD 24.78 billion from 2022 to 2027, OEM push for embedded ... PR ...",
    "banner_image": null,
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.27994,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "TRMB",
        "relevance_score": "0.061315",
        "ticker_sentiment_score": "0.061021",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "VZ",
        "relevance_score": "0.061315",
        "ticker_sentiment_score": "0.061021",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "VOD",
        "relevance_score": "0.061315",
        "ticker_sentiment_score": "0.061021",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GRMN",
        "relevance_score": "0.061315",
        "ticker_sentiment_score": "0.061021",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "VC",
        "relevance_score": "0.061315",
        "ticker_sentiment_score": "0.061021",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DXC",
        "relevance_score": "0.061315",
        "ticker_sentiment_score": "0.061021",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BRDCF",
        "relevance_score": "0.061315",
        "ticker_sentiment_score": "0.061021",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CTTAF",
        "relevance_score": "0.061315",
        "ticker_sentiment_score": "0.061021",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.061315",
        "ticker_sentiment_score": "0.061021",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "VLEEF",
        "relevance_score": "0.061315",
        "ticker_sentiment_score": "0.061021",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Here's How Much You Would Have Made Owning Danaher Stock In The Last 10 Years - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/news/24/02/36960070/heres-how-much-you-would-have-made-owning-danaher-stock-in-the-last-10-years",
    "time_published": "20240206T163020",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Danaher DHR has outperformed the market over the past 10 years by 6.61% on an annualized basis producing an average annual return of 17.08%. Currently, Danaher has a market capitalization of $181.10 billion.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_0.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.160819,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.983605",
        "ticker_sentiment_score": "0.387251",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Carlisle  ( CSL )  Q4 Earnings Beat Estimates, Revenues Decline Y/Y",
    "url": "https://www.zacks.com/stock/news/2222679/carlisle-csl-q4-earnings-beat-estimates-revenues-decline-yy",
    "time_published": "20240207T151800",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Carlisle (CSL) fourth-quarter 2023 results benefit from higher revenues across the Carlisle Construction Materials segment.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default256.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.96136"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.092527,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MMM",
        "relevance_score": "0.127795",
        "ticker_sentiment_score": "0.183383",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "CSL",
        "relevance_score": "0.370602",
        "ticker_sentiment_score": "0.301559",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "GE",
        "relevance_score": "0.127795",
        "ticker_sentiment_score": "0.074364",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.127795",
        "ticker_sentiment_score": "-0.022677",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Forensic Technologies Market Revenue to Cross USD 87.4 billion by 2028| Transparency Market Research, Inc.",
    "url": "https://www.benzinga.com/pressreleases/24/02/g36970809/forensic-technologies-market-revenue-to-cross-usd-87-4-billion-by-2028-transparency-market-researc",
    "time_published": "20240207T011500",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, Feb. 06, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global forensic technologies market is estimated to flourish at a CAGR of 13.2% from 2021 to 2028.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      }
    ],
    "overall_sentiment_score": 0.282523,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "A",
        "relevance_score": "0.068502",
        "ticker_sentiment_score": "0.047744",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GOOG",
        "relevance_score": "0.034282",
        "ticker_sentiment_score": "0.049937",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SHMZF",
        "relevance_score": "0.034282",
        "ticker_sentiment_score": "-0.023432",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.102595",
        "ticker_sentiment_score": "0.059714",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NEOG",
        "relevance_score": "0.068502",
        "ticker_sentiment_score": "0.386127",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.102595",
        "ticker_sentiment_score": "0.079525",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ERFSF",
        "relevance_score": "0.034282",
        "ticker_sentiment_score": "0.186317",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.034282",
        "ticker_sentiment_score": "0.091143",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Straits Research forecasts that the Global Macrofiltration Market revenue will surge to USD 12,436.47 million by 2031, with a steady Compound Annual Growth Rate  ( CAGR )  of 6.0%",
    "url": "https://www.benzinga.com/pressreleases/24/02/g37011449/straits-research-forecasts-that-the-global-macrofiltration-market-revenue-will-surge-to-usd-12-436",
    "time_published": "20240208T155000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "New York, United States, Feb. 08, 2024 ( GLOBE NEWSWIRE ) -- Macrofiltration is extracting from water solid non-solvent particles larger than 1.0 microns. Particles are filtered when they travel through a porous medium or membrane. In hard and unclean water, solid particles are suspended.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.200723,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "PH",
        "relevance_score": "0.03642",
        "ticker_sentiment_score": "0.050408",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "META",
        "relevance_score": "0.03642",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PNR",
        "relevance_score": "0.03642",
        "ticker_sentiment_score": "0.050408",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WTII",
        "relevance_score": "0.072765",
        "ticker_sentiment_score": "0.073979",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.03642",
        "ticker_sentiment_score": "0.050408",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "ITT Q4 Earnings In Line With Estimates, Revenues Increase Y/Y",
    "url": "https://www.zacks.com/stock/news/2224216/itt-q4-earnings-in-line-with-estimates-revenues-increase-yy",
    "time_published": "20240209T160100",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "ITT's Q4 revenues increase 7% year over year, driven by higher Friction original equipment volumes in the Motion Technologies segment and pricing actions in the Connect & Control Technologies segment.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default56.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.995869"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.221929,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ITT",
        "relevance_score": "0.313104",
        "ticker_sentiment_score": "0.192178",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MMM",
        "relevance_score": "0.091684",
        "ticker_sentiment_score": "0.163779",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.091684",
        "ticker_sentiment_score": "-0.020052",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Molecular Cytogenetics Market is Expected to Reach $4.9 Billion | MarketsandMarkets\u2122",
    "url": "https://www.benzinga.com/pressreleases/24/02/g37031674/molecular-cytogenetics-market-is-expected-to-reach-4-9-billion-marketsandmarkets",
    "time_published": "20240209T123000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Chicago, Feb. 09, 2024 ( GLOBE NEWSWIRE ) -- Molecular Cytogenetics market in terms of revenue was estimated to be worth $3.1 billion in 2023 and is poised to reach $4.9 billion by 2028, growing at a CAGR of 9.9% from 2023 to 2028 according to a latest report published by MarketsandMarkets\u2122.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.142737,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "A",
        "relevance_score": "0.045224",
        "ticker_sentiment_score": "0.048006",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TECH",
        "relevance_score": "0.045224",
        "ticker_sentiment_score": "0.048006",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.045224",
        "ticker_sentiment_score": "0.048006",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "OCX",
        "relevance_score": "0.045224",
        "ticker_sentiment_score": "0.048006",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ILMN",
        "relevance_score": "0.045224",
        "ticker_sentiment_score": "0.048006",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.045224",
        "ticker_sentiment_score": "0.048006",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BIO",
        "relevance_score": "0.045224",
        "ticker_sentiment_score": "0.048006",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.045224",
        "ticker_sentiment_score": "0.048006",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Replace The Flawed 25X Retirement Rule With A Better CEF Strategy",
    "url": "https://www.forbes.com/sites/michaelfoster/2024/02/13/this-25x-retirement-rule-is-a-mess/",
    "time_published": "20240213T145400",
    "authors": [
      "Michael Foster"
    ],
    "summary": "One of the worst investing mistakes you can make in planning for your financial future is following the 25X rule. Consider a recent article by Bankrate which is as simple as it is deceptive. This piece tells us that you \"should have 25 times the annual amount you plan to spend in retirement saved ...",
    "banner_image": "https://imageio.forbes.com/specials-images/imageserve/65c39c0aba742165742f58ce/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds",
    "source": "Forbes",
    "category_within_source": "n/a",
    "source_domain": "www.forbes.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.918141"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.122174,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MSFT",
        "relevance_score": "0.11983",
        "ticker_sentiment_score": "0.149663",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SNEJF",
        "relevance_score": "0.11983",
        "ticker_sentiment_score": "0.149663",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "STRR",
        "relevance_score": "0.060085",
        "ticker_sentiment_score": "0.132006",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "UNH",
        "relevance_score": "0.11983",
        "ticker_sentiment_score": "0.149663",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "V",
        "relevance_score": "0.11983",
        "ticker_sentiment_score": "0.149663",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.11983",
        "ticker_sentiment_score": "0.149663",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Behind the Scenes of Danaher's Latest Options Trends - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/options/24/02/37137209/behind-the-scenes-of-danahers-latest-options-trends",
    "time_published": "20240214T200143",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Whales with a lot of money to spend have taken a noticeably bullish stance on Danaher. Looking at options history for Danaher DHR we detected 12 trades. If we consider the specifics of each trade, it is accurate to state that 66% of the investors opened trades with bullish expectations and 33% ...",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Markets",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.316726"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.124359,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "VLTO",
        "relevance_score": "0.090474",
        "ticker_sentiment_score": "0.03517",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BCS",
        "relevance_score": "0.090474",
        "ticker_sentiment_score": "-0.186365",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "C",
        "relevance_score": "0.090474",
        "ticker_sentiment_score": "0.098555",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.827318",
        "ticker_sentiment_score": "0.230379",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "GSK ADR Clears Technical Benchmark, Hitting 80-Plus RS Rating",
    "url": "https://www.investors.com/ibd-data-stories/gsk-adr-clears-technical-benchmark-hitting-80-plus-rs-rating-2/",
    "time_published": "20240214T080000",
    "authors": [
      "Investor's Business Daily",
      "INVESTOR'S BUSINESS DAILY"
    ],
    "summary": "When looking for the best stocks to buy and watch, focus on those with rising relative price strength. One stock that fits that bill is GSK ADR ( GSK ) , which had its Relative Strength ( RS ) Rating upgraded from 76 to 82 Wednesday.",
    "banner_image": "https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg",
    "source": "Investors Business Daily",
    "category_within_source": "n/a",
    "source_domain": "www.investors.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.360215"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      }
    ],
    "overall_sentiment_score": 0.349693,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.318897",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Engaging In Options Activity, Georgeann Couchara Exercises Options Valued At $465K In Danaher - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/news/24/02/37159852/engaging-in-options-activity-georgeann-couchara-exercises-options-valued-at-465k-in-danaher",
    "time_published": "20240215T150129",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "A substantial insider activity was disclosed on February 14, as Couchara, SVP at Danaher DHR, reported the exercise of a large sell of company stock options. What Happened: A Form 4 filing with the U.S.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/insider_image_4.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.993856"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.995077"
      }
    ],
    "overall_sentiment_score": 0.245028,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "VLTO",
        "relevance_score": "0.064797",
        "ticker_sentiment_score": "0.034019",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.430716",
        "ticker_sentiment_score": "0.473289",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Larry Culp Has Revived GE's Stock. He's About To Make His Next Move.",
    "url": "https://www.forbes.com/sites/jimosman/2024/02/19/larry-culp-has-revived-ges-stock-hes-about-to-make-his-next-move/",
    "time_published": "20240219T203010",
    "authors": [
      "Jim Osman"
    ],
    "summary": "General Electric ( GE ) has undergone extensive reorganization and strategic realignment during Larry Culp's leadership, with the goals of stabilizing the corporation and guiding it towards profitability and growth.",
    "banner_image": "https://imageio.forbes.com/specials-images/imageserve/65d390da1cf56ff96f73131d/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds",
    "source": "Forbes",
    "category_within_source": "n/a",
    "source_domain": "www.forbes.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.288956,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GE",
        "relevance_score": "0.7887",
        "ticker_sentiment_score": "0.476217",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.02493",
        "ticker_sentiment_score": "0.204908",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Preparative and Process Chromatography Research Report 2023",
    "url": "https://www.prnewswire.com/news-releases/preparative-and-process-chromatography-research-report-2023-302064986.html",
    "time_published": "20240219T174500",
    "authors": [
      "Research and Markets"
    ],
    "summary": "DUBLIN, Feb. 19, 2024 /PRNewswire/ -- The \"Preparative and Process Chromatography Market by Type ( Preparative Chromatography ( Chemicals & Reagents, Resins ( Affinity, HIC, Ion Exchange ) , Columns, Systems, Services ) , Process Chromatography ) , End User ( Pharma, Biotech ) & Region - Global ...",
    "banner_image": "https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg?p=facebook",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      }
    ],
    "overall_sentiment_score": 0.258927,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BIO",
        "relevance_score": "0.060388",
        "ticker_sentiment_score": "0.116005",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SUVPF",
        "relevance_score": "0.060388",
        "ticker_sentiment_score": "0.116005",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.060388",
        "ticker_sentiment_score": "0.116005",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.060388",
        "ticker_sentiment_score": "0.116005",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Microarray Scanners Market Size Estimated to Reach US$ 1.7 billion, Rising at a CAGR of 7.5% by 2031: Transparency Market Research, Inc.",
    "url": "https://www.benzinga.com/pressreleases/24/02/g37209171/microarray-scanners-market-size-estimated-to-reach-us-1-7-billion-rising-at-a-cagr-of-7-5-by-2031-",
    "time_published": "20240220T123000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, Feb. 20, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global microarray scanners market is estimated to flourish at a CAGR of 7.5% from 2023 to 2031.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.302594,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "A",
        "relevance_score": "0.131105",
        "ticker_sentiment_score": "0.137997",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GOOG",
        "relevance_score": "0.032916",
        "ticker_sentiment_score": "0.049617",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ARRY",
        "relevance_score": "0.032916",
        "ticker_sentiment_score": "0.242588",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ILMN",
        "relevance_score": "0.098524",
        "ticker_sentiment_score": "0.168928",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.098524",
        "ticker_sentiment_score": "0.192634",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BIO",
        "relevance_score": "0.065775",
        "ticker_sentiment_score": "0.166976",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.098524",
        "ticker_sentiment_score": "0.106282",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GE",
        "relevance_score": "0.065775",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.032916",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Unpacking the Latest Options Trading Trends in Danaher - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/options/24/02/37268722/unpacking-the-latest-options-trading-trends-in-danaher",
    "time_published": "20240222T184552",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "High-rolling investors have positioned themselves bearish on Danaher DHR, and it's important for retail traders to take note. \\This activity came to our attention today through Benzinga's tracking of publicly available options data.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Markets",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.155817,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "VLTO",
        "relevance_score": "0.084127",
        "ticker_sentiment_score": "0.034731",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BCS",
        "relevance_score": "0.084127",
        "ticker_sentiment_score": "-0.183852",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "C",
        "relevance_score": "0.084127",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.795061",
        "ticker_sentiment_score": "0.268729",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "The Zacks Analyst Blog Highlights Alphabet, Bank of America, Advanced Micro Devices, Danaher and TJX",
    "url": "https://www.zacks.com/stock/news/2229801/the-zacks-analyst-blog-highlights-alphabet-bank-of-america-advanced-micro-devices-danaher-and-tjx",
    "time_published": "20240222T090500",
    "authors": [
      "Zacks Investment Research"
    ],
    "summary": "Alphabet, Bank of America, Advanced Micro Devices, Danaher and TJX are included in this Analyst Blog.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/20/444.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.2"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.2"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.2"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.2"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.2"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.360215"
      }
    ],
    "overall_sentiment_score": 0.320724,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "AMD",
        "relevance_score": "0.402403",
        "ticker_sentiment_score": "0.315019",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "GOOG",
        "relevance_score": "0.139669",
        "ticker_sentiment_score": "0.040016",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TJX",
        "relevance_score": "0.139669",
        "ticker_sentiment_score": "0.040016",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BAC",
        "relevance_score": "0.208166",
        "ticker_sentiment_score": "0.052488",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.139669",
        "ticker_sentiment_score": "0.040016",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Industrial Gas Phase Filtration System Market size to grow by USD 615.45 million from 2022 to 2027, Camfil AB, Circul ... - PR Newswire",
    "url": "https://www.prnewswire.com/news-releases/industrial-gas-phase-filtration-system-market-size-to-grow-by-usd-615-45-million-from-2022-to-2027--camfil-ab-circul-aire-inc-cosmos-air-purification-to-emerge-as-some-of-the-key-companies-technavio-302068744.html",
    "time_published": "20240223T082400",
    "authors": [],
    "summary": "Industrial Gas Phase Filtration System Market size to grow by USD 615.45 million from 2022 to 2027, Camfil AB, Circul ... PR ...",
    "banner_image": null,
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.335517,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DKILF",
        "relevance_score": "0.038843",
        "ticker_sentiment_score": "0.08393",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JCI",
        "relevance_score": "0.038843",
        "ticker_sentiment_score": "0.08393",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.038843",
        "ticker_sentiment_score": "0.08393",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "DANAHER ALERT: Bragar Eagel & Squire, P.C. is Investigating Danaher Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/pressreleases/24/02/g37304853/danaher-alert-bragar-eagel-squire-p-c-is-investigating-danaher-corporation-on-behalf-of-long-term-",
    "time_published": "20240226T020000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "NEW YORK, Feb. 25, 2024 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Danaher Corporation DHR on behalf of long-term stockholders following a class action complaint that was filed against Danaher ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999499"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.538269"
      }
    ],
    "overall_sentiment_score": -0.050487,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.617346",
        "ticker_sentiment_score": "-0.09377",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Danaher's Spun-Off Company Veralto Is \"Next High-Quality Serial Compounder\" - Analyst - Veralto  ( NYSE:VLTO ) ",
    "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/02/37345008/danahers-spun-off-company-veralto-is-next-high-quality-serial-compounder-analyst",
    "time_published": "20240227T191534",
    "authors": [
      "Lekha Gupta"
    ],
    "summary": "BMO Capital Markets analyst John P. McNulty initiated coverage on Veralto Corporation VLTO at an Outperform rating with a price target of $97. The analyst says the company is poised for strong EPS growth in the next 2-3 years, led by recovery in its two secular growth businesses- Water Quality ...",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/VLTO.png?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.858979"
      },
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.459462"
      }
    ],
    "overall_sentiment_score": 0.263093,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "VLTO",
        "relevance_score": "0.913524",
        "ticker_sentiment_score": "0.392128",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.392948",
        "ticker_sentiment_score": "0.178217",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Why the Market Dipped But Danaher  ( DHR )  Gained Today",
    "url": "https://www.zacks.com/stock/news/2233469/why-the-market-dipped-but-danaher-dhr-gained-today",
    "time_published": "20240228T230006",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Danaher (DHR) reachead $255.71 at the closing of the latest trading day, reflecting a +0.33% change compared to its last close.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default261.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.961735"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.138678,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.545136",
        "ticker_sentiment_score": "0.066863",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "$1000 Invested In Danaher 10 Years Ago Would Be Worth This Much Today - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/news/24/02/37363358/1000-invested-in-danaher-10-years-ago-would-be-worth-this-much-today",
    "time_published": "20240228T140018",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Danaher DHR has outperformed the market over the past 10 years by 6.95% on an annualized basis producing an average annual return of 17.37%. Currently, Danaher has a market capitalization of $188.25 billion.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_0.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.160819,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.983605",
        "ticker_sentiment_score": "0.387251",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Why Is Danaher  ( DHR )  Up 6.6% Since Last Earnings Report?",
    "url": "https://www.zacks.com/stock/news/2234031/why-is-danaher-dhr-up-66-since-last-earnings-report",
    "time_published": "20240229T163040",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Danaher (DHR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default52.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.986413"
      }
    ],
    "overall_sentiment_score": 0.049713,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "GE",
        "relevance_score": "0.185306",
        "ticker_sentiment_score": "0.074347",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.480769",
        "ticker_sentiment_score": "0.113817",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Transfection Technologies Market is Expected to Reach $1.8 Billion | MarketsandMarkets\u2122",
    "url": "https://www.benzinga.com/pressreleases/24/02/g37390067/transfection-technologies-market-is-expected-to-reach-1-8-billion-marketsandmarkets",
    "time_published": "20240229T123000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Chicago, Feb. 29, 2024 ( GLOBE NEWSWIRE ) -- Transfection Technologies market in terms of revenue was estimated to be worth $1.2 billion in 2023 and is poised to reach $1.8 billion by 2028, growing at a CAGR of 9.4% from 2023 to 2028 according to a latest report published by MarketsandMarkets\u2122.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.238825,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "A",
        "relevance_score": "0.03792",
        "ticker_sentiment_score": "0.029564",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SUVPF",
        "relevance_score": "0.03792",
        "ticker_sentiment_score": "0.029564",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "STMM",
        "relevance_score": "0.03792",
        "ticker_sentiment_score": "0.029564",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.03792",
        "ticker_sentiment_score": "0.029564",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BIO",
        "relevance_score": "0.03792",
        "ticker_sentiment_score": "0.029564",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "QGEN",
        "relevance_score": "0.03792",
        "ticker_sentiment_score": "0.029564",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.03792",
        "ticker_sentiment_score": "0.029564",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Is Trending Stock Danaher Corporation  ( DHR )  a Buy Now?",
    "url": "https://www.zacks.com/stock/news/2234484/is-trending-stock-danaher-corporation-dhr-a-buy-now",
    "time_published": "20240301T140012",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Danaher (DHR) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default231.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999999"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.54554"
      }
    ],
    "overall_sentiment_score": 0.250246,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.489394",
        "ticker_sentiment_score": "0.185906",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Biopharmaceutical Fermentation Systems Market Projected to Reach USD 52.6 billion by 2031, with a CAGR of 9.5%: Report by Transparency Market Research Inc.",
    "url": "https://www.benzinga.com/pressreleases/24/03/g37413606/biopharmaceutical-fermentation-systems-market-projected-to-reach-usd-52-6-billion-by-2031-with-a-c",
    "time_published": "20240301T063200",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, March 01, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global biopharmaceutical fermentation systems market is projected to grow at a CAGR of 9.5% from 2023 to 2031.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.684621"
      }
    ],
    "overall_sentiment_score": 0.199972,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GOOG",
        "relevance_score": "0.036926",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SDMHF",
        "relevance_score": "0.036926",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.110462",
        "ticker_sentiment_score": "0.037501",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.036926",
        "ticker_sentiment_score": "0.210295",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.036926",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Spatial Genomics & Transcriptomics Market Anticipated to Reach USD 2 billion, Rising at a CAGR of 17% by 2033: Transparency Market Research, Inc.",
    "url": "https://www.benzinga.com/pressreleases/24/03/g37457436/spatial-genomics-transcriptomics-market-anticipated-to-reach-usd-2-billion-rising-at-a-cagr-of-17-",
    "time_published": "20240304T143000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, March 04, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global spatial genomics & transcriptomics market is estimated to flourish at a CAGR of 17% from 2023 to 2033.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      }
    ],
    "overall_sentiment_score": 0.350779,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DTST",
        "relevance_score": "0.065957",
        "ticker_sentiment_score": "0.13718",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GOOG",
        "relevance_score": "0.033006",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TECH",
        "relevance_score": "0.033006",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TXG",
        "relevance_score": "0.033006",
        "ticker_sentiment_score": "0.10449",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ILMN",
        "relevance_score": "0.033006",
        "ticker_sentiment_score": "0.10449",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BIO",
        "relevance_score": "0.033006",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NSTGQ",
        "relevance_score": "0.033006",
        "ticker_sentiment_score": "0.10449",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AKYA",
        "relevance_score": "0.098794",
        "ticker_sentiment_score": "0.141882",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.098794",
        "ticker_sentiment_score": "0.080811",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.033006",
        "ticker_sentiment_score": "0.20985",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Soundcore Capital Partners Appoints Brian Pfeifer as President of Door & Dock Holdings",
    "url": "https://www.prnewswire.com/news-releases/soundcore-capital-partners-appoints-brian-pfeifer-as-president-of-door--dock-holdings-302077759.html",
    "time_published": "20240304T140000",
    "authors": [
      "Soundcore Capital Partners"
    ],
    "summary": "NEW YORK, March 4, 2024 /PRNewswire/ -- Soundcore Capital Partners, LP ( \"Soundcore\" ) , a New York-based private equity firm specializing in buy-and-build investments in the lower middle-market, is pleased to announce the appointment of Brian Pfeifer as President of Door & Dock Holdings, LLC ( ...",
    "banner_image": "https://mma.prnewswire.com/media/1796474/Logo__eps_Logo.jpg?p=facebook",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.87644"
      }
    ],
    "overall_sentiment_score": 0.391267,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.06211",
        "ticker_sentiment_score": "0.127047",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Tome Biosciences Forms Science and Technology Advisory Committee",
    "url": "https://www.benzinga.com/pressreleases/24/03/g37453306/tome-biosciences-forms-science-and-technology-advisory-committee",
    "time_published": "20240304T130000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "WATERTOWN, Mass., March 04, 2024 ( GLOBE NEWSWIRE ) -- Tome Biosciences, Inc., the programmable genomic integration ( PGI ) company, announces the formation of its Science and Technology Advisory Committee ( STAC ) comprised of four leaders in the delivery, development and manufacturing of ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.094121,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "HON",
        "relevance_score": "0.032469",
        "ticker_sentiment_score": "0.058091",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PFE",
        "relevance_score": "0.032469",
        "ticker_sentiment_score": "0.058091",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.032469",
        "ticker_sentiment_score": "0.029329",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Should You Invest in the Invesco Water Resources ETF  ( PHO ) ?",
    "url": "https://www.zacks.com/stock/news/2235047/should-you-invest-in-the-invesco-water-resources-etf-pho",
    "time_published": "20240304T112007",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Sector ETF report for PHO ...",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default252.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "1.0"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.184464,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "SPGI",
        "relevance_score": "0.193723",
        "ticker_sentiment_score": "0.198666",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "VLTO",
        "relevance_score": "0.129866",
        "ticker_sentiment_score": "0.070234",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FERG",
        "relevance_score": "0.129866",
        "ticker_sentiment_score": "0.070234",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "IVZ",
        "relevance_score": "0.317254",
        "ticker_sentiment_score": "0.178731",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.129866",
        "ticker_sentiment_score": "0.070234",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Danaher  ( DHR )  Stock Moves -0.7%: What You Should Know",
    "url": "https://www.zacks.com/stock/news/2236341/danaher-dhr-stock-moves--07-what-you-should-know",
    "time_published": "20240305T230011",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Danaher (DHR) reachead $254.39 at the closing of the latest trading day, reflecting a -0.7% change compared to its last close.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default2.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.961735"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      }
    ],
    "overall_sentiment_score": 0.161267,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.613743",
        "ticker_sentiment_score": "0.179956",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "General Electric To Split Into Two On April 2",
    "url": "https://www.forbes.com/sites/joecornell/2024/03/05/ge-massively-outperforms-the-index-as-spin-off-unlocks-value/",
    "time_published": "20240305T181854",
    "authors": [
      "Joe Cornell"
    ],
    "summary": "Brief Backdrop on GE Stock Performance Before 2021 Spin-off Announcements In the 2000s, GE's expansion was spurred by GE Capital's success, the company's financial arm, along with the company's diversification strategy.",
    "banner_image": "https://imageio.forbes.com/specials-images/imageserve/65e75d67685fb8b22a6273fe/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds",
    "source": "Forbes",
    "category_within_source": "n/a",
    "source_domain": "www.forbes.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.25"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.25"
      },
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "1.0"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.25"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.158519"
      }
    ],
    "overall_sentiment_score": 0.256731,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ECIFF",
        "relevance_score": "0.014988",
        "ticker_sentiment_score": "0.059641",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WFC",
        "relevance_score": "0.014988",
        "ticker_sentiment_score": "-0.022798",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BX",
        "relevance_score": "0.014988",
        "ticker_sentiment_score": "-0.022798",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MHVYF",
        "relevance_score": "0.014988",
        "ticker_sentiment_score": "0.00089",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BKR",
        "relevance_score": "0.014988",
        "ticker_sentiment_score": "0.08712",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PH",
        "relevance_score": "0.014988",
        "ticker_sentiment_score": "0.00089",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MSBHF",
        "relevance_score": "0.014988",
        "ticker_sentiment_score": "0.00089",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GE",
        "relevance_score": "0.972042",
        "ticker_sentiment_score": "0.442789",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.014988",
        "ticker_sentiment_score": "0.042424",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Should You Invest in the Invesco Global Water ETF  ( PIO ) ?",
    "url": "https://www.zacks.com/stock/news/2235759/should-you-invest-in-the-invesco-global-water-etf-pio",
    "time_published": "20240305T112007",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Sector ETF report for PIO ...",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default86.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.999999"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.214172,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "VLTO",
        "relevance_score": "0.138863",
        "ticker_sentiment_score": "0.072689",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "IVZ",
        "relevance_score": "0.338119",
        "ticker_sentiment_score": "0.168023",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PNR",
        "relevance_score": "0.138863",
        "ticker_sentiment_score": "0.072689",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.138863",
        "ticker_sentiment_score": "0.072689",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Stem Cell Manufacturing Market Worth USD 26.6 billion, Growing At 9.2% CAGR by 2033 - Report By Transparency Market Research, Inc.",
    "url": "https://www.benzinga.com/pressreleases/24/03/g37528867/stem-cell-manufacturing-market-worth-usd-26-6-billion-growing-at-9-2-cagr-by-2033-report-by-transp",
    "time_published": "20240307T095900",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, March 07, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. -The global stem cell manufacturing market is estimated to flourish at a CAGR of 9.2% from 2023 to 2033.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.796627"
      }
    ],
    "overall_sentiment_score": 0.371649,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GOOG",
        "relevance_score": "0.033562",
        "ticker_sentiment_score": "0.052617",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SUVPF",
        "relevance_score": "0.067064",
        "ticker_sentiment_score": "0.185644",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.033562",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "STMM",
        "relevance_score": "0.067064",
        "ticker_sentiment_score": "0.195114",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.067064",
        "ticker_sentiment_score": "0.195114",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BIO",
        "relevance_score": "0.033562",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FUJIF",
        "relevance_score": "0.033562",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LZAGF",
        "relevance_score": "0.067064",
        "ticker_sentiment_score": "0.203035",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.100448",
        "ticker_sentiment_score": "0.078162",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.033562",
        "ticker_sentiment_score": "0.114243",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Protein Expression Market size to grow by USD 2.45 billion from 2023 to 2027, North America accounts for 37% of ... - PR Newswire",
    "url": "https://www.prnewswire.com/news-releases/protein-expression-market-size-to-grow-by-usd-2-45-billion-from-2023-to-2027--north-america-accounts-for-37-of-market-growth-technavio-302083091.html",
    "time_published": "20240308T224800",
    "authors": [],
    "summary": "Protein Expression Market size to grow by USD 2.45 billion from 2023 to 2027, North America accounts for 37% of ... PR ...",
    "banner_image": null,
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.265097,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "A",
        "relevance_score": "0.064885",
        "ticker_sentiment_score": "0.024012",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SUVPF",
        "relevance_score": "0.032469",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.032469",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GNNSF",
        "relevance_score": "0.032469",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.032469",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BIO",
        "relevance_score": "0.032469",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "QGEN",
        "relevance_score": "0.032469",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AMGN",
        "relevance_score": "0.032469",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PFE",
        "relevance_score": "0.032469",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.032469",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Why Danaher  ( DHR )  Dipped More Than Broader Market Today",
    "url": "https://www.zacks.com/stock/news/2238938/why-danaher-dhr-dipped-more-than-broader-market-today",
    "time_published": "20240311T221521",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Danaher (DHR) closed the most recent trading day at $252.80, moving -0.35% from the previous trading session.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default1.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.986564"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      }
    ],
    "overall_sentiment_score": 0.222922,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.548363",
        "ticker_sentiment_score": "0.208277",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Danaher  ( DHR )  Gains But Lags Market: What You Should Know",
    "url": "https://www.zacks.com/stock/news/2239588/danaher-dhr-gains-but-lags-market-what-you-should-know",
    "time_published": "20240312T220019",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Danaher (DHR) reachead $253.10 at the closing of the latest trading day, reflecting a +0.12% change compared to its last close.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default18.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.976913"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.316726"
      }
    ],
    "overall_sentiment_score": 0.26044,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.540358",
        "ticker_sentiment_score": "0.313839",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Japan In-Vitro Diagnostics Market Analysis Report 2024-2030: Strategic Partnerships Drive Innovations, Tumor Marker Testing Gains Momentum",
    "url": "https://www.prnewswire.com/news-releases/japan-in-vitro-diagnostics-market-analysis-report-2024-2030-strategic-partnerships-drive-innovations-tumor-marker-testing-gains-momentum-302085636.html",
    "time_published": "20240312T023000",
    "authors": [
      "Research and Markets"
    ],
    "summary": "Japan In-Vitro Diagnostics Market Analysis Report 2024-2030: Strategic Partnerships Drive Innovations, Tumor Marker ... PR ...",
    "banner_image": "https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg?p=facebook",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.204707,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BMXMF",
        "relevance_score": "0.258351",
        "ticker_sentiment_score": "0.226323",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ONTTF",
        "relevance_score": "0.05257",
        "ticker_sentiment_score": "0.117906",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.05257",
        "ticker_sentiment_score": "0.117906",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SSMXF",
        "relevance_score": "0.258351",
        "ticker_sentiment_score": "0.226323",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.05257",
        "ticker_sentiment_score": "0.117906",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.05257",
        "ticker_sentiment_score": "0.117906",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Top 7 Biotech Winners Of Novo Nordisk, Eli Lilly's Outsourcing Strategy For Weight-Loss Drugs: Goldman Sachs - Agilent Technologies  ( NYSE:A ) , Avantor  ( NYSE:AVTR ) ",
    "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/03/37668318/top-7-biotech-winners-of-novo-nordisk-eli-lillys-outsourcing-strategy-for-weight-lo",
    "time_published": "20240313T163538",
    "authors": [
      "Piero Cingari"
    ],
    "summary": "Goldman Sachs analysts identified a substantial opportunity in the manufacturing sector for new obesity therapeutics, as demand for these treatments escalates. Goldman Sachs projects the global obesity market to potentially reach $100 billion by 2030, with a more optimistic outlook suggesting it ...",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/Genetic-Research-And-Biotech-Science-Con_3.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.276455,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "A",
        "relevance_score": "0.080728",
        "ticker_sentiment_score": "0.114066",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WUXAY",
        "relevance_score": "0.160633",
        "ticker_sentiment_score": "0.139069",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVO",
        "relevance_score": "0.31482",
        "ticker_sentiment_score": "0.072735",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "APG",
        "relevance_score": "0.080728",
        "ticker_sentiment_score": "0.107571",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LLY",
        "relevance_score": "0.238913",
        "ticker_sentiment_score": "0.03309",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GS",
        "relevance_score": "0.387674",
        "ticker_sentiment_score": "0.279985",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "AVTR",
        "relevance_score": "0.238913",
        "ticker_sentiment_score": "0.189468",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.238913",
        "ticker_sentiment_score": "0.34917",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Danaher  ( DHR )  Benefits From Business Strength Amid Risks",
    "url": "https://www.zacks.com/stock/news/2240039/danaher-dhr-benefits-from-business-strength-amid-risks",
    "time_published": "20240313T142300",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Danaher (DHR) gains from strength in academic and life science research markets, Abcam buyout and pro-investor policies. However, softness in its Biotechnology and Diagnostics units is concerning.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/58/4678.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.769861"
      }
    ],
    "overall_sentiment_score": 0.275182,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "VGR",
        "relevance_score": "0.15697",
        "ticker_sentiment_score": "0.168503",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ABCZF",
        "relevance_score": "0.07887",
        "ticker_sentiment_score": "0.282644",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "CSL",
        "relevance_score": "0.233556",
        "ticker_sentiment_score": "0.181274",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "GFF",
        "relevance_score": "0.15697",
        "ticker_sentiment_score": "0.130492",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.627119",
        "ticker_sentiment_score": "0.475258",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "UNTC",
        "relevance_score": "0.07887",
        "ticker_sentiment_score": "0.269286",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Global In Vitro Toxicology Testing Market Size is projected to reach USD 28.19 billion by 2031, growing at a CAGR of 10.8%: Straits Research",
    "url": "https://www.benzinga.com/pressreleases/24/03/g37656766/global-in-vitro-toxicology-testing-market-size-is-projected-to-reach-usd-28-19-billion-by-2031-gro",
    "time_published": "20240313T123000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "New York, United States, March 13, 2024 ( GLOBE NEWSWIRE ) -- In Vitro toxicology testing is used to determine the toxicity of a substance on non-living cells or tissues. It is a crucial component of preclinical safety evaluation in the pharmaceutical, chemical, and regulatory industries.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.152705,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "A",
        "relevance_score": "0.03319",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "META",
        "relevance_score": "0.03319",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.03319",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DGX",
        "relevance_score": "0.03319",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CTLT",
        "relevance_score": "0.03319",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BIO",
        "relevance_score": "0.03319",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CRL",
        "relevance_score": "0.03319",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LH",
        "relevance_score": "0.03319",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ERFSF",
        "relevance_score": "0.03319",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.03319",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Danaher's Options Frenzy: What You Need to Know - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/options/24/03/37758040/danahers-options-frenzy-what-you-need-to-know",
    "time_published": "20240315T193122",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Whales with a lot of money to spend have taken a noticeably bearish stance on Danaher. Looking at options history for Danaher DHR we detected 8 trades. If we consider the specifics of each trade, it is accurate to state that 37% of the investors opened trades with bullish expectations and 62% ...",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Markets",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.189732,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "VLTO",
        "relevance_score": "0.109455",
        "ticker_sentiment_score": "0.037009",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.729067",
        "ticker_sentiment_score": "0.164336",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Here's How Much $1000 Invested In Danaher 5 Years Ago Would Be Worth Today - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/news/24/03/37747455/heres-how-much-1000-invested-in-danaher-5-years-ago-would-be-worth-today",
    "time_published": "20240315T140033",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Danaher DHR has outperformed the market over the past 5 years by 4.4% on an annualized basis producing an average annual return of 16.94%. Currently, Danaher has a market capitalization of $186.08 billion.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_1.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.238974,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.95919",
        "ticker_sentiment_score": "0.384695",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Is Invesco Water Resources ETF  ( PHO )  a Strong ETF Right Now?",
    "url": "https://www.zacks.com/stock/news/2241160/is-invesco-water-resources-etf-pho-a-strong-etf-right-now",
    "time_published": "20240315T102005",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Smart Beta ETF report for PHO ...",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default25.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.999953"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.249165,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "SPGI",
        "relevance_score": "0.174167",
        "ticker_sentiment_score": "0.184158",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "VLTO",
        "relevance_score": "0.116631",
        "ticker_sentiment_score": "0.060259",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FERG",
        "relevance_score": "0.116631",
        "ticker_sentiment_score": "0.060259",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "IVZ",
        "relevance_score": "0.286193",
        "ticker_sentiment_score": "0.244637",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.116631",
        "ticker_sentiment_score": "0.060259",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Why Danaher  ( DHR )  Outpaced the Stock Market Today",
    "url": "https://www.zacks.com/stock/news/2242515/why-danaher-dhr-outpaced-the-stock-market-today",
    "time_published": "20240318T221517",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "The latest trading day saw Danaher (DHR) settling at $251.47, representing a +0.83% change from its previous close.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default78.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.95493"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.221875,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.615462",
        "ticker_sentiment_score": "0.318566",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Silvernail Elected International Paper Chief Executive Officer - PR Newswire",
    "url": "https://www.prnewswire.com/news-releases/silvernail-elected-international-paper-chief-executive-officer-302092838.html",
    "time_published": "20240319T131500",
    "authors": [],
    "summary": "Silvernail Elected International Paper Chief Executive Officer PR ...",
    "banner_image": null,
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.360215"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.25"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.25"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.25"
      }
    ],
    "overall_sentiment_score": 0.512037,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BAC",
        "relevance_score": "0.060694",
        "ticker_sentiment_score": "0.115008",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SYK",
        "relevance_score": "0.060694",
        "ticker_sentiment_score": "0.057",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "IEX",
        "relevance_score": "0.121037",
        "ticker_sentiment_score": "0.064599",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.060694",
        "ticker_sentiment_score": "0.057",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "IP",
        "relevance_score": "0.852019",
        "ticker_sentiment_score": "0.732576",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Danaher  ( DHR )  Stock Declines While Market Improves: Some Information for Investors",
    "url": "https://www.zacks.com/stock/news/2243768/danaher-dhr-stock-declines-while-market-improves-some-information-for-investors",
    "time_published": "20240320T220018",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "The latest trading day saw Danaher (DHR) settling at $251.68, representing a -0.81% change from its previous close.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default210.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.95493"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      }
    ],
    "overall_sentiment_score": 0.269848,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.545136",
        "ticker_sentiment_score": "0.360492",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Here is What to Know Beyond Why Danaher Corporation  ( DHR )  is a Trending Stock",
    "url": "https://www.zacks.com/stock/news/2243982/here-is-what-to-know-beyond-why-danaher-corporation-dhr-is-a-trending-stock",
    "time_published": "20240321T130011",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Zacks.com users have recently been watching Danaher (DHR) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default72.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999999"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.54554"
      }
    ],
    "overall_sentiment_score": 0.234857,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.482982",
        "ticker_sentiment_score": "0.184387",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Point of Care Diagnostics Market is Expected to Reach $77.8 billion | MarketsandMarkets\u2122",
    "url": "https://www.benzinga.com/pressreleases/24/03/g37889705/point-of-care-diagnostics-market-is-expected-to-reach-77-8-billion-marketsandmarkets",
    "time_published": "20240322T123000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Chicago, March 22, 2024 ( GLOBE NEWSWIRE ) -- Point of Care Diagnostics market in terms of revenue was estimated to be worth $49.7 billion in 2023 and is poised to reach $77.8 billion by 2028, growing at a CAGR of 9.4% from 2023 to 2028 according to a latest report published by ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.285736,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BMXMF",
        "relevance_score": "0.037622",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TRIB",
        "relevance_score": "0.037622",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.037622",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "EKDHF",
        "relevance_score": "0.037622",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.037622",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.037622",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.037622",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "QDEL",
        "relevance_score": "0.037622",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "If You Invested $100 In This Stock 10 Years Ago, You Would Have $500 Today - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/news/24/03/37914362/if-you-invested-100-in-this-stock-10-years-ago-you-would-have-500-today",
    "time_published": "20240325T140031",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Danaher DHR has outperformed the market over the past 10 years by 6.72% on an annualized basis producing an average annual return of 17.41%. Currently, Danaher has a market capitalization of $188.46 billion.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_0.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.238974,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.95919",
        "ticker_sentiment_score": "0.384695",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Danaher  ( DHR )  Gains As Market Dips: What You Should Know",
    "url": "https://www.zacks.com/stock/news/2246357/danaher-dhr-gains-as-market-dips-what-you-should-know",
    "time_published": "20240326T221519",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Danaher (DHR) reachead $248.46 at the closing of the latest trading day, reflecting a +0.27% change compared to its last close.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default46.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.986564"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      }
    ],
    "overall_sentiment_score": 0.126127,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.52949",
        "ticker_sentiment_score": "0.094363",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Looking Into Danaher's Recent Short Interest - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/short-sellers/24/03/37944602/looking-into-danahers-recent-short-interest",
    "time_published": "20240326T191521",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Danaher's DHR short percent of float has fallen 5.38% since its last report. The company recently reported that it has 5.80 million shares sold short, which is 0.88% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.37 days to cover their ...",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.264538,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.212115",
        "ticker_sentiment_score": "0.081887",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Boeing needs to act faster to find its next CEO",
    "url": "https://www.moneycontrol.com/news/opinion/boeing-needs-to-act-faster-to-find-its-next-ceo-12522831.html",
    "time_published": "20240326T065705",
    "authors": [],
    "summary": "Boeing had been struggling with serious quality issues dating back to the two tragic crashes of the 737 Max, but the final straw came when workers failed to put the bolts on the fuselage panel of an Alaska Airlines aircraft. It can't afford a drawn-out transition, certainly not until December.",
    "banner_image": "https://images.moneycontrol.com/static-mcnews/2024/02/BeFunky-collage-2024-02-27T133449.301-378x213.jpg?impolicy=website&width=168&height=118",
    "source": "Money Control",
    "category_within_source": "Economy",
    "source_domain": "www.moneycontrol.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      },
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.158519"
      }
    ],
    "overall_sentiment_score": 0.136774,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "FTV",
        "relevance_score": "0.053153",
        "ticker_sentiment_score": "0.239816",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "VRT",
        "relevance_score": "0.10607",
        "ticker_sentiment_score": "-0.011075",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GE",
        "relevance_score": "0.451494",
        "ticker_sentiment_score": "0.340123",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "HON",
        "relevance_score": "0.053153",
        "ticker_sentiment_score": "0.020004",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BA",
        "relevance_score": "0.495015",
        "ticker_sentiment_score": "0.229749",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.053153",
        "ticker_sentiment_score": "0.239816",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Danaher  ( DHR )  Rises Yet Lags Behind Market: Some Facts Worth Knowing",
    "url": "https://www.zacks.com/stock/news/2246997/danaher-dhr-rises-yet-lags-behind-market-some-facts-worth-knowing",
    "time_published": "20240327T220021",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Danaher (DHR) reachead $248.77 at the closing of the latest trading day, reflecting a +0.12% change compared to its last close.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default307.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.95493"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.217,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.636698",
        "ticker_sentiment_score": "0.27159",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Danaher Options Trading: A Deep Dive into Market Sentiment - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/options/24/03/37963485/danaher-options-trading-a-deep-dive-into-market-sentiment",
    "time_published": "20240327T160104",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Investors with significant funds have taken a bullish position in Danaher DHR, a development that retail traders should be aware of. This was brought to our attention today through our monitoring of publicly accessible options data at Benzinga.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Markets",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.187823,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "VLTO",
        "relevance_score": "0.103778",
        "ticker_sentiment_score": "0.036383",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.703273",
        "ticker_sentiment_score": "0.26315",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Wall Street Analysts See Danaher  ( DHR )  as a Buy: Should You Invest?",
    "url": "https://www.zacks.com/stock/news/2246601/wall-street-analysts-see-danaher-dhr-as-a-buy-should-you-invest",
    "time_published": "20240327T133011",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "According to the average brokerage recommendation (ABR), one should invest in Danaher (DHR). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default288.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.890401"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.459462"
      }
    ],
    "overall_sentiment_score": 0.290785,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.363768",
        "ticker_sentiment_score": "0.172996",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Who can fix Boeing? Here are some potential CEO candidates | Business",
    "url": "https://www.cnn.com/2024/03/27/business/boeing-ceo-successor-choices/index.html",
    "time_published": "20240327T100000",
    "authors": [
      "Chris Isidore"
    ],
    "summary": "Who can fix Boeing? Here are some potential CEO candidates ...",
    "banner_image": "https://media.cnn.com/api/v1/images/stellar/prod/gettyimages-1953489234.jpg?c=16x9&q=w_800,c_fill",
    "source": "CNN",
    "category_within_source": "Markets",
    "source_domain": "www.cnn.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.25"
      },
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.25"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.25"
      }
    ],
    "overall_sentiment_score": 0.012002,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "NOC",
        "relevance_score": "0.020509",
        "ticker_sentiment_score": "0.175294",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BAC",
        "relevance_score": "0.020509",
        "ticker_sentiment_score": "0.0645",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SPR",
        "relevance_score": "0.061473",
        "ticker_sentiment_score": "0.008034",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DSSMY",
        "relevance_score": "0.061473",
        "ticker_sentiment_score": "-0.00801",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GM",
        "relevance_score": "0.061473",
        "ticker_sentiment_score": "-0.111226",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WBD",
        "relevance_score": "0.041004",
        "ticker_sentiment_score": "-0.007892",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AAL",
        "relevance_score": "0.020509",
        "ticker_sentiment_score": "0.165752",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "GE",
        "relevance_score": "0.30021",
        "ticker_sentiment_score": "0.074594",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BA",
        "relevance_score": "0.671363",
        "ticker_sentiment_score": "0.045002",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.020509",
        "ticker_sentiment_score": "0.013201",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Is Invesco Global Water ETF  ( PIO )  a Strong ETF Right Now?",
    "url": "https://www.zacks.com/stock/news/2247096/is-invesco-global-water-etf-pio-a-strong-etf-right-now",
    "time_published": "20240328T102006",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Smart Beta ETF report for PIO ...",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default323.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.999992"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.229461,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "VLTO",
        "relevance_score": "0.125134",
        "ticker_sentiment_score": "0.069019",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "IVZ",
        "relevance_score": "0.306198",
        "ticker_sentiment_score": "0.198254",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PNR",
        "relevance_score": "0.125134",
        "ticker_sentiment_score": "0.069019",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.125134",
        "ticker_sentiment_score": "0.069019",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Boeing Need A Rockstar CEO; Larry Culp Fits The Bill",
    "url": "https://www.forbes.com/sites/jimosman/2024/03/29/boeing-need-a-rockstar-ceo-larry-culp-fits-the-bill/",
    "time_published": "20240329T204225",
    "authors": [
      "Jim Osman"
    ],
    "summary": "Boeing Need A Rockstar CEO. Larry Culp Fits The Bill Forbes ...",
    "banner_image": "https://imageio.forbes.com/specials-images/imageserve/1180437964/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds",
    "source": "Forbes",
    "category_within_source": "n/a",
    "source_domain": "www.forbes.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Economy - Fiscal",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.145233,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "GIC",
        "relevance_score": "0.028023",
        "ticker_sentiment_score": "-0.034832",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GE",
        "relevance_score": "0.539306",
        "ticker_sentiment_score": "0.20632",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BA",
        "relevance_score": "0.401759",
        "ticker_sentiment_score": "0.324841",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.056011",
        "ticker_sentiment_score": "0.049053",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Global Sample Preparation Market Analysis and Outlook 2023-2030 Featuring Profiles of Agilent Technologies, Bio-Rad Labs, Danaher Corp, Illumina, Merck, and Other Key Players",
    "url": "https://www.prnewswire.com/news-releases/global-sample-preparation-market-analysis-and-outlook-2023-2030-featuring-profiles-of-agilent-technologies-bio-rad-labs-danaher-corp-illumina-merck-and-other-key-players-302101618.html",
    "time_published": "20240329T103000",
    "authors": [
      "Research and Markets"
    ],
    "summary": "Global Sample Preparation Market Analysis and Outlook 2023-2030 Featuring Profiles of Agilent Technologies, Bio ... PR ...",
    "banner_image": "https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg?p=facebook",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.1877,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "A",
        "relevance_score": "0.041682",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BIO",
        "relevance_score": "0.041682",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "QGEN",
        "relevance_score": "0.041682",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ILMN",
        "relevance_score": "0.041682",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.041682",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.083251",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Danaher  ( DHR )  Suffers a Larger Drop Than the General Market: Key Insights",
    "url": "https://www.zacks.com/stock/news/2249455/danaher-dhr-suffers-a-larger-drop-than-the-general-market-key-insights",
    "time_published": "20240402T221518",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "In the closing of the recent trading day, Danaher (DHR) stood at $245.94, denoting a -0.75% change from the preceding trading day.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default181.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.986564"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.182136,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.651499",
        "ticker_sentiment_score": "0.192766",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "3M  ( MMM )  Completes Divestiture of Its Healthcare Business",
    "url": "https://www.zacks.com/stock/news/2249069/3m-mmm-completes-divestiture-of-its-healthcare-business",
    "time_published": "20240402T133600",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "3M's (MMM) divestment of the healthcare business will enable it to focus more on its core businesses.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/84/473.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.316726"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.769861"
      },
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.158519"
      }
    ],
    "overall_sentiment_score": 0.220528,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MMM",
        "relevance_score": "0.269776",
        "ticker_sentiment_score": "0.224377",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "CSL",
        "relevance_score": "0.269776",
        "ticker_sentiment_score": "0.241558",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "GFF",
        "relevance_score": "0.181819",
        "ticker_sentiment_score": "0.070441",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.181819",
        "ticker_sentiment_score": "-0.034227",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "GE Aerospace  ( GE )  Debuts as Aviation-Focused Public Company",
    "url": "https://www.zacks.com/stock/news/2250048/ge-aerospace-ge-debuts-as-aviation-focused-public-company",
    "time_published": "20240403T170500",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "GE Aerospace (GE) commences its business operations as an independent public company, following the spin-off of the GE Vernova business from General Electric.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/cf/75.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.769861"
      },
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.158519"
      }
    ],
    "overall_sentiment_score": 0.224096,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "CSL",
        "relevance_score": "0.249531",
        "ticker_sentiment_score": "0.227235",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "GE",
        "relevance_score": "0.956005",
        "ticker_sentiment_score": "0.446483",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "GFF",
        "relevance_score": "0.167904",
        "ticker_sentiment_score": "0.066615",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.167904",
        "ticker_sentiment_score": "-0.032345",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Atom Power Appoints New CEO as Company Enters Next Phase of Growth",
    "url": "https://www.benzinga.com/pressreleases/24/04/g38066569/atom-power-appoints-new-ceo-as-company-enters-next-phase-of-growth",
    "time_published": "20240403T120000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "CHARLOTTE, N.C., April 03, 2024 ( GLOBE NEWSWIRE ) -- Atom Power, the pioneer in solid-state digital circuit breaker technology, today announced that Mr. Bharat Vats has been appointed as the company's President & CEO effective immediately.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.533809,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GE",
        "relevance_score": "0.068896",
        "ticker_sentiment_score": "0.383246",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.068896",
        "ticker_sentiment_score": "0.383246",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "DUK",
        "relevance_score": "0.068896",
        "ticker_sentiment_score": "0.217683",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Unpacking the Latest Options Trading Trends in Danaher - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/options/24/04/38100350/unpacking-the-latest-options-trading-trends-in-danaher",
    "time_published": "20240404T201608",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Financial giants have made a conspicuous bearish move on Danaher. Our analysis of options history for Danaher DHR revealed 8 unusual trades. Delving into the details, we found 37% of traders were bullish, while 62% showed bearish tendencies.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Markets",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      }
    ],
    "overall_sentiment_score": 0.177156,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "VLTO",
        "relevance_score": "0.128822",
        "ticker_sentiment_score": "0.039563",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.805471",
        "ticker_sentiment_score": "0.215253",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Investors Heavily Search Danaher Corporation  ( DHR ) : Here is What You Need to Know",
    "url": "https://www.zacks.com/stock/news/2250359/investors-heavily-search-danaher-corporation-dhr-here-is-what-you-need-to-know",
    "time_published": "20240404T130011",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Danaher (DHR) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default334.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.5855"
      }
    ],
    "overall_sentiment_score": 0.232916,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.48028",
        "ticker_sentiment_score": "0.169376",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Genome Editing Market size is set to grow by USD 7.23 bn from 2024-2028,rapid technological advancements in ... - PR Newswire",
    "url": "https://www.prnewswire.com/news-releases/genome-editing-market-size-is-set-to-grow-by-usd-7-23-bn-from-2024-2028-rapid-technological-advancements-in-genome-editing-boost-the-market--technavio-302109018.html",
    "time_published": "20240405T220200",
    "authors": [],
    "summary": "Genome Editing Market size is set to grow by USD 7.23 bn from 2024-2028,rapid technological advancements in ... PR ...",
    "banner_image": null,
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.141478,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "DCYHF",
        "relevance_score": "0.027351",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "EDIT",
        "relevance_score": "0.054669",
        "ticker_sentiment_score": "0.164921",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "CLLS",
        "relevance_score": "0.027351",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.027351",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BEAM",
        "relevance_score": "0.081924",
        "ticker_sentiment_score": "0.021724",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SGMO",
        "relevance_score": "0.027351",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DTIL",
        "relevance_score": "0.027351",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AZN",
        "relevance_score": "0.027351",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GNNSF",
        "relevance_score": "0.027351",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.027351",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ARCT",
        "relevance_score": "0.081924",
        "ticker_sentiment_score": "0.021724",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CRBU",
        "relevance_score": "0.027351",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NTLA",
        "relevance_score": "0.027351",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Here's Why Danaher  ( DHR )  Gained But Lagged the Market Today",
    "url": "https://www.zacks.com/stock/news/2251478/heres-why-danaher-dhr-gained-but-lagged-the-market-today",
    "time_published": "20240405T220021",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "In the closing of the recent trading day, Danaher (DHR) stood at $244.28, denoting a +0.98% change from the preceding trading day.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default250.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.961735"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.142694,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.463792",
        "ticker_sentiment_score": "0.111758",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Single-use Bioprocessing System Market size is set to grow by USD 15.32 bn from 2024-2028,high demand for ... - PR Newswire",
    "url": "https://www.prnewswire.com/news-releases/single-use-bioprocessing-system-market-size-is-set-to-grow-by-usd-15-32-bn-from-2024-2028-high-demand-for-biopharmaceuticals-to-treat-various-diseases-boost-the-market--technavio-302109013.html",
    "time_published": "20240405T100100",
    "authors": [],
    "summary": "Single-use Bioprocessing System Market size is set to grow by USD 15.32 bn from 2024-2028,high demand for ... PR ...",
    "banner_image": null,
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.166402,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "CODGF",
        "relevance_score": "0.029802",
        "ticker_sentiment_score": "0.044174",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GLW",
        "relevance_score": "0.029802",
        "ticker_sentiment_score": "0.044174",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SUVPF",
        "relevance_score": "0.029802",
        "ticker_sentiment_score": "0.044174",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.029802",
        "ticker_sentiment_score": "0.044174",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GEHC",
        "relevance_score": "0.029802",
        "ticker_sentiment_score": "0.044174",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PH",
        "relevance_score": "0.029802",
        "ticker_sentiment_score": "0.044174",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GNGBY",
        "relevance_score": "0.029802",
        "ticker_sentiment_score": "0.044174",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ENTG",
        "relevance_score": "0.059562",
        "ticker_sentiment_score": "0.05502",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MMM",
        "relevance_score": "0.029802",
        "ticker_sentiment_score": "0.044174",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AVTR",
        "relevance_score": "0.029802",
        "ticker_sentiment_score": "0.044174",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.059562",
        "ticker_sentiment_score": "0.05502",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Jim Cramer Isn't Going With This Tech Company: 'I'm A Nvidia Guy' - Academy Sports  ( NASDAQ:ASO ) , Amazon.com  ( NASDAQ:AMZN ) ",
    "url": "https://www.benzinga.com/trading-ideas/long-ideas/24/04/38136452/jim-cramer-isnt-going-with-this-tech-company-its-complicated-im-a-nvidia-guy",
    "time_published": "20240408T122610",
    "authors": [
      "Avi Kapoor"
    ],
    "summary": "On CNBC's \"Mad Money Lightning Round,\" Jim Cramer recommended buying Uber Technologies, Inc. UBER. \"I think Uber is really well run,\" he noted. Uber recently entered into a new nationwide partnership with The Vitamin Shoppe, bringing the New Jersey-based health and wellness retailer's selection ...",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/04/08/nvidia_shutterstock_2309474539.jpg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.2"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.2"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.2"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.2"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.2"
      }
    ],
    "overall_sentiment_score": 0.317755,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BB",
        "relevance_score": "0.334762",
        "ticker_sentiment_score": "-0.344264",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.334762",
        "ticker_sentiment_score": "-0.271466",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "C",
        "relevance_score": "0.436009",
        "ticker_sentiment_score": "0.128643",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WFC",
        "relevance_score": "0.227007",
        "ticker_sentiment_score": "-0.159777",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "ILMN",
        "relevance_score": "0.334762",
        "ticker_sentiment_score": "0.615191",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "SMCI",
        "relevance_score": "0.436009",
        "ticker_sentiment_score": "-0.286846",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "RMD",
        "relevance_score": "0.334762",
        "ticker_sentiment_score": "0.346927",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BN",
        "relevance_score": "0.334762",
        "ticker_sentiment_score": "0.626044",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "ASO",
        "relevance_score": "0.334762",
        "ticker_sentiment_score": "0.346509",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "UBER",
        "relevance_score": "0.613172",
        "ticker_sentiment_score": "0.622976",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "AMZN",
        "relevance_score": "0.227007",
        "ticker_sentiment_score": "0.58412",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.227007",
        "ticker_sentiment_score": "0.58801",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "This Is What Whales Are Betting On Danaher - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/options/24/04/38225229/this-is-what-whales-are-betting-on-danaher",
    "time_published": "20240412T173208",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Deep-pocketed investors have adopted a bearish approach towards Danaher DHR, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Markets",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.459462"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.150366,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "VLTO",
        "relevance_score": "0.086556",
        "ticker_sentiment_score": "0.034888",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BCS",
        "relevance_score": "0.086556",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.672055",
        "ticker_sentiment_score": "0.197197",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Reasons Why Danaher  ( DHR )  Should be in Your Portfolio Now",
    "url": "https://www.zacks.com/stock/news/2254795/reasons-why-danaher-dhr-should-be-in-your-portfolio-now",
    "time_published": "20240412T163000",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Danaher (DHR) is set to benefit from strength across its businesses, acquired assets and shareholder-friendly policies.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/58/4678.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.769861"
      }
    ],
    "overall_sentiment_score": 0.485769,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "VGR",
        "relevance_score": "0.150592",
        "ticker_sentiment_score": "0.12721",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CDRE",
        "relevance_score": "0.22421",
        "ticker_sentiment_score": "0.172177",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ABCZF",
        "relevance_score": "0.075635",
        "ticker_sentiment_score": "0.315973",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "CSL",
        "relevance_score": "0.22421",
        "ticker_sentiment_score": "0.175535",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.657566",
        "ticker_sentiment_score": "0.766022",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Billionaire Dan Loeb Just Bought 1 Shocking Stock",
    "url": "https://www.fool.com/investing/2024/04/13/billionaire-dan-loeb-had-1-shocking-buy/",
    "time_published": "20240413T090900",
    "authors": [
      "Travis Hoium"
    ],
    "summary": "Loeb is selling AI stocks for a big dividend payer.",
    "banner_image": "https://g.foolcdn.com/editorial/images/772382/investing-growth.jpg",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.25"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.25"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.25"
      }
    ],
    "overall_sentiment_score": -0.298024,
    "overall_sentiment_label": "Somewhat-Bearish",
    "ticker_sentiment": [
      {
        "ticker": "MSFT",
        "relevance_score": "0.595343",
        "ticker_sentiment_score": "-0.474464",
        "ticker_sentiment_label": "Bearish"
      },
      {
        "ticker": "TMUS",
        "relevance_score": "0.218817",
        "ticker_sentiment_score": "-0.247452",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "META",
        "relevance_score": "0.595343",
        "ticker_sentiment_score": "-0.474464",
        "ticker_sentiment_label": "Bearish"
      },
      {
        "ticker": "VZ",
        "relevance_score": "0.421485",
        "ticker_sentiment_score": "-0.395327",
        "ticker_sentiment_label": "Bearish"
      },
      {
        "ticker": "AMZN",
        "relevance_score": "0.421485",
        "ticker_sentiment_score": "-0.395327",
        "ticker_sentiment_label": "Bearish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.218817",
        "ticker_sentiment_score": "-0.247452",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "TSM",
        "relevance_score": "0.218817",
        "ticker_sentiment_score": "-0.247452",
        "ticker_sentiment_label": "Somewhat-Bearish"
      }
    ]
  },
  {
    "title": "Optical Biometry Devices Market size is set to grow by USD 93.26 million from 2023-2027, Rise in prevalence of ... - PR Newswire",
    "url": "https://www.prnewswire.com/news-releases/optical-biometry-devices-market-size-is-set-to-grow-by-usd-93-26-million-from-2023-2027--rise-in-prevalence-of-cataracts-among-geriatric-population-boost-the-market-technavio-302115534.html",
    "time_published": "20240415T071200",
    "authors": [],
    "summary": "Optical Biometry Devices Market size is set to grow by USD 93.26 million from 2023-2027, Rise in prevalence of ... PR ...",
    "banner_image": null,
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.284367,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "COO",
        "relevance_score": "0.030485",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MTLZF",
        "relevance_score": "0.030485",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ALC",
        "relevance_score": "0.030485",
        "ticker_sentiment_score": "0.140769",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AME",
        "relevance_score": "0.030485",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BAX",
        "relevance_score": "0.030485",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BLCO",
        "relevance_score": "0.030485",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HOCPF",
        "relevance_score": "0.030485",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TOPCF",
        "relevance_score": "0.060925",
        "ticker_sentiment_score": "0.122256",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.030485",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Blood Collection Market size worth $ 14.76 Billion, Globally, by 2031 at 5.10% CAGR - Report By Verified Market Research\u00ae",
    "url": "https://www.benzinga.com/pressreleases/24/04/g38294071/blood-collection-market-size-worth-14-76-billion-globally-by-2031-at-5-10-cagr-report-by-verified-",
    "time_published": "20240417T143000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Jersey City, New Jersey, April 17, 2024 ( GLOBE NEWSWIRE ) -- The Global Blood Collection Market is projected to grow at a CAGR of 5.10% from 2024 to 2031, according to a new report published by Verified Market Research\u00ae.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.214378"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      }
    ],
    "overall_sentiment_score": 0.284943,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ABT",
        "relevance_score": "0.033144",
        "ticker_sentiment_score": "0.098403",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TRUMF",
        "relevance_score": "0.033144",
        "ticker_sentiment_score": "0.098403",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.033144",
        "ticker_sentiment_score": "0.098403",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RSSS",
        "relevance_score": "0.033144",
        "ticker_sentiment_score": "0.171113",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.033144",
        "ticker_sentiment_score": "0.098403",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SEMHF",
        "relevance_score": "0.033144",
        "ticker_sentiment_score": "0.098403",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MDT",
        "relevance_score": "0.033144",
        "ticker_sentiment_score": "0.098403",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.033144",
        "ticker_sentiment_score": "0.098403",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Global Radioimmunoassay Market to Grow at a Minimal CAGR of ~3% by 2030 | DelveInsight",
    "url": "https://www.prnewswire.com/news-releases/global-radioimmunoassay-market-to-grow-at-a-minimal-cagr-of-3-by-2030--delveinsight-302119197.html",
    "time_published": "20240418T213100",
    "authors": [
      "DelveInsight Business Research",
      "LLP"
    ],
    "summary": "The increasing need for radioimmunoassay is mainly driven by the rising occurrence of cancer, infectious diseases, and various other health conditions, along with a growing number of epidemics and pandemics and increasing health awareness.",
    "banner_image": "https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg?p=facebook",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.146788,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "BMXMF",
        "relevance_score": "0.028388",
        "ticker_sentiment_score": "-0.0967",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "A",
        "relevance_score": "0.028388",
        "ticker_sentiment_score": "-0.0967",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CNTG",
        "relevance_score": "0.028388",
        "ticker_sentiment_score": "-0.0967",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "EXAS",
        "relevance_score": "0.028388",
        "ticker_sentiment_score": "-0.0967",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "EKTAY",
        "relevance_score": "0.028388",
        "ticker_sentiment_score": "-0.082191",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SKXJF",
        "relevance_score": "0.028388",
        "ticker_sentiment_score": "-0.173153",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "NVS",
        "relevance_score": "0.056741",
        "ticker_sentiment_score": "-0.035994",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DSKYF",
        "relevance_score": "0.028388",
        "ticker_sentiment_score": "-0.173153",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "AMGN",
        "relevance_score": "0.056741",
        "ticker_sentiment_score": "-0.035994",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PFE",
        "relevance_score": "0.056741",
        "ticker_sentiment_score": "-0.035994",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.028388",
        "ticker_sentiment_score": "0.060148",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.028388",
        "ticker_sentiment_score": "-0.0967",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TCRT",
        "relevance_score": "0.028388",
        "ticker_sentiment_score": "0.02269",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "QGEN",
        "relevance_score": "0.028388",
        "ticker_sentiment_score": "-0.0967",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SNY",
        "relevance_score": "0.056741",
        "ticker_sentiment_score": "-0.035994",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CLDX",
        "relevance_score": "0.028388",
        "ticker_sentiment_score": "0.02269",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BGNE",
        "relevance_score": "0.028388",
        "ticker_sentiment_score": "0.02269",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SSMXF",
        "relevance_score": "0.028388",
        "ticker_sentiment_score": "-0.0967",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BAYZF",
        "relevance_score": "0.028388",
        "ticker_sentiment_score": "0.02269",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ILMN",
        "relevance_score": "0.028388",
        "ticker_sentiment_score": "-0.0967",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ALPMF",
        "relevance_score": "0.028388",
        "ticker_sentiment_score": "0.02269",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BIO",
        "relevance_score": "0.028388",
        "ticker_sentiment_score": "-0.0967",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABBV",
        "relevance_score": "0.056741",
        "ticker_sentiment_score": "-0.035994",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BMY",
        "relevance_score": "0.056741",
        "ticker_sentiment_score": "-0.035994",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HOLX",
        "relevance_score": "0.028388",
        "ticker_sentiment_score": "-0.0967",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DGX",
        "relevance_score": "0.028388",
        "ticker_sentiment_score": "-0.0967",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AZN",
        "relevance_score": "0.056741",
        "ticker_sentiment_score": "-0.035994",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ARAY",
        "relevance_score": "0.028388",
        "ticker_sentiment_score": "-0.082191",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MYGN",
        "relevance_score": "0.028388",
        "ticker_sentiment_score": "-0.0967",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.028388",
        "ticker_sentiment_score": "-0.0967",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GILD",
        "relevance_score": "0.056741",
        "ticker_sentiment_score": "-0.035994",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Will Danaher  ( DHR )  Beat Estimates Again in Its Next Earnings Report?",
    "url": "https://www.zacks.com/stock/news/2257937/will-danaher-dhr-beat-estimates-again-in-its-next-earnings-report",
    "time_published": "20240418T161016",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Danaher (DHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default247.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.99998"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.337718,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.417304",
        "ticker_sentiment_score": "0.495435",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "If You Invested $100 In This Stock 10 Years Ago, You Would Have $500 Today - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/news/24/04/38318895/if-you-invested-100-in-this-stock-10-years-ago-you-would-have-500-today",
    "time_published": "20240418T160053",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Danaher DHR has outperformed the market over the past 10 years by 6.65% on an annualized basis producing an average annual return of 17.02%. Currently, Danaher has a market capitalization of $175.79 billion.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_3.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.238974,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.95919",
        "ticker_sentiment_score": "0.384695",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Danaher  ( DHR )  Gears Up to Post Q1 Earnings: Is a Beat Likely?",
    "url": "https://www.zacks.com/stock/news/2257902/danaher-dhr-gears-up-to-post-q1-earnings-is-a-beat-likely",
    "time_published": "20240418T145800",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Danaher's (DHR) Q1 earnings are likely to be hurt by weakness in the Biotechnology unit. Improving supply chains and strong price realization are expected to be positives.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/d9/554.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.99989"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.108088,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ALLE",
        "relevance_score": "0.117486",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CSL",
        "relevance_score": "0.117486",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ATR",
        "relevance_score": "0.117486",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.624759",
        "ticker_sentiment_score": "0.327123",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Carlisle  ( CSL )  Earnings Expected to Grow: What to Know Ahead of Next Week's Release",
    "url": "https://www.zacks.com/stock/news/2257699/carlisle-csl-earnings-expected-to-grow-what-to-know-ahead-of-next-weeks-release",
    "time_published": "20240418T140157",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Carlisle (CSL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default246.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.176775,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.177475",
        "ticker_sentiment_score": "0.069229",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Curious about Danaher  ( DHR )  Q1 Performance? Explore Wall Street Estimates for Key Metrics",
    "url": "https://www.zacks.com/stock/news/2257538/curious-about-danaher-dhr-q1-performance-explore-wall-street-estimates-for-key-metrics",
    "time_published": "20240418T131521",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Evaluate the expected performance of Danaher (DHR) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default45.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.967321"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      }
    ],
    "overall_sentiment_score": 0.132744,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.495015",
        "ticker_sentiment_score": "0.03147",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Why Danaher  ( DHR )  Might Surprise This Earnings Season",
    "url": "https://www.zacks.com/stock/news/2258493/why-danaher-dhr-might-surprise-this-earnings-season",
    "time_published": "20240419T135200",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Danaher (DHR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/d9/554.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.99237"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.459651,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.872847",
        "ticker_sentiment_score": "0.589707",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Spotlight on Danaher: Analyzing the Surge in Options Activity - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/options/24/04/38362091/spotlight-on-danaher-analyzing-the-surge-in-options-activity",
    "time_published": "20240422T170235",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Financial giants have made a conspicuous bearish move on Danaher. Our analysis of options history for Danaher DHR revealed 9 unusual trades. Delving into the details, we found 11% of traders were bullish, while 66% showed bearish tendencies.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Markets",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.413559"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.164596,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "VLTO",
        "relevance_score": "0.095899",
        "ticker_sentiment_score": "0.035619",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BCS",
        "relevance_score": "0.095899",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.721785",
        "ticker_sentiment_score": "0.125946",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Honeywell  ( HON )  to Report Q1 Earnings: Is a Beat in Store?",
    "url": "https://www.zacks.com/stock/news/2259366/honeywell-hon-to-report-q1-earnings-is-a-beat-in-store",
    "time_published": "20240422T134300",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Honeywell's (HON) first-quarter results are likely to have benefited from strength across most of its businesses. Weakness in the warehouse automation market might have been a spoilsport.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/b6/1336.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.99989"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.245804,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ITT",
        "relevance_score": "0.158868",
        "ticker_sentiment_score": "0.056335",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ALLE",
        "relevance_score": "0.158868",
        "ticker_sentiment_score": "0.053706",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HON",
        "relevance_score": "0.407019",
        "ticker_sentiment_score": "0.316468",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.158868",
        "ticker_sentiment_score": "0.043197",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Today's Earnings: Pulte Home, Danaher Rally; JetBlue Dives",
    "url": "https://www.investors.com/news/earnings-today-pultegroup-danaher-rally-jetblue-dives/",
    "time_published": "20240423T153300",
    "authors": [
      "Investor's Business Daily",
      "ALAN R. ELLIOTT"
    ],
    "summary": "Earnings Today: PulteGroup, Danaher Rally. JetBlue Dives Investor's Business Daily ...",
    "banner_image": "https://www.investors.com/wp-content/uploads/2017/07/Biz05-builders-071117-adobe.jpg",
    "source": "Investors Business Daily",
    "category_within_source": "n/a",
    "source_domain": "www.investors.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.87644"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.995973"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.09131,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "PHM",
        "relevance_score": "0.320974",
        "ticker_sentiment_score": "0.086608",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GM",
        "relevance_score": "0.163909",
        "ticker_sentiment_score": "-0.022546",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.465196",
        "ticker_sentiment_score": "0.228725",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Danaher  ( DHR )  Q1 Earnings Beat, Biotechnology Sales Dip Y/Y",
    "url": "https://www.zacks.com/stock/news/2260391/danaher-dhr-q1-earnings-beat-biotechnology-sales-dip-yy",
    "time_published": "20240423T152900",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "While Danaher (DHR) surpasses first-quarter earnings and revenue estimates, its performance is hurt by a decrease in core sales in the Biotechnology segment.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/98/1265.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.25"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.25"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.938238"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.25"
      }
    ],
    "overall_sentiment_score": 0.117096,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "AIT",
        "relevance_score": "0.114682",
        "ticker_sentiment_score": "0.138073",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ATMU",
        "relevance_score": "0.114682",
        "ticker_sentiment_score": "0.088846",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CSL",
        "relevance_score": "0.171282",
        "ticker_sentiment_score": "0.125709",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.529185",
        "ticker_sentiment_score": "-0.064745",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "HealthStream Reports Upbeat Results, Joins Spotify, Ryder System And Other Big Stocks Moving Higher On Tuesday - BeiGene  ( NASDAQ:BGNE ) , Bloom Energy  ( NYSE:BE ) ",
    "url": "https://www.benzinga.com/news/24/04/38382031/healthstream-reports-upbeat-results-joins-spotify-ryder-system-and-other-big-stocks-moving-higher-on",
    "time_published": "20240423T145019",
    "authors": [
      "Avi Kapoor"
    ],
    "summary": "U.S. stocks were higher, with the Nasdaq Composite gaining over 200 points on Tuesday. Shares of HealthStream, Inc. HSTM rose sharply during Tuesday's session following upbeat quarterly results. HealthStream posted first-quarter GAAP earnings of 17 cents per share, beating market estimates of 11 ...",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/04/23/Movers.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Markets",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.166667"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.714479"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.166667"
      }
    ],
    "overall_sentiment_score": 0.340542,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "HIBB",
        "relevance_score": "0.179788",
        "ticker_sentiment_score": "0.303128",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MARA",
        "relevance_score": "0.179788",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SES",
        "relevance_score": "0.179788",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ROKU",
        "relevance_score": "0.179788",
        "ticker_sentiment_score": "0.37874",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "BE",
        "relevance_score": "0.090474",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BGNE",
        "relevance_score": "0.179788",
        "ticker_sentiment_score": "-0.080665",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FCEL",
        "relevance_score": "0.179788",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SPOT",
        "relevance_score": "0.179788",
        "ticker_sentiment_score": "0.238467",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "HSTM",
        "relevance_score": "0.350564",
        "ticker_sentiment_score": "0.310481",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SMCI",
        "relevance_score": "0.179788",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.266828",
        "ticker_sentiment_score": "0.530411",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "HRTX",
        "relevance_score": "0.179788",
        "ticker_sentiment_score": "0.006092",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JDDSF",
        "relevance_score": "0.090474",
        "ticker_sentiment_score": "0.222046",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MESO",
        "relevance_score": "0.179788",
        "ticker_sentiment_score": "-0.341895",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "SMXT",
        "relevance_score": "0.179788",
        "ticker_sentiment_score": "0.37874",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "CRML",
        "relevance_score": "0.266828",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "R",
        "relevance_score": "0.179788",
        "ticker_sentiment_score": "0.432176",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "SG",
        "relevance_score": "0.179788",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RGEN",
        "relevance_score": "0.179788",
        "ticker_sentiment_score": "0.416302",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "RNAC",
        "relevance_score": "0.179788",
        "ticker_sentiment_score": "0.1644",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SPCE",
        "relevance_score": "0.179788",
        "ticker_sentiment_score": "0.476343",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "MTC",
        "relevance_score": "0.179788",
        "ticker_sentiment_score": "0.651723",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "LZM",
        "relevance_score": "0.179788",
        "ticker_sentiment_score": "0.121484",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Why Is Life Science-Focused Danaher Trading Higher On Tuesday? - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/news/earnings/24/04/38381098/why-is-life-science-focused-danaher-trading-higher-on-tuesday",
    "time_published": "20240423T141327",
    "authors": [
      "Vandana Singh"
    ],
    "summary": "Tuesday, Danaher Corp DHR said its first-quarter sales decreased 2.5% Y/Y to $5.79 billion, beating the consensus of $5.62 billion. Non-GAAP core revenue decreased 4%, exceeding expectations of a high-single-digit decline. Operating cash flow was $1.7 billion, and non-GAAP free cash flow was ...",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/04/23/chart-ai2.png?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.977154"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.20206,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.636698",
        "ticker_sentiment_score": "-0.102153",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Danaher  ( DHR )  Surpasses Q1 Earnings and Revenue Estimates",
    "url": "https://www.zacks.com/stock/news/2259778/danaher-dhr-surpasses-q1-earnings-and-revenue-estimates",
    "time_published": "20240423T111004",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Danaher (DHR) delivered earnings and revenue surprises of 11.63% and 2.85%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default254.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999997"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.161841,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.398148",
        "ticker_sentiment_score": "0.196864",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Top Stock Reports for Danaher, Regeneron Pharmaceuticals & Palo Alto Networks",
    "url": "https://www.zacks.com/research-daily/2261192/top-stock-reports-for-danaher-regeneron-pharmaceuticals-palo-alto-networks",
    "time_published": "20240424T195100",
    "authors": [
      "Mark Vickery"
    ],
    "summary": "Today's Research Daily features new research reports on 16 major stocks, including Danaher Corporation (DHR), Regeneron Pharmaceuticals, Inc. (REGN) and Palo Alto Networks, Inc. (PANW).",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/f1/39591.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.165047,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "REGN",
        "relevance_score": "0.105141",
        "ticker_sentiment_score": "0.161998",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.105141",
        "ticker_sentiment_score": "-0.105657",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PANW",
        "relevance_score": "0.105141",
        "ticker_sentiment_score": "0.282329",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Tesla To $180? Here Are 10 Top Analyst Forecasts For Wednesday - CoStar Gr  ( NASDAQ:CSGP ) , Amazon.com  ( NASDAQ:AMZN ) ",
    "url": "https://www.benzinga.com/news/24/04/38400974/tesla-to-180-here-are-10-top-analyst-forecasts-for-wednesday",
    "time_published": "20240424T114442",
    "authors": [
      "Avi Kapoor"
    ],
    "summary": "Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Wedbush boosted the price target for Amazon.com, Inc. AMZN from $220 to $225.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/04/24/Elon-Musk-Tesla.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.25"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.999897"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.25"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.25"
      }
    ],
    "overall_sentiment_score": 0.223172,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MELI",
        "relevance_score": "0.246167",
        "ticker_sentiment_score": "0.152019",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TSLA",
        "relevance_score": "0.246167",
        "ticker_sentiment_score": "0.03552",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SPOT",
        "relevance_score": "0.246167",
        "ticker_sentiment_score": "0.203364",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "CSGP",
        "relevance_score": "0.246167",
        "ticker_sentiment_score": "-0.039706",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GM",
        "relevance_score": "0.246167",
        "ticker_sentiment_score": "0.219473",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MSCI",
        "relevance_score": "0.246167",
        "ticker_sentiment_score": "0.011687",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PINS",
        "relevance_score": "0.246167",
        "ticker_sentiment_score": "-0.117262",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PLCE",
        "relevance_score": "0.246167",
        "ticker_sentiment_score": "0.17105",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "AMZN",
        "relevance_score": "0.165598",
        "ticker_sentiment_score": "0.243204",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.246167",
        "ticker_sentiment_score": "0.437241",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Stocks With Rising Relative Price Strength: Danaher",
    "url": "https://www.investors.com/ibd-data-stories/stocks-with-rising-relative-price-strength-danaher-2/",
    "time_published": "20240424T070000",
    "authors": [
      "Investor's Business Daily",
      "INVESTOR'S BUSINESS DAILY"
    ],
    "summary": "Danaher ( DHR ) had its Relative Strength ( RS ) Rating upgraded from 61 to 80 Wednesday. X IBD's proprietary RS Rating measures market leadership by using a 1 ( worst ) to 99 ( best ) score that identifies how a stock's price performance over the trailing 52 weeks matches up against the rest ...",
    "banner_image": "https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg",
    "source": "Investors Business Daily",
    "category_within_source": "n/a",
    "source_domain": "www.investors.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.684621"
      }
    ],
    "overall_sentiment_score": 0.34791,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.682689",
        "ticker_sentiment_score": "0.217172",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Honeywell  ( HON )  Q1 Earnings Beat, Aerospace Sales Rise Y/Y",
    "url": "https://www.zacks.com/stock/news/2262658/honeywell-hon-q1-earnings-beat-aerospace-sales-rise-yy",
    "time_published": "20240425T162900",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Honeywell's (HON) first-quarter 2024 revenues increase approximately 3%, driven by strong momentum in the Aerospace Technologies segment.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/d9/554.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.25"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.995869"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.25"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.25"
      }
    ],
    "overall_sentiment_score": 0.129065,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "IEX",
        "relevance_score": "0.105604",
        "ticker_sentiment_score": "0.068986",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HON",
        "relevance_score": "0.404563",
        "ticker_sentiment_score": "0.172431",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.105604",
        "ticker_sentiment_score": "-0.020913",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MKL",
        "relevance_score": "0.105604",
        "ticker_sentiment_score": "0.13086",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "The Zacks Analyst Blog Highlights Danaher, Regeneron Pharmaceuticals, Palo Alto Networks, Workday and American Electric Power",
    "url": "https://www.zacks.com/stock/news/2262238/the-zacks-analyst-blog-highlights-danaher-regeneron-pharmaceuticals-palo-alto-networks-workday-and-american-electric-power",
    "time_published": "20240425T124400",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Danaher, Regeneron Pharmaceuticals, Palo Alto Networks, Workday and American Electric Power are part of the Zacks top Analyst Blog.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/58/4678.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.139019,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "AEP",
        "relevance_score": "0.142144",
        "ticker_sentiment_score": "0.036722",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "REGN",
        "relevance_score": "0.279813",
        "ticker_sentiment_score": "0.132735",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WDAY",
        "relevance_score": "0.142144",
        "ticker_sentiment_score": "0.036722",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.345674",
        "ticker_sentiment_score": "-0.009813",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PANW",
        "relevance_score": "0.279813",
        "ticker_sentiment_score": "0.203266",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Options Exercise: Rainer Blair At Danaher Realizes $7.05M - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/news/24/04/38462602/options-exercise-rainer-blair-at-danaher-realizes-7-05m",
    "time_published": "20240426T150105",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "In a new SEC filing on April 25, it was revealed that Blair, President & CEO at Danaher DHR, executed a significant exercise of company stock options. What Happened: A Form 4 filing with the U.S.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/insider_image_0.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.993856"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.99793"
      }
    ],
    "overall_sentiment_score": 0.154127,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "VLTO",
        "relevance_score": "0.063763",
        "ticker_sentiment_score": "0.032009",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.368773",
        "ticker_sentiment_score": "0.30986",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "The Forgotten Stock Advice That Delivers 170%+ Payout Growth",
    "url": "https://www.forbes.com/sites/brettowens/2024/05/01/the-forgotten-stock-advice-that-delivers-170-payout-growth/",
    "time_published": "20240501T131500",
    "authors": [
      "Brett Owens"
    ],
    "summary": "One of the best ways to grab a dividend payer set to surge is a strategy you never hear about anymore: Pick up shares of a conglomerate. I know, I know. The word brings to mind \"old school\" companies like 3M ( MMM ) -which we discussed a couple weeks ago-and Honeywell International ( HON ) .",
    "banner_image": "https://imageio.forbes.com/specials-images/imageserve/662ad1e985461e21e502532f/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds",
    "source": "Forbes",
    "category_within_source": "n/a",
    "source_domain": "www.forbes.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.459462"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.744043"
      },
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.158519"
      }
    ],
    "overall_sentiment_score": 0.157727,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "VLTO",
        "relevance_score": "0.074692",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HON",
        "relevance_score": "0.074692",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.457724",
        "ticker_sentiment_score": "0.258552",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.111834",
        "ticker_sentiment_score": "-0.017918",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Markel  ( MKL )  Q1 Earnings, Revenues Miss Estimates, Rise Y/Y",
    "url": "https://www.zacks.com/stock/news/2268235/markel-mkl-q1-earnings-revenues-miss-estimates-rise-yy",
    "time_published": "20240503T174800",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Markel (MKL) first-quarter results reflect improved earned premiums and increased net investment income.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/59/54380.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.684621"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.998917"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.181233,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MMM",
        "relevance_score": "0.121445",
        "ticker_sentiment_score": "0.139041",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HON",
        "relevance_score": "0.16144",
        "ticker_sentiment_score": "0.110176",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.081138",
        "ticker_sentiment_score": "-0.019553",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MKL",
        "relevance_score": "0.316337",
        "ticker_sentiment_score": "0.260071",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "How Is The Market Feeling About Danaher? - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/short-sellers/24/05/38641938/how-is-the-market-feeling-about-danaher",
    "time_published": "20240506T130029",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Danaher's DHR short percent of float has risen 11.63% since its last report. The company recently reported that it has 6.35 million shares sold short, which is 0.96% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.39 days to cover their ...",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.289997,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.212115",
        "ticker_sentiment_score": "0.151778",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Danaher Corporation  ( DHR )  Is a Trending Stock: Facts to Know Before Betting on It",
    "url": "https://www.zacks.com/stock/news/2270377/danaher-corporation-dhr-is-a-trending-stock-facts-to-know-before-betting-on-it",
    "time_published": "20240508T130011",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Danaher (DHR) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default260.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999999"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.54554"
      }
    ],
    "overall_sentiment_score": 0.25025,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.487546",
        "ticker_sentiment_score": "0.188457",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Danaher Sees Relative Strength Rating Climb To 71",
    "url": "https://www.investors.com/ibd-data-stories/danaher-sees-relative-strength-rating-climb-to-71/",
    "time_published": "20240509T070000",
    "authors": [
      "Investor's Business Daily",
      "INVESTOR'S BUSINESS DAILY"
    ],
    "summary": "Danaher ( DHR ) had its Relative Strength ( RS ) Rating upgraded from 68 to 71 Thursday - a welcome improvement, but still shy of the 80 or higher score you look for. X IBD's unique rating identifies price performance with a 1 ( worst ) to 99 ( best ) score.",
    "banner_image": "https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg",
    "source": "Investors Business Daily",
    "category_within_source": "n/a",
    "source_domain": "www.investors.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.451494"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.538269"
      }
    ],
    "overall_sentiment_score": 0.394743,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "LLY",
        "relevance_score": "0.350564",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AWON",
        "relevance_score": "0.179788",
        "ticker_sentiment_score": "0.152952",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.744196",
        "ticker_sentiment_score": "0.478197",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "$1000 Invested In Danaher 10 Years Ago Would Be Worth This Much Today - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/news/24/05/38794096/1000-invested-in-danaher-10-years-ago-would-be-worth-this-much-today",
    "time_published": "20240513T153014",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Danaher DHR has outperformed the market over the past 10 years by 6.79% on an annualized basis producing an average annual return of 17.56%. Currently, Danaher has a market capitalization of $187.59 billion.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_0.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.238974,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.95919",
        "ticker_sentiment_score": "0.384695",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Cannabis Testing Market size is set to grow by USD 1.50 bn from 2023-2027, increasing use of cannabis for medical ... - PR Newswire",
    "url": "https://www.prnewswire.com/news-releases/cannabis-testing-market-size-is-set-to-grow-by-usd-1-50-bn-from-2023-2027--increasing-use-of-cannabis-for-medical-purposes-to-boost-the-market-growth-technavio-302142370.html",
    "time_published": "20240513T095000",
    "authors": [],
    "summary": "Cannabis Testing Market size is set to grow by USD 1.50 bn from 2023-2027, increasing use of cannabis for medical ... PR ...",
    "banner_image": null,
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.158519"
      }
    ],
    "overall_sentiment_score": 0.215721,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "A",
        "relevance_score": "0.03704",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SUVPF",
        "relevance_score": "0.03704",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SHMZF",
        "relevance_score": "0.03704",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.03704",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BIO",
        "relevance_score": "0.03704",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WAT",
        "relevance_score": "0.03704",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MTD",
        "relevance_score": "0.03704",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DIGP",
        "relevance_score": "0.03704",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ERFSF",
        "relevance_score": "0.03704",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.03704",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Danaher  ( DHR )  Rides on Business Strength Amid Headwinds",
    "url": "https://www.zacks.com/stock/news/2274232/danaher-dhr-rides-on-business-strength-amid-headwinds",
    "time_published": "20240515T144300",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Danaher (DHR) gains from strength in academic and applied markets, Abcam buyout and pro-investor policies. However, softness in its Biotechnology unit is concerning.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/58/4678.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.769861"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.299533,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ITT",
        "relevance_score": "0.160099",
        "ticker_sentiment_score": "0.064548",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CSL",
        "relevance_score": "0.160099",
        "ticker_sentiment_score": "0.16398",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "GFF",
        "relevance_score": "0.160099",
        "ticker_sentiment_score": "0.11489",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.520477",
        "ticker_sentiment_score": "0.500581",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "UNTC",
        "relevance_score": "0.080458",
        "ticker_sentiment_score": "0.244165",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Oligonucleotide Synthesis Market is Expected to Reach $19.7 billion | MarketsandMarkets\u2122",
    "url": "https://www.benzinga.com/pressreleases/24/05/g38842275/oligonucleotide-synthesis-market-is-expected-to-reach-19-7-billion-marketsandmarkets",
    "time_published": "20240515T123000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Chicago, May 15, 2024 ( GLOBE NEWSWIRE ) -- Oligonucleotide Synthesis market in terms of revenue was estimated to be worth $8.8 billion in 2024 and is poised to reach $19.7 billion by 2029, growing at a CAGR of 17.5% from 2024 to 2029 according to a latest report published by MarketsandMarkets\u2122.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.684621"
      }
    ],
    "overall_sentiment_score": 0.187503,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "A",
        "relevance_score": "0.042571",
        "ticker_sentiment_score": "-0.027158",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TWST",
        "relevance_score": "0.042571",
        "ticker_sentiment_score": "-0.027158",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SRPT",
        "relevance_score": "0.042571",
        "ticker_sentiment_score": "-0.027158",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ALNY",
        "relevance_score": "0.042571",
        "ticker_sentiment_score": "-0.027158",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ALPMF",
        "relevance_score": "0.042571",
        "ticker_sentiment_score": "-0.027158",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "IONS",
        "relevance_score": "0.042571",
        "ticker_sentiment_score": "-0.027158",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVS",
        "relevance_score": "0.042571",
        "ticker_sentiment_score": "-0.027158",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ASOMF",
        "relevance_score": "0.042571",
        "ticker_sentiment_score": "0.078546",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "KANKF",
        "relevance_score": "0.042571",
        "ticker_sentiment_score": "-0.027158",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.042571",
        "ticker_sentiment_score": "-0.027158",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AZN",
        "relevance_score": "0.042571",
        "ticker_sentiment_score": "-0.027158",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JAZZ",
        "relevance_score": "0.042571",
        "ticker_sentiment_score": "-0.027158",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GNNSF",
        "relevance_score": "0.042571",
        "ticker_sentiment_score": "-0.027158",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NPNKF",
        "relevance_score": "0.042571",
        "ticker_sentiment_score": "-0.027158",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.042571",
        "ticker_sentiment_score": "-0.027158",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AZTA",
        "relevance_score": "0.042571",
        "ticker_sentiment_score": "-0.027158",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MRVI",
        "relevance_score": "0.042571",
        "ticker_sentiment_score": "-0.027158",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ERFSF",
        "relevance_score": "0.042571",
        "ticker_sentiment_score": "-0.027158",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BIIB",
        "relevance_score": "0.042571",
        "ticker_sentiment_score": "-0.027158",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Industrial Automation Market In Life Sciences Industry size is set to grow by USD 5.06 bn from 2024-2028, growing ... - PR Newswire",
    "url": "https://www.prnewswire.com/news-releases/industrial-automation-market-in-life-sciences-industry-size-is-set-to-grow-by-usd-5-06-bn-from-2024-2028--growing-global-demand-for-healthcare-services-to-boost-the-market-growth-technavio-302149472.html",
    "time_published": "20240518T172700",
    "authors": [],
    "summary": "Industrial Automation Market In Life Sciences Industry size is set to grow by USD 5.06 bn from 2024-2028, growing ... PR ...",
    "banner_image": null,
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.2"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.2"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.2"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.2"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.2"
      }
    ],
    "overall_sentiment_score": 0.283787,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GIC",
        "relevance_score": "0.032646",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AMAT",
        "relevance_score": "0.032646",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SAP",
        "relevance_score": "0.032646",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SMAWF",
        "relevance_score": "0.032646",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABLZF",
        "relevance_score": "0.032646",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HON",
        "relevance_score": "0.032646",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AZPN",
        "relevance_score": "0.032646",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "EMR",
        "relevance_score": "0.032646",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HCSG",
        "relevance_score": "0.032646",
        "ticker_sentiment_score": "0.124691",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.032646",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ROK",
        "relevance_score": "0.032646",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DTST",
        "relevance_score": "0.032646",
        "ticker_sentiment_score": "0.130507",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JCI",
        "relevance_score": "0.032646",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "OMRNF",
        "relevance_score": "0.032646",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DASTF",
        "relevance_score": "0.032646",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "YMATF",
        "relevance_score": "0.032646",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "XOM",
        "relevance_score": "0.032646",
        "ticker_sentiment_score": "0.08176",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PH",
        "relevance_score": "0.032646",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MSBHF",
        "relevance_score": "0.032646",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SBGSF",
        "relevance_score": "0.032646",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MIELF",
        "relevance_score": "0.032646",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "YOKEF",
        "relevance_score": "0.065238",
        "ticker_sentiment_score": "0.063219",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Top Stock Reports for UnitedHealth, Danaher & Abbott",
    "url": "https://www.zacks.com/research-daily/2275925/top-stock-reports-for-unitedhealth-danaher-abbott",
    "time_published": "20240520T170800",
    "authors": [
      "Sheraz Mian"
    ],
    "summary": "Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), Danaher Corporation (DHR) and Abbott Laboratories (ABT), as well as a micro-cap stock Ark Restaurants Corp. (ARKR).",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default287.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.495866"
      }
    ],
    "overall_sentiment_score": 0.245011,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ARKR",
        "relevance_score": "0.138066",
        "ticker_sentiment_score": "0.101858",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.138066",
        "ticker_sentiment_score": "0.115522",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: UnitedHealth, Danaher, Abbott and Ark Restaurants",
    "url": "https://www.zacks.com/stock/news/2276402/the-zacks-analyst-blog-highlights-stocks-recently-featured-in-the-blog-include-unitedhealth-danaher-abbott-and-ark-restaurants",
    "time_published": "20240521T105900",
    "authors": [
      "Zacks Investment Research"
    ],
    "summary": "UnitedHealth, Danaher, Abbott and Ark Restaurants are included in this Analyst Blog.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/3c/1479.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.495866"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.217868,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ABT",
        "relevance_score": "0.162073",
        "ticker_sentiment_score": "0.054406",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ARKR",
        "relevance_score": "0.266828",
        "ticker_sentiment_score": "0.113503",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "UNH",
        "relevance_score": "0.162073",
        "ticker_sentiment_score": "0.054406",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.266828",
        "ticker_sentiment_score": "0.130703",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Why Is Danaher  ( DHR )  Up 6.7% Since Last Earnings Report?",
    "url": "https://www.zacks.com/stock/news/2278078/why-is-danaher-dhr-up-67-since-last-earnings-report",
    "time_published": "20240523T153041",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Danaher (DHR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default273.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.838487"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.101535,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.497126",
        "ticker_sentiment_score": "0.10971",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Recursion Appoints Robert Hershberg M.D., Ph.D, as New Chair of the Board - Recursion Pharmaceuticals  ( NASDAQ:RXRX ) ",
    "url": "https://www.benzinga.com/pressreleases/24/05/g39014038/recursion-appoints-robert-hershberg-m-d-ph-d-as-new-chair-of-the-board",
    "time_published": "20240524T203000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "SALT LAKE CITY, May 24, 2024 ( GLOBE NEWSWIRE ) -- Recursion RXRX, a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced that Robert Hershberg, M.D., Ph.D, has been appointed the new Chair of the Board of Recursion, effective at the end of ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.158344,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ADPT",
        "relevance_score": "0.061949",
        "ticker_sentiment_score": "-0.008004",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BMY",
        "relevance_score": "0.061949",
        "ticker_sentiment_score": "-0.008004",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.061949",
        "ticker_sentiment_score": "-0.008004",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HLVX",
        "relevance_score": "0.061949",
        "ticker_sentiment_score": "-0.008004",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Recursion Appoints Robert Hershberg M.D., Ph.D, as New Chair of the Board",
    "url": "https://www.globenewswire.com/news-release/2024/05/24/2888179/0/en/Recursion-Appoints-Robert-Hershberg-M-D-Ph-D-as-New-Chair-of-the-Board.html",
    "time_published": "20240524T203000",
    "authors": [
      "Recursion Pharmaceuticals"
    ],
    "summary": "Dr. Hershberg is a current board member with over 25 years of experience as a physician, scientist, and entrepreneur Dr. Hershberg is a current board member with over 25 years of experience as a physician, scientist, and entrepreneur ...",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/fab48155-72e9-4a16-8540-173095b5ba88",
    "source": "GlobeNewswire",
    "category_within_source": "n/a",
    "source_domain": "www.globenewswire.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.310843"
      }
    ],
    "overall_sentiment_score": 0.142086,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ADPT",
        "relevance_score": "0.041323",
        "ticker_sentiment_score": "-0.007784",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BMY",
        "relevance_score": "0.041323",
        "ticker_sentiment_score": "-0.007784",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.041323",
        "ticker_sentiment_score": "-0.007784",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HLVX",
        "relevance_score": "0.041323",
        "ticker_sentiment_score": "-0.007784",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Global Immunoassay Market to Witness Growth at a CAGR of ~8% by 2030 | DelveInsight",
    "url": "https://www.prnewswire.com/news-releases/global-immunoassay-market-to-witness-growth-at-a-cagr-of-8-by-2030--delveinsight-302155907.html",
    "time_published": "20240527T140100",
    "authors": [
      "DelveInsight Business Research",
      "LLP"
    ],
    "summary": "The surge in the immunoassay market is mainly from the rising occurrence of persistent conditions like cancer and lifestyle-related ailments such as diabetes mellitus. Notably, the uptick in different types of cancer, including breast and prostate cancer, plays a pivotal role in driving market ...",
    "banner_image": "https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg?p=facebook",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.195097,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BMXMF",
        "relevance_score": "0.023981",
        "ticker_sentiment_score": "0.022058",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "A",
        "relevance_score": "0.023981",
        "ticker_sentiment_score": "0.022058",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SSMXF",
        "relevance_score": "0.04794",
        "ticker_sentiment_score": "0.068239",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PHCCF",
        "relevance_score": "0.023981",
        "ticker_sentiment_score": "0.015846",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BIO",
        "relevance_score": "0.023981",
        "ticker_sentiment_score": "0.022058",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LAB",
        "relevance_score": "0.023981",
        "ticker_sentiment_score": "0.022058",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.04794",
        "ticker_sentiment_score": "0.073213",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HOLX",
        "relevance_score": "0.023981",
        "ticker_sentiment_score": "0.022058",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.023981",
        "ticker_sentiment_score": "0.076847",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.04794",
        "ticker_sentiment_score": "0.023626",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DSRLF",
        "relevance_score": "0.04794",
        "ticker_sentiment_score": "0.019682",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GRFS",
        "relevance_score": "0.023981",
        "ticker_sentiment_score": "0.022058",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "QGEN",
        "relevance_score": "0.023981",
        "ticker_sentiment_score": "0.022058",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SZIHF",
        "relevance_score": "0.04794",
        "ticker_sentiment_score": "0.017711",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Anatomic Pathology Market Surges to USD 27.62 Billion by 2031, Propelled by 5.67% CAGR - Verified Market Research\u00ae",
    "url": "https://www.benzinga.com/pressreleases/24/05/g39087994/anatomic-pathology-market-surges-to-usd-27-62-billion-by-2031-propelled-by-5-67-cagr-verified-mark",
    "time_published": "20240530T140000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Lewes, Delaware, May 30, 2024 ( GLOBE NEWSWIRE ) -- The Global Anatomic Pathology Market is projected to grow at a CAGR of 5.67% from 2024 to 2031, according to a new report published by Verified Market Research\u00ae.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.245616,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MFCSF",
        "relevance_score": "0.058615",
        "ticker_sentiment_score": "0.173321",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "A",
        "relevance_score": "0.029327",
        "ticker_sentiment_score": "0.098599",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HOLX",
        "relevance_score": "0.029327",
        "ticker_sentiment_score": "0.098599",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.029327",
        "ticker_sentiment_score": "0.098599",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RSSS",
        "relevance_score": "0.029327",
        "ticker_sentiment_score": "0.169054",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.029327",
        "ticker_sentiment_score": "0.098599",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.029327",
        "ticker_sentiment_score": "0.098599",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Repligen  ( RGEN )  Down 10.9% Since Last Earnings Report: Can It Rebound?",
    "url": "https://www.zacks.com/stock/news/2282142/repligen-rgen-down-109-since-last-earnings-report-can-it-rebound",
    "time_published": "20240531T153149",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Repligen (RGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default233.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.99915"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.929393"
      }
    ],
    "overall_sentiment_score": 0.009544,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "RGEN",
        "relevance_score": "0.488217",
        "ticker_sentiment_score": "0.141055",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BIIB",
        "relevance_score": "0.18856",
        "ticker_sentiment_score": "0.022396",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.047559",
        "ticker_sentiment_score": "-0.188679",
        "ticker_sentiment_label": "Somewhat-Bearish"
      }
    ]
  },
  {
    "title": "What the Options Market Tells Us About Danaher - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/options/24/06/39144610/what-the-options-market-tells-us-about-danaher",
    "time_published": "20240603T190045",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Investors with a lot of money to spend have taken a bearish stance on Danaher DHR. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Markets",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.87644"
      }
    ],
    "overall_sentiment_score": 0.164126,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "VLTO",
        "relevance_score": "0.101154",
        "ticker_sentiment_score": "0.033986",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.837979",
        "ticker_sentiment_score": "0.22804",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Danaher Earns RS Rating Upgrade",
    "url": "https://www.investors.com/ibd-data-stories/danaher-earns-rs-rating-upgrade/",
    "time_published": "20240603T070000",
    "authors": [
      "Investor's Business Daily",
      "INVESTOR'S BUSINESS DAILY"
    ],
    "summary": "On Monday, Danaher ( DHR ) received an upgrade to its Relative Strength ( RS ) Rating, from 68 to 72. X This proprietary rating measures technical performance by showing how a stock's price action over the last 52 weeks compares to that of the other stocks in our database.",
    "banner_image": "https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg",
    "source": "Investors Business Daily",
    "category_within_source": "n/a",
    "source_domain": "www.investors.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.538269"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.796627"
      }
    ],
    "overall_sentiment_score": 0.432568,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "AZN",
        "relevance_score": "0.360752",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.651499",
        "ticker_sentiment_score": "0.679831",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Danaher Unusual Options Activity For June 13 - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/options/24/06/39318347/danaher-unusual-options-activity-for-june-13",
    "time_published": "20240613T171637",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Whales with a lot of money to spend have taken a noticeably bearish stance on Danaher. Looking at options history for Danaher DHR we detected 38 trades. If we consider the specifics of each trade, it is accurate to state that 26% of the investors opened trades with bullish expectations and 52% ...",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Markets",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.316726"
      }
    ],
    "overall_sentiment_score": 0.212658,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "VLTO",
        "relevance_score": "0.109956",
        "ticker_sentiment_score": "0.034882",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.731269",
        "ticker_sentiment_score": "0.190761",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Here's Why Hold Strategy Is Apt for Danaher  ( DHR )  Stock Now",
    "url": "https://www.zacks.com/stock/news/2288506/heres-why-hold-strategy-is-apt-for-danaher-dhr-stock-now",
    "time_published": "20240614T140000",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Strength in the Life Sciences segment augurs well for Danaher (DHR). The company's measures to reward its shareholders are promising.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default332.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.769861"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.402364,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ITT",
        "relevance_score": "0.21686",
        "ticker_sentiment_score": "0.206939",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "CSL",
        "relevance_score": "0.145583",
        "ticker_sentiment_score": "0.154812",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "GFF",
        "relevance_score": "0.145583",
        "ticker_sentiment_score": "0.108417",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.417995",
        "ticker_sentiment_score": "0.504487",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Danaher  ( NYSE:DHR )  Upgraded by StockNews.com to \"Buy\"",
    "url": "https://www.defenseworld.net/2024/06/18/danaher-nysedhr-upgraded-by-stocknews-com-to-buy.html",
    "time_published": "20240618T071444",
    "authors": [
      "Defense World Staff"
    ],
    "summary": "StockNews.com upgraded shares of Danaher ( NYSE:DHR - Free Report ) from a hold rating to a buy rating in a research report report published on Monday morning. A number of other research analysts have also weighed in on DHR. Robert W.",
    "banner_image": "https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&Symbol=DHR",
    "source": "Stocknews.com",
    "category_within_source": "n/a",
    "source_domain": "www.defenseworld.net",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "1.0"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.976913"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.261931,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "JEF",
        "relevance_score": "0.040691",
        "ticker_sentiment_score": "0.065855",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NTRS",
        "relevance_score": "0.081276",
        "ticker_sentiment_score": "0.163696",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BAC",
        "relevance_score": "0.040691",
        "ticker_sentiment_score": "0.065855",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.738328",
        "ticker_sentiment_score": "0.428555",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Top Stock Reports for Walmart, Exxon Mobil & Danaher",
    "url": "https://www.zacks.com/research-daily/2290732/top-stock-reports-for-walmart-exxon-mobil-danaher",
    "time_published": "20240620T165200",
    "authors": [
      "Sheraz Mian"
    ],
    "summary": "Today's Research Daily features new research reports on 16 major stocks, including Walmart Inc. (WMT), Exxon Mobil Corporation (XOM) and Danaher Corporation (DHR), as well as a micro-cap stock GSI Technology, Inc. (GSIT).",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default301.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.284243,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GSIT",
        "relevance_score": "0.068698",
        "ticker_sentiment_score": "-0.098158",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.136888",
        "ticker_sentiment_score": "0.094142",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "XOM",
        "relevance_score": "0.204072",
        "ticker_sentiment_score": "0.196224",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Medical Facility Environmental Monitoring System Market size is set to grow by USD 114.3 million from 2024-2028 ... - PR Newswire",
    "url": "https://www.prnewswire.com/news-releases/medical-facility-environmental-monitoring-system-market-size-is-set-to-grow-by-usd-114-3-million-from-2024-2028--higher-efficiency-than-manual-monitoring-to-boost-the-market-growth-technavio-302177845.html",
    "time_published": "20240621T221500",
    "authors": [],
    "summary": "Medical Facility Environmental Monitoring System Market size is set to grow by USD 114.3 million from 2024-2028 ... PR ...",
    "banner_image": null,
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.257814,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MFCSF",
        "relevance_score": "0.035608",
        "ticker_sentiment_score": "0.240241",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "HLMAF",
        "relevance_score": "0.035608",
        "ticker_sentiment_score": "0.077978",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MLAB",
        "relevance_score": "0.035608",
        "ticker_sentiment_score": "0.077978",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WM",
        "relevance_score": "0.071145",
        "ticker_sentiment_score": "0.065083",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AZTA",
        "relevance_score": "0.035608",
        "ticker_sentiment_score": "0.077978",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "VAIAF",
        "relevance_score": "0.035608",
        "ticker_sentiment_score": "0.077978",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "XYL",
        "relevance_score": "0.035608",
        "ticker_sentiment_score": "0.077978",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.035608",
        "ticker_sentiment_score": "0.077978",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "If You Invested $100 In This Stock 10 Years Ago, You Would Have $500 Today - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/news/24/06/39437468/if-you-invested-100-in-this-stock-10-years-ago-you-would-have-500-today",
    "time_published": "20240621T170025",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Danaher DHR has outperformed the market over the past 10 years by 6.07% on an annualized basis producing an average annual return of 16.87%. Currently, Danaher has a market capitalization of $184.06 billion.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_0.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.238974,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.95919",
        "ticker_sentiment_score": "0.384695",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "The Zacks Analyst Blog Highlights Walmart, Exxon Mobil, Danaher and GSI Technology",
    "url": "https://www.zacks.com/stock/news/2291507/the-zacks-analyst-blog-highlights-walmart-exxon-mobil-danaher-and-gsi-technology",
    "time_published": "20240621T124900",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Walmart, Exxon Mobil, Danaher and GSI Technology are part of the Zacks top Analyst Blog.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/0d/436.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.25"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.25"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.25"
      }
    ],
    "overall_sentiment_score": 0.247383,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GSIT",
        "relevance_score": "0.210274",
        "ticker_sentiment_score": "-0.003346",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.261117",
        "ticker_sentiment_score": "0.112521",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMT",
        "relevance_score": "0.158519",
        "ticker_sentiment_score": "0.057569",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "XOM",
        "relevance_score": "0.310843",
        "ticker_sentiment_score": "0.190182",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Cardiac Marker Testing Market Surges to USD 8.69 Billion by 2031, Propelled by 8.8% CAGR - Verified Market Research\u00ae",
    "url": "https://www.benzinga.com/pressreleases/24/06/g39481612/cardiac-marker-testing-market-surges-to-usd-8-69-billion-by-2031-propelled-by-8-8-cagr-verified-ma",
    "time_published": "20240625T141500",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Lewes, Delaware, June 25, 2024 ( GLOBE NEWSWIRE ) -- The Global Cardiac Marker Testing Market is projected to grow at a CAGR of 8.8% from 2024 to 2031, according to a new report published by Verified Market Research\u00ae.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.220659,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BMXMF",
        "relevance_score": "0.027042",
        "ticker_sentiment_score": "0.023253",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TRIB",
        "relevance_score": "0.027042",
        "ticker_sentiment_score": "0.023253",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.027042",
        "ticker_sentiment_score": "0.023253",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "EKDHF",
        "relevance_score": "0.027042",
        "ticker_sentiment_score": "0.023253",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RSSS",
        "relevance_score": "0.027042",
        "ticker_sentiment_score": "0.167652",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.027042",
        "ticker_sentiment_score": "0.023253",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DSRLF",
        "relevance_score": "0.027042",
        "ticker_sentiment_score": "0.023253",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SEMHF",
        "relevance_score": "0.027042",
        "ticker_sentiment_score": "0.023253",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SZIHF",
        "relevance_score": "0.027042",
        "ticker_sentiment_score": "0.023253",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PHG",
        "relevance_score": "0.027042",
        "ticker_sentiment_score": "0.023253",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.027042",
        "ticker_sentiment_score": "0.023253",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "StockNews.com Downgrades Danaher  ( NYSE:DHR )  to Hold",
    "url": "https://www.defenseworld.net/2024/06/25/stocknews-com-downgrades-danaher-nysedhr-to-hold.html",
    "time_published": "20240625T053858",
    "authors": [
      "Defense World Staff"
    ],
    "summary": "Danaher ( NYSE:DHR - Get Free Report ) was downgraded by investment analysts at StockNews.com from a \"buy\" rating to a \"hold\" rating in a research report issued on Tuesday. Several other equities research analysts also recently weighed in on the company.",
    "banner_image": "https://www.marketbeat.com/logos/danaher-co-logo-1200x675.png?v=20210524093152",
    "source": "Stocknews.com",
    "category_within_source": "n/a",
    "source_domain": "www.defenseworld.net",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "1.0"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.967645"
      },
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.161647"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.215351,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "JEF",
        "relevance_score": "0.046724",
        "ticker_sentiment_score": "0.032412",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "C",
        "relevance_score": "0.046724",
        "ticker_sentiment_score": "0.032412",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BAC",
        "relevance_score": "0.046724",
        "ticker_sentiment_score": "0.032412",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.046724",
        "ticker_sentiment_score": "0.037769",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Protein Expression Market size is set to grow by USD 3.40 billion from 2024-2028, Increasing advances in proteomics ... - PR Newswire",
    "url": "https://www.prnewswire.com/news-releases/protein-expression-market-size-is-set-to-grow-by-usd-3-40-billion-from-2024-2028--increasing-advances-in-proteomics-research-boost-the-market-technavio-302185318.html",
    "time_published": "20240628T213100",
    "authors": [],
    "summary": "Protein Expression Market size is set to grow by USD 3.40 billion from 2024-2028, Increasing advances in proteomics ... PR ...",
    "banner_image": null,
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.172504,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "A",
        "relevance_score": "0.035983",
        "ticker_sentiment_score": "0.054656",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GOOG",
        "relevance_score": "0.035983",
        "ticker_sentiment_score": "0.055498",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SUVPF",
        "relevance_score": "0.035983",
        "ticker_sentiment_score": "0.054656",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.035983",
        "ticker_sentiment_score": "0.054656",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GNNSF",
        "relevance_score": "0.035983",
        "ticker_sentiment_score": "0.054656",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.071892",
        "ticker_sentiment_score": "0.057587",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BIO",
        "relevance_score": "0.071892",
        "ticker_sentiment_score": "0.057587",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "QGEN",
        "relevance_score": "0.035983",
        "ticker_sentiment_score": "0.054656",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "AMGN",
        "relevance_score": "0.035983",
        "ticker_sentiment_score": "0.054656",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PFE",
        "relevance_score": "0.035983",
        "ticker_sentiment_score": "0.054656",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.035983",
        "ticker_sentiment_score": "0.054656",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "'s 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet - Dutch Bros  ( NYSE:BROS ) , Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/top-stories/24/06/39551432/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet",
    "time_published": "20240628T150346",
    "authors": [
      "Chris Katje"
    ],
    "summary": "Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks just under the surface and warrant attention. Investors are constantly on the hunt for undervalued, under-followed and emerging stocks.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/06/28/Stock-Whisper-Index-Logo-6-copy.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.2"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.2"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.2"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.2"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.413559"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.2"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.310843"
      }
    ],
    "overall_sentiment_score": 0.282808,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BIG",
        "relevance_score": "0.053509",
        "ticker_sentiment_score": "0.239851",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "WEN",
        "relevance_score": "0.053509",
        "ticker_sentiment_score": "0.194777",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "FIVE",
        "relevance_score": "0.053509",
        "ticker_sentiment_score": "0.239851",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BCS",
        "relevance_score": "0.053509",
        "ticker_sentiment_score": "-0.002003",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "C",
        "relevance_score": "0.159569",
        "ticker_sentiment_score": "0.094924",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TJX",
        "relevance_score": "0.262805",
        "ticker_sentiment_score": "0.319366",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MS",
        "relevance_score": "0.053509",
        "ticker_sentiment_score": "-0.002003",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RIVN",
        "relevance_score": "0.106778",
        "ticker_sentiment_score": "0.098601",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BROS",
        "relevance_score": "0.262805",
        "ticker_sentiment_score": "0.28664",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.211652",
        "ticker_sentiment_score": "0.227166",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Global Microscopy Market to Reach USD 10.6 Billion by 2029 driven by Healthcare Innovations | MarketsandMarkets\u2122",
    "url": "https://www.prnewswire.com/news-releases/global-microscopy-market-to-reach-usd-10-6-billion-by-2029-driven-by-healthcare-innovations--marketsandmarkets-302189451.html",
    "time_published": "20240704T103000",
    "authors": [
      "MarketsandMarkets"
    ],
    "summary": "CHICAGO, July 4, 2024 /PRNewswire/ -- The global microscopy market is poised for significant growth, expected to reach USD 10.6 billion by 2029 from USD 8.1 billion in 2024, growing at a CAGR of 5.4%.",
    "banner_image": "https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg?p=facebook",
    "source": "PR Newswire",
    "category_within_source": "n/a",
    "source_domain": "www.prnewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.416984,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.220809",
        "ticker_sentiment_score": "0.312748",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.220809",
        "ticker_sentiment_score": "0.312748",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Single Use Bioprocessing Market: $17.7B to $34.9B Growth Forecast  ( 2024-2029 )  | MarketsandMarkets\u2122",
    "url": "https://www.benzinga.com/pressreleases/24/07/g39633540/single-use-bioprocessing-market-17-7b-to-34-9b-growth-forecast-2024-2029-marketsandmarkets",
    "time_published": "20240704T101500",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Chicago, July 04, 2024 ( GLOBE NEWSWIRE ) -- The \"Single Use Bioprocessing Market Size, Share & Trends by Product ( Equipment ( Bioreactors, Mixers, Filtration, Chromatography ) , Consumables ( Filters, Bags, Assemblies, Sensors ) ) , Application, Workflow, Molecule Type ( mAbs, Vaccines, CGT, ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.222034,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "AULSF",
        "relevance_score": "0.045918",
        "ticker_sentiment_score": "0.133321",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SUVPF",
        "relevance_score": "0.137148",
        "ticker_sentiment_score": "0.122083",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GE",
        "relevance_score": "0.045918",
        "ticker_sentiment_score": "0.133321",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.091684",
        "ticker_sentiment_score": "0.109693",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.045918",
        "ticker_sentiment_score": "0.090638",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "$100 Invested In Danaher 10 Years Ago Would Be Worth This Much Today - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/news/24/07/39713322/100-invested-in-danaher-10-years-ago-would-be-worth-this-much-today",
    "time_published": "20240710T160045",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Danaher DHR has outperformed the market over the past 10 years by 5.49% on an annualized basis producing an average annual return of 16.45%. Currently, Danaher has a market capitalization of $177.61 billion.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_0.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.238974,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.95919",
        "ticker_sentiment_score": "0.384695",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Top Analyst Reports for Danaher, Morgan Stanley & Pfizer",
    "url": "https://www.zacks.com/research-daily/2299883/top-analyst-reports-for-danaher-morgan-stanley-pfizer",
    "time_published": "20240711T173800",
    "authors": [
      "Sheraz Mian"
    ],
    "summary": "Today's Research Daily features new research reports on 16 major stocks, including Danaher Corporation (DHR), Morgan Stanley (MS) and Pfizer Inc. (PFE), as well as two micro-cap stocks, Elite Pharmaceuticals, Inc. (ELTP) and Oil-Dri Corporation of America (ODC).",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default235.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.538269"
      },
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.14995,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MSBHF",
        "relevance_score": "0.08687",
        "ticker_sentiment_score": "0.137126",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PFE",
        "relevance_score": "0.08687",
        "ticker_sentiment_score": "-0.047028",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.172713",
        "ticker_sentiment_score": "-0.115457",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMT",
        "relevance_score": "0.08687",
        "ticker_sentiment_score": "-0.116344",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Should You Invest in the Invesco Global Water ETF  ( PIO ) ?",
    "url": "https://www.zacks.com/stock/news/2299676/should-you-invest-in-the-invesco-global-water-etf-pio",
    "time_published": "20240711T102006",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Sector ETF report for PIO ...",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default88.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "1.0"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.161618,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ROP",
        "relevance_score": "0.136113",
        "ticker_sentiment_score": "0.07192",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "IVZ",
        "relevance_score": "0.392948",
        "ticker_sentiment_score": "0.161327",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PNR",
        "relevance_score": "0.136113",
        "ticker_sentiment_score": "0.07192",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.136113",
        "ticker_sentiment_score": "0.07192",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Should You Invest in the Invesco Water Resources ETF  ( PHO ) ?",
    "url": "https://www.zacks.com/stock/news/2299684/should-you-invest-in-the-invesco-water-resources-etf-pho",
    "time_published": "20240711T102005",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Sector ETF report for PHO ...",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default215.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.179465,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "SPGI",
        "relevance_score": "0.195814",
        "ticker_sentiment_score": "0.200241",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ROP",
        "relevance_score": "0.131284",
        "ticker_sentiment_score": "0.070609",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "IVZ",
        "relevance_score": "0.380012",
        "ticker_sentiment_score": "0.172774",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.131284",
        "ticker_sentiment_score": "0.070609",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ECL",
        "relevance_score": "0.131284",
        "ticker_sentiment_score": "0.070609",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "The Zacks Analyst Blog Highlights Danaher, Morgan Stanley, Pfizer, Elite Pharmaceuticals and Oil-Dri",
    "url": "https://www.zacks.com/stock/news/2300964/the-zacks-analyst-blog-highlights-danaher-morgan-stanley-pfizer-elite-pharmaceuticals-and-oil-dri",
    "time_published": "20240712T142000",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Danaher, Morgan Stanley, Pfizer, Elite Pharmaceuticals and Oil-Dri are part of the Zacks top Analyst Blog.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/89/447.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.25"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.796627"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.25"
      },
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.25"
      }
    ],
    "overall_sentiment_score": 0.176129,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MSBHF",
        "relevance_score": "0.059194",
        "ticker_sentiment_score": "0.133",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MS",
        "relevance_score": "0.233556",
        "ticker_sentiment_score": "0.134376",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PFE",
        "relevance_score": "0.233556",
        "ticker_sentiment_score": "0.080783",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.344074",
        "ticker_sentiment_score": "0.087802",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ODC",
        "relevance_score": "0.176287",
        "ticker_sentiment_score": "0.108453",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMT",
        "relevance_score": "0.059194",
        "ticker_sentiment_score": "-0.111217",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "This 'Corporate Raider' Is Urging Us To Buy These 8%+ Paying Funds Now",
    "url": "https://www.forbes.com/sites/michaelfoster/2024/07/13/this-corporate-raider-is-urging-us-to-buy-these-8-paying-funds-now/",
    "time_published": "20240713T131500",
    "authors": [
      "Michael Foster"
    ],
    "summary": "Closed-end funds ( CEFs ) -our favorite 8%+ yielding investments-have a new ( and popular! ) fan. And he's making a big move I see sending CEF prices higher. I'm talking about Bill Ackman, one of the best-known activist investors out there.",
    "banner_image": "https://imageio.forbes.com/specials-images/imageserve/668d7fcaad691fa95e08e836/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds",
    "source": "Forbes",
    "category_within_source": "n/a",
    "source_domain": "www.forbes.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "IPO",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.25"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.99999"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.25"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.25"
      }
    ],
    "overall_sentiment_score": 0.30002,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BLK",
        "relevance_score": "0.033609",
        "ticker_sentiment_score": "0.039147",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MSFT",
        "relevance_score": "0.067158",
        "ticker_sentiment_score": "0.15548",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TGT",
        "relevance_score": "0.067158",
        "ticker_sentiment_score": "-0.017223",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WEN",
        "relevance_score": "0.067158",
        "ticker_sentiment_score": "-0.017223",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HLF",
        "relevance_score": "0.067158",
        "ticker_sentiment_score": "-0.017223",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MA",
        "relevance_score": "0.033609",
        "ticker_sentiment_score": "0.216206",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "STRR",
        "relevance_score": "0.033609",
        "ticker_sentiment_score": "0.128415",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "V",
        "relevance_score": "0.067158",
        "ticker_sentiment_score": "0.15548",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "AXP",
        "relevance_score": "0.067158",
        "ticker_sentiment_score": "0.224935",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "UNH",
        "relevance_score": "0.067158",
        "ticker_sentiment_score": "0.15548",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.067158",
        "ticker_sentiment_score": "0.15548",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PSHZF",
        "relevance_score": "0.033609",
        "ticker_sentiment_score": "0.041391",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Is Invesco Water Resources ETF a Strong ETF Right Now? - Invesco S&P Global Water Index ETF  ( ARCA:CGW ) , Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/news/large-cap/24/07/39769141/is-invesco-water-resources-etf-a-strong-etf-right-now",
    "time_published": "20240715T195934",
    "authors": [
      "Zacks"
    ],
    "summary": "The Invesco Water Resources ETF PHO was launched on 12/06/2005, and is a smart beta exchange traded fund designed to offer broad exposure to the Industrials ETFs category of the market.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/07/15/giorgio-trovato-wyxqqpyfnk8-unsplash.jpg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.999892"
      }
    ],
    "overall_sentiment_score": 0.278353,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "SPGI",
        "relevance_score": "0.182967",
        "ticker_sentiment_score": "0.222283",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ROP",
        "relevance_score": "0.122581",
        "ticker_sentiment_score": "0.108538",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "IVZ",
        "relevance_score": "0.30021",
        "ticker_sentiment_score": "0.292954",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.122581",
        "ticker_sentiment_score": "0.108538",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ECL",
        "relevance_score": "0.122581",
        "ticker_sentiment_score": "0.108538",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Is Invesco Water Resources ETF  ( PHO )  a Strong ETF Right Now?",
    "url": "https://www.zacks.com/stock/news/2301339/is-invesco-water-resources-etf-pho-a-strong-etf-right-now",
    "time_published": "20240715T102005",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Smart Beta ETF report for PHO ...",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default253.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.999992"
      }
    ],
    "overall_sentiment_score": 0.25561,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "SPGI",
        "relevance_score": "0.178021",
        "ticker_sentiment_score": "0.186978",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ROP",
        "relevance_score": "0.119235",
        "ticker_sentiment_score": "0.067585",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "IVZ",
        "relevance_score": "0.29234",
        "ticker_sentiment_score": "0.264884",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.119235",
        "ticker_sentiment_score": "0.067585",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ECL",
        "relevance_score": "0.119235",
        "ticker_sentiment_score": "0.067585",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": " ( DHR )  - Analyzing Danaher's Short Interest - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/short-sellers/24/07/39802878/dhr-analyzing-danahers-short-interest",
    "time_published": "20240716T193024",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Danaher's DHR short percent of float has risen 11.11% since its last report. The company recently reported that it has 8.61 million shares sold short, which is 1.3% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.24 days to cover their ...",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.289997,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.212115",
        "ticker_sentiment_score": "0.151778",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Danaher  ( DHR )  Upgraded to Buy: Here's What You Should Know",
    "url": "https://www.zacks.com/stock/news/2302814/danaher-dhr-upgraded-to-buy-heres-what-you-should-know",
    "time_published": "20240716T160018",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Danaher (DHR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default238.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.997845"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.658903"
      }
    ],
    "overall_sentiment_score": 0.309332,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.372448",
        "ticker_sentiment_score": "0.380736",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Is Danaher  ( DHR )  Stock Outpacing Its Conglomerates Peers This Year?",
    "url": "https://www.zacks.com/stock/news/2302449/is-danaher-dhr-stock-outpacing-its-conglomerates-peers-this-year",
    "time_published": "20240716T134012",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Here is how Danaher (DHR) and Honeywell International Inc. (HON) have performed compared to their sector so far this year.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default223.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.614606"
      }
    ],
    "overall_sentiment_score": 0.200165,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "HON",
        "relevance_score": "0.520773",
        "ticker_sentiment_score": "0.238516",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.797189",
        "ticker_sentiment_score": "0.292107",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Genomics Market Projected to Surpass USD 411.35 Billion by 2031, Witnessing 19.4% CAGR Growth",
    "url": "https://www.benzinga.com/pressreleases/24/07/g39813983/genomics-market-projected-to-surpass-usd-411-35-billion-by-2031-witnessing-19-4-cagr-growth",
    "time_published": "20240717T123000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Westford, USA, July 17, 2024 ( GLOBE NEWSWIRE ) -- SkyQuest projects that the global Genomics Market will attain a value of USD 411.35 billion by 2031, with a CAGR of 19.4% during the forecast period ( 2024-2031 ) . Genomics has been scientifically proven in the prevention, management and ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.282161,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "VCYT",
        "relevance_score": "0.042953",
        "ticker_sentiment_score": "0.046717",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "A",
        "relevance_score": "0.042953",
        "ticker_sentiment_score": "0.046717",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TXG",
        "relevance_score": "0.042953",
        "ticker_sentiment_score": "0.046717",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TWST",
        "relevance_score": "0.042953",
        "ticker_sentiment_score": "0.046717",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PSNL",
        "relevance_score": "0.042953",
        "ticker_sentiment_score": "0.046717",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ILMN",
        "relevance_score": "0.042953",
        "ticker_sentiment_score": "0.181222",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BIO",
        "relevance_score": "0.042953",
        "ticker_sentiment_score": "0.046717",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.042953",
        "ticker_sentiment_score": "0.046717",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NTRA",
        "relevance_score": "0.042953",
        "ticker_sentiment_score": "0.046717",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PACB",
        "relevance_score": "0.042953",
        "ticker_sentiment_score": "0.046717",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MYGN",
        "relevance_score": "0.042953",
        "ticker_sentiment_score": "0.046717",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ONTTF",
        "relevance_score": "0.042953",
        "ticker_sentiment_score": "0.046717",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ERFSF",
        "relevance_score": "0.042953",
        "ticker_sentiment_score": "0.046717",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "$100 Invested In Danaher 10 Years Ago Would Be Worth This Much Today - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/news/24/07/39845237/100-invested-in-danaher-10-years-ago-would-be-worth-this-much-today",
    "time_published": "20240718T173018",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Danaher DHR has outperformed the market over the past 10 years by 6.31% on an annualized basis producing an average annual return of 17.12%. Currently, Danaher has a market capitalization of $182.69 billion.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_4.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.238974,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.95919",
        "ticker_sentiment_score": "0.384695",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "3M  ( MMM )  Rises 13.4% in 3 Months: How Should You Play the Stock?",
    "url": "https://www.zacks.com/stock/news/2304576/3m-mmm-rises-134-in-3-months-how-should-you-play-the-stock",
    "time_published": "20240718T142500",
    "authors": [
      "Avisekh Bhattacharjee"
    ],
    "summary": "3M (MMM) is making strides in the diversified technology services market, which makes the stock worth a watch amid certain headwinds.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/d9/573.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.723405"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.295491,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ITT",
        "relevance_score": "0.093108",
        "ticker_sentiment_score": "0.19388",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "HON",
        "relevance_score": "0.093108",
        "ticker_sentiment_score": "0.113619",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.093108",
        "ticker_sentiment_score": "0.19388",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Danaher  ( DHR )  Gears Up to Post Q2 Earnings: What to Expect",
    "url": "https://www.zacks.com/stock/news/2304555/danaher-dhr-gears-up-to-post-q2-earnings-what-to-expect",
    "time_published": "20240718T141900",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Danaher's (DHR) second-quarter earnings are likely to be aided by strength in the Diagnostics and Life Sciences segment.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default104.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.99998"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.215089,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ITT",
        "relevance_score": "0.13347",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ALLE",
        "relevance_score": "0.13347",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MMM",
        "relevance_score": "0.13347",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.59928",
        "ticker_sentiment_score": "0.426965",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Digital PCR Market: $10.0B to $14.8B Growth Forecast  ( 2024-2029 )  | MarketsandMarkets\u2122",
    "url": "https://www.benzinga.com/pressreleases/24/07/g39836891/digital-pcr-market-10-0b-to-14-8b-growth-forecast-2024-2029-marketsandmarkets",
    "time_published": "20240718T123000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Chicago, July 18, 2024 ( GLOBE NEWSWIRE ) -- The \"Digital PCR Market Size, Share & Trends by Offering ( Product ( Reagents & Consumables, Instrument ) , Software, Services ) , Application ( Clinical ( infectious, Oncology ) , Research, Forensic, Environmental ) - Global Forecast to 2029\" report ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      }
    ],
    "overall_sentiment_score": 0.245629,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BMXMF",
        "relevance_score": "0.032207",
        "ticker_sentiment_score": "0.046874",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ENZ",
        "relevance_score": "0.032207",
        "ticker_sentiment_score": "0.046874",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "A",
        "relevance_score": "0.032207",
        "ticker_sentiment_score": "0.046874",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.032207",
        "ticker_sentiment_score": "0.046874",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.032207",
        "ticker_sentiment_score": "0.046874",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.064362",
        "ticker_sentiment_score": "0.089099",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BIO",
        "relevance_score": "0.032207",
        "ticker_sentiment_score": "0.046874",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "QGEN",
        "relevance_score": "0.032207",
        "ticker_sentiment_score": "0.046874",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LAB",
        "relevance_score": "0.032207",
        "ticker_sentiment_score": "0.046874",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.064362",
        "ticker_sentiment_score": "0.115153",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "QDEL",
        "relevance_score": "0.032207",
        "ticker_sentiment_score": "0.046874",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Will Danaher  ( DHR )  Beat Estimates Again in Its Next Earnings Report?",
    "url": "https://www.zacks.com/stock/news/2305527/will-danaher-dhr-beat-estimates-again-in-its-next-earnings-report",
    "time_published": "20240719T161014",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Danaher (DHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default179.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.99989"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.333444,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.424317",
        "ticker_sentiment_score": "0.500174",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Market Whales and Their Recent Bets on DHR Options - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/options/24/07/39889159/market-whales-and-their-recent-bets-on-dhr-options",
    "time_published": "20240722T163046",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Investors with a lot of money to spend have taken a bullish stance on Danaher DHR. We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Markets",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.316726"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.182228,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "EVR",
        "relevance_score": "0.097062",
        "ticker_sentiment_score": "0.211857",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "VLTO",
        "relevance_score": "0.097062",
        "ticker_sentiment_score": "0.033619",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.670742",
        "ticker_sentiment_score": "0.308096",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Danaher  ( DHR )  Q2 Earnings Beat, Biotechnology Sales Dip Y/Y",
    "url": "https://www.zacks.com/stock/news/2307200/danaher-dhr-q2-earnings-beat-biotechnology-sales-dip-yy",
    "time_published": "20240723T162200",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Danaher's (DHR) second-quarter earnings and revenues surpass estimates. However, the company's performance reflects a decrease in core sales in the Biotechnology segment.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default56.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.938238"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.112886,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "PDD",
        "relevance_score": "0.173749",
        "ticker_sentiment_score": "0.192649",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "CSL",
        "relevance_score": "0.116348",
        "ticker_sentiment_score": "0.089346",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GFF",
        "relevance_score": "0.116348",
        "ticker_sentiment_score": "0.097208",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.535653",
        "ticker_sentiment_score": "-0.065211",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Here's Why Danaher Stock Surged Today",
    "url": "https://www.fool.com/investing/2024/07/23/heres-why-danaher-stock-surged-today/",
    "time_published": "20240723T155045",
    "authors": [
      "Lee Samaha"
    ],
    "summary": "The biotechnology, diagnostics, and life sciences company looks set to return to its long-term growth rate.",
    "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F784266%2Flife-sciences-stocks-to-buy-best-medical-stocks.jpg&op=resize&w=700",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999894"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.538269"
      }
    ],
    "overall_sentiment_score": 0.152567,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.432291",
        "ticker_sentiment_score": "0.174881",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Danaher Posts Upbeat Earnings, Joins Spotify, MSCI, Owens & Minor And Other Big Stocks Moving Higher On Tuesday - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/news/24/07/39909934/danaher-posts-upbeat-earnings-joins-spotify-msci-owens-minor-and-other-big-stocks-moving-higher-on-t",
    "time_published": "20240723T150422",
    "authors": [
      "Avi Kapoor"
    ],
    "summary": "U.S. stocks were mixed, with the Dow Jones index falling around 50 points on Tuesday. Shares of Danaher Corporation DHR rose sharply during Tuesday's session after the company reported better-than-expected second quarter earnings.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/07/23/xrdDAFySnxfpTI2-j4953240827673953644-t23.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.142857"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.142857"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.142857"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.142857"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.142857"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.142857"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.999999"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.142857"
      }
    ],
    "overall_sentiment_score": 0.416301,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "PCT",
        "relevance_score": "0.147818",
        "ticker_sentiment_score": "0.427518",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "SAP",
        "relevance_score": "0.147818",
        "ticker_sentiment_score": "0.224442",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SPOT",
        "relevance_score": "0.147818",
        "ticker_sentiment_score": "0.282289",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "HIMS",
        "relevance_score": "0.147818",
        "ticker_sentiment_score": "0.427518",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "MSCI",
        "relevance_score": "0.147818",
        "ticker_sentiment_score": "0.476302",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "ZIONL",
        "relevance_score": "0.07423",
        "ticker_sentiment_score": "0.253123",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "CCK",
        "relevance_score": "0.147818",
        "ticker_sentiment_score": "0.404566",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "OMI",
        "relevance_score": "0.147818",
        "ticker_sentiment_score": "0.124552",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "KREF",
        "relevance_score": "0.147818",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.290607",
        "ticker_sentiment_score": "0.155979",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BEAM",
        "relevance_score": "0.220141",
        "ticker_sentiment_score": "0.146493",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "IRDM",
        "relevance_score": "0.147818",
        "ticker_sentiment_score": "0.296051",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MESO",
        "relevance_score": "0.220141",
        "ticker_sentiment_score": "-0.265948",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "KNSA",
        "relevance_score": "0.147818",
        "ticker_sentiment_score": "0.365484",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "PNR",
        "relevance_score": "0.147818",
        "ticker_sentiment_score": "0.365484",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "SMR",
        "relevance_score": "0.147818",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "IPAR",
        "relevance_score": "0.147818",
        "ticker_sentiment_score": "0.466869",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "UP",
        "relevance_score": "0.07423",
        "ticker_sentiment_score": "0.346992",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BRO",
        "relevance_score": "0.147818",
        "ticker_sentiment_score": "0.510113",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "MMYT",
        "relevance_score": "0.147818",
        "ticker_sentiment_score": "0.191816",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Life Science Giant Danaher's Q2 Earnings Beat Estimates On 'Sustained Positive Momentum In Bioprocessing Business', Maintains Guidance - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/news/earnings/24/07/39907956/life-science-giant-danahers-q2-earnings-beat-estimates-on-sustained-positive-momentum-in-bioprocess",
    "time_published": "20240723T135934",
    "authors": [
      "Vandana Singh"
    ],
    "summary": "On Tuesday, Danaher Corp's DHR second quarter sales decreased 3% year-over-year to $$5.743 billion, beating the consensus of $5.59 billion. Non-GAAP core revenue decreased by 3.5%, compared to the expectations of a decline in the mid-single digits.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/07/23/Danaher.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.459462"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.105135,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.718897",
        "ticker_sentiment_score": "-0.173849",
        "ticker_sentiment_label": "Somewhat-Bearish"
      }
    ]
  },
  {
    "title": "Danaher  ( DHR )  Q2 Earnings and Revenues Beat Estimates",
    "url": "https://www.zacks.com/stock/news/2306570/danaher-dhr-q2-earnings-and-revenues-beat-estimates",
    "time_published": "20240723T111004",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Danaher (DHR) delivered earnings and revenue surprises of 9.55% and 2.78%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default237.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999992"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.162323,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.406745",
        "ticker_sentiment_score": "0.166389",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "3M  ( MMM )  Stock Before Q2 Earnings: To Buy or Not to Buy?",
    "url": "https://www.zacks.com/stock/news/2308181/3m-mmm-stock-before-q2-earnings-to-buy-or-not-to-buy",
    "time_published": "20240724T152000",
    "authors": [
      "Avisekh Bhattacharjee"
    ],
    "summary": "As 3M (MMM) gears up to report second-quarter earnings, let us find out how the expectations stack up and whether it is the right time to buy the stock.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/84/473.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.316726"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.99237"
      },
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.306591,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ITT",
        "relevance_score": "0.096283",
        "ticker_sentiment_score": "0.238067",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MMM",
        "relevance_score": "0.327987",
        "ticker_sentiment_score": "0.45301",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "HON",
        "relevance_score": "0.096283",
        "ticker_sentiment_score": "0.238067",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.096283",
        "ticker_sentiment_score": "0.238067",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Company News for Jul 24, 2024",
    "url": "https://www.zacks.com/stock/news/2307669/company-news-for-jul-24-2024",
    "time_published": "20240724T131900",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Companies in The News Are: DHR, GM, PM, ARE ...",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/ac/479.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.857896"
      },
      {
        "topic": "Real Estate & Construction",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.041526,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "ARE",
        "relevance_score": "0.318897",
        "ticker_sentiment_score": "0.161078",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PM",
        "relevance_score": "0.588876",
        "ticker_sentiment_score": "0.144761",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GM",
        "relevance_score": "0.588876",
        "ticker_sentiment_score": "-0.305314",
        "ticker_sentiment_label": "Somewhat-Bearish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.588876",
        "ticker_sentiment_score": "0.144761",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "DNA Diagnostics Market: $13.3B to $21.2B Growth Forecast  ( 2024-2029 )  | MarketsandMarkets\u2122",
    "url": "https://www.benzinga.com/pressreleases/24/07/g39930424/dna-diagnostics-market-13-3b-to-21-2b-growth-forecast-2024-2029-marketsandmarkets",
    "time_published": "20240724T123000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Chicago, July 24, 2024 ( GLOBE NEWSWIRE ) -- The \"DNA Diagnostics Market Size, Share & Trends by Product ( Instruments, Reagents & Kits, Services & Software ) , Technology ( PCR, Mass Spectroscopy, Microarrays ) , Application ( Infectious Disease ( Hepatitis, HIV, HPV ) , Oncology ) , Specimen ( ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.684621"
      }
    ],
    "overall_sentiment_score": 0.287199,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ILMN",
        "relevance_score": "0.104531",
        "ticker_sentiment_score": "0.171726",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.034933",
        "ticker_sentiment_score": "0.09816",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Top Stock Reports for Costco, Danaher & ServiceNow",
    "url": "https://www.zacks.com/research-daily/2309676/top-stock-reports-for-costco-danaher-servicenow",
    "time_published": "20240726T201800",
    "authors": [
      "Mark Vickery"
    ],
    "summary": "Today's Research Daily features new research reports on 16 major stocks, including Costco Wholesale Corporation (COST), Danaher Corporation (DHR) and ServiceNow, Inc. (NOW), as well as two micro-cap stocks AMREP Corporation (AXR) and Autoscope Technologies Corporation (AATC).",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/58/2932.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.351991,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "AATC",
        "relevance_score": "0.064973",
        "ticker_sentiment_score": "0.211982",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "COST",
        "relevance_score": "0.064973",
        "ticker_sentiment_score": "0.49506",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.064973",
        "ticker_sentiment_score": "0.239283",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "NOW",
        "relevance_score": "0.193207",
        "ticker_sentiment_score": "0.110155",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "It's Time for Some Enthusiasm for Small-Cap Stocks",
    "url": "https://www.fool.com/investing/2024/07/26/its-time-for-some-enthusiasm-for-small-cap-stocks/",
    "time_published": "20240726T185300",
    "authors": [
      "Motley Fool Staff"
    ],
    "summary": "After a year and a half of big names pushing the market forward, some smaller companies are starting to go on a run.",
    "banner_image": "https://g.foolcdn.com/editorial/images/784353/mfm_19.jpg",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.2"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.2"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.2"
      },
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.682689"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.2"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.995973"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.2"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.999981"
      }
    ],
    "overall_sentiment_score": 0.16304,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "NFLX",
        "relevance_score": "0.042464",
        "ticker_sentiment_score": "0.058436",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CVS",
        "relevance_score": "0.006069",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GOOG",
        "relevance_score": "0.018206",
        "ticker_sentiment_score": "0.133557",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVDA",
        "relevance_score": "0.006069",
        "ticker_sentiment_score": "0.155642",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "AAPL",
        "relevance_score": "0.012138",
        "ticker_sentiment_score": "0.025564",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CRWD",
        "relevance_score": "0.036402",
        "ticker_sentiment_score": "-0.046598",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WING",
        "relevance_score": "0.006069",
        "ticker_sentiment_score": "0.072375",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SPOT",
        "relevance_score": "0.006069",
        "ticker_sentiment_score": "0.207624",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TTD",
        "relevance_score": "0.012138",
        "ticker_sentiment_score": "0.068105",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LUV",
        "relevance_score": "0.006069",
        "ticker_sentiment_score": "-0.075366",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.018206",
        "ticker_sentiment_score": "0.133179",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RBRK",
        "relevance_score": "0.018206",
        "ticker_sentiment_score": "0.040358",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FIVE",
        "relevance_score": "0.012138",
        "ticker_sentiment_score": "-0.037404",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SG",
        "relevance_score": "0.006069",
        "ticker_sentiment_score": "0.155642",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "ADBE",
        "relevance_score": "0.006069",
        "ticker_sentiment_score": "0.040792",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CHWY",
        "relevance_score": "0.006069",
        "ticker_sentiment_score": "0.059121",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CMG",
        "relevance_score": "0.012138",
        "ticker_sentiment_score": "0.152705",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "AMZN",
        "relevance_score": "0.018206",
        "ticker_sentiment_score": "0.044933",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "3M  ( MMM )  Q2 Earnings & Revenues Surpass Estimates, Rise Y/Y",
    "url": "https://www.zacks.com/stock/news/2310327/3m-mmm-q2-earnings-revenues-surpass-estimates-rise-yy",
    "time_published": "20240726T172500",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "3M (MMM) reports y/y adjusted revenue growth of 1.1% in second-quarter 2024 results.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default357.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999813"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.10895,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "MMM",
        "relevance_score": "0.250902",
        "ticker_sentiment_score": "0.153023",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "CSL",
        "relevance_score": "0.101797",
        "ticker_sentiment_score": "0.142322",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HON",
        "relevance_score": "0.101797",
        "ticker_sentiment_score": "0.128326",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.101797",
        "ticker_sentiment_score": "-0.021757",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "HTHIY or DHR: Which Is the Better Value Stock Right Now?",
    "url": "https://www.zacks.com/stock/news/2310190/hthiy-or-dhr-which-is-the-better-value-stock-right-now",
    "time_published": "20240726T154012",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "HTHIY vs. DHR: Which Stock Is the Better Value Option?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default205.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.890401"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.491154,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "HTHIF",
        "relevance_score": "0.190417",
        "ticker_sentiment_score": "0.350923",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.60098",
        "ticker_sentiment_score": "0.542228",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Freeport-McMoRan, Pfizer, Danaher And An Industrial Stock: CNBC's 'Final Trades' - Freeport-McMoRan  ( NYSE:FCX ) , Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/trading-ideas/long-ideas/24/07/39983971/freeport-mcmoran-pfizer-danaher-and-an-industrial-stock-cnbcs-final-trades",
    "time_published": "20240726T130819",
    "authors": [
      "Avi Kapoor"
    ],
    "summary": "On CNBC's \"Halftime Report Final Trades,\" Bryn Talkington of Requisite Capital Management named Freeport-McMoRan Inc. FCX as her final trade. On July 23, Freeport-McMoRan said second-quarter revenue came in at $6.62 billion, beating the consensus of $5.99 billion.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/07/26/xrdDAF-NNvttUM10-j1658873036453876435-t2.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.891286"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.5"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.176005,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "FCX",
        "relevance_score": "0.488007",
        "ticker_sentiment_score": "-0.040724",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "URI",
        "relevance_score": "0.488007",
        "ticker_sentiment_score": "0.337807",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PFE",
        "relevance_score": "0.488007",
        "ticker_sentiment_score": "0.145612",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.488007",
        "ticker_sentiment_score": "0.340722",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "The Zacks Analyst Blog Highlights Costco, Danaher, ServiceNow, AMREP and Autoscope",
    "url": "https://www.zacks.com/stock/news/2310511/the-zacks-analyst-blog-highlights-costco-danaher-servicenow-amrep-and-autoscope",
    "time_published": "20240729T110200",
    "authors": [
      "Zacks Investment Research"
    ],
    "summary": "Costco, Danaher, ServiceNow, AMREP and Autoscope are included in this Analyst Blog.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/a0/810.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.25"
      },
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.451494"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.25"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.25"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.310843"
      }
    ],
    "overall_sentiment_score": 0.295316,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "AATC",
        "relevance_score": "0.174272",
        "ticker_sentiment_score": "0.133472",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "COST",
        "relevance_score": "0.174272",
        "ticker_sentiment_score": "0.222331",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "AXR",
        "relevance_score": "0.21686",
        "ticker_sentiment_score": "0.116633",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.174272",
        "ticker_sentiment_score": "0.140545",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NOW",
        "relevance_score": "0.21686",
        "ticker_sentiment_score": "0.092346",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Jim Cramer Says No To This Health Care Stock, Recommends Holding On To Constellation Energy: 'It's Up A Huge Amount' - Meta Platforms  ( NASDAQ:META ) ",
    "url": "https://www.benzinga.com/trading-ideas/long-ideas/24/07/40036664/jim-cramer-says-no-to-this-health-care-stock-recommends-holding-on-to-constellation-ener",
    "time_published": "20240730T124805",
    "authors": [
      "Avi Kapoor"
    ],
    "summary": "On CNBC's \"Mad Money Lightning Round,\" Jim Cramer said no to Illumina, Inc. ILMN, adding that he likes Danaher Corporation DHR. Illumina will issue results for the second quarter after the closing bell on Tuesday, Aug. 6.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/07/30/Photo-Courtesy-of-Scott-Beale-on-Flickr.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.165887,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "META",
        "relevance_score": "0.293506",
        "ticker_sentiment_score": "-0.10965",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BAC",
        "relevance_score": "0.293506",
        "ticker_sentiment_score": "-0.014305",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CEG",
        "relevance_score": "0.384397",
        "ticker_sentiment_score": "0.339506",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "IBN",
        "relevance_score": "0.293506",
        "ticker_sentiment_score": "0.469047",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "ILMN",
        "relevance_score": "0.384397",
        "ticker_sentiment_score": "-0.125286",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MS",
        "relevance_score": "0.09989",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "OGN",
        "relevance_score": "0.469744",
        "ticker_sentiment_score": "0.327536",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "PFE",
        "relevance_score": "0.198221",
        "ticker_sentiment_score": "0.087421",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.198221",
        "ticker_sentiment_score": "-0.177855",
        "ticker_sentiment_label": "Somewhat-Bearish"
      }
    ]
  },
  {
    "title": " ( DHR )  - Analyzing Danaher's Short Interest - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/short-sellers/24/08/40110619/dhr-analyzing-danahers-short-interest",
    "time_published": "20240801T180024",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Danaher's DHR short percent of float has fallen 21.54% since its last report. The company recently reported that it has 6.55 million shares sold short, which is 1.02% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.2 days to cover their ...",
    "banner_image": "https://www.benzinga.com/files/images/story/2024/1722535221_0.png",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.264538,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.212115",
        "ticker_sentiment_score": "0.081887",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "$1000 Invested In Danaher 10 Years Ago Would Be Worth This Much Today - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/news/24/08/40143553/1000-invested-in-danaher-10-years-ago-would-be-worth-this-much-today",
    "time_published": "20240802T213032",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Danaher DHR has outperformed the market over the past 10 years by 7.93% on an annualized basis producing an average annual return of 18.74%. Currently, Danaher has a market capitalization of $199.87 billion.",
    "banner_image": "https://www.benzinga.com/files/images/story/2024/1722634229_0.png",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.238974,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.95919",
        "ticker_sentiment_score": "0.384695",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Markel's  ( MKL )  Q2 Earnings Beat Estimates, Revenues Miss",
    "url": "https://www.zacks.com/stock/news/2315542/markels-mkl-q2-earnings-beat-estimates-revenues-miss",
    "time_published": "20240802T172000",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Markel's (MKL) Q2 results reflect improvement in earned premiums and increased net investment income.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/6e/54381.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.684621"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.976671"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.200639,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MMM",
        "relevance_score": "0.110462",
        "ticker_sentiment_score": "0.172699",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "HON",
        "relevance_score": "0.110462",
        "ticker_sentiment_score": "0.133963",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.110462",
        "ticker_sentiment_score": "-0.022396",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MKL",
        "relevance_score": "0.421485",
        "ticker_sentiment_score": "0.399788",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Behind the Scenes of Danaher's Latest Options Trends - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/options/24/08/40163865/behind-the-scenes-of-danahers-latest-options-trends",
    "time_published": "20240805T150050",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Financial giants have made a conspicuous bullish move on Danaher. Our analysis of options history for Danaher DHR revealed 10 unusual trades. Delving into the details, we found 60% of traders were bullish, while 10% showed bearish tendencies.",
    "banner_image": "https://www.benzinga.com/files/images/story/2024/1722870047_0.png",
    "source": "Benzinga",
    "category_within_source": "Markets",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.929393"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.194244,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "VLTO",
        "relevance_score": "0.087503",
        "ticker_sentiment_score": "0.032894",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BCS",
        "relevance_score": "0.087503",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.846873",
        "ticker_sentiment_score": "0.209693",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Immunoassay Market Surges to USD 39.66 Billion by 2031, Propelled by 4.67% CAGR - Verified Market Research\u00ae",
    "url": "https://www.benzinga.com/pressreleases/24/08/g40161821/immunoassay-market-surges-to-usd-39-66-billion-by-2031-propelled-by-4-67-cagr-verified-market-rese",
    "time_published": "20240805T141500",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Lewes, Delaware, Aug. 05, 2024 ( GLOBE NEWSWIRE ) -- The Global Immunoassay Market Size is projected to grow at a CAGR of 4.67% from 2024 to 2031, according to a new report published by Verified Market Research\u00ae.",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/54097ce1-6e07-411d-8cc7-f86096bda0f1/immunoassay-market-size-and-forecast-1024x576.jpg",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      }
    ],
    "overall_sentiment_score": 0.274905,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "TRIB",
        "relevance_score": "0.027795",
        "ticker_sentiment_score": "0.095953",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.027795",
        "ticker_sentiment_score": "0.095953",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SSMXF",
        "relevance_score": "0.027795",
        "ticker_sentiment_score": "0.095953",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.027795",
        "ticker_sentiment_score": "0.095953",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.027795",
        "ticker_sentiment_score": "0.095953",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RSSS",
        "relevance_score": "0.027795",
        "ticker_sentiment_score": "0.168128",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BIO",
        "relevance_score": "0.027795",
        "ticker_sentiment_score": "0.095953",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SEMHF",
        "relevance_score": "0.027795",
        "ticker_sentiment_score": "0.095953",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.027795",
        "ticker_sentiment_score": "0.095953",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Polymerase Chain Reaction Market to Reach $16 Billion by 2034 at 10% CAGR - Fact.MR Analysis",
    "url": "https://www.benzinga.com/pressreleases/24/08/g40156065/polymerase-chain-reaction-market-to-reach-16-billion-by-2034-at-10-cagr-fact-mr-analysis",
    "time_published": "20240805T103000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Rockville, MD, Aug. 05, 2024 ( GLOBE NEWSWIRE ) -- As per this updated industry report by Fact.MR, a market research and competitive intelligence provider, the global polymerase chain reaction market size is expected to attain a valuation of US$ 6.2 billion in 2024.",
    "banner_image": "https://ml.globenewswire.com/media/f482b854-04d1-4f4e-9237-f7c7c6823e10/small/factmr-logo-png.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.318234,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BMXMF",
        "relevance_score": "0.033236",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MSFT",
        "relevance_score": "0.033236",
        "ticker_sentiment_score": "0.091702",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "A",
        "relevance_score": "0.033236",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.033236",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.033236",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.066414",
        "ticker_sentiment_score": "0.079129",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BIO",
        "relevance_score": "0.033236",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "QGEN",
        "relevance_score": "0.033236",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "LAB",
        "relevance_score": "0.033236",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.033236",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Whole Slide Imaging Systems Market is Projected to Reach US$ 1.08 Billion at a CAGR of 9.2% By 2034 | Fact.MR",
    "url": "https://www.benzinga.com/pressreleases/24/08/g40246191/whole-slide-imaging-systems-market-is-projected-to-reach-us-1-08-billion-at-a-cagr-of-9-2-by-2034-",
    "time_published": "20240808T102625",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Rockville, MD, Aug. 08, 2024 ( GLOBE NEWSWIRE ) -- Worldwide revenue from the sales of whole slide imaging systems Market is set to reach US$ 446.5 million in 2024 and go on to ascend to US$ 1.08 billion by the end of 2034.",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/82dec0f8-7d40-4b77-89b2-13e90ad2c841/whole-slide-imaging-system.jpg",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.285938,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "LAB",
        "relevance_score": "0.032781",
        "ticker_sentiment_score": "0.172199",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "OCPNF",
        "relevance_score": "0.032781",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DIGP",
        "relevance_score": "0.032781",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HPHTF",
        "relevance_score": "0.065506",
        "ticker_sentiment_score": "0.073083",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.032781",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Metabolomics Market Surges to USD 7.22 Billion by 2031, Propelled by 13.13% CAGR - Verified Market Research\u00ae",
    "url": "https://www.benzinga.com/pressreleases/24/08/g40285856/metabolomics-market-surges-to-usd-7-22-billion-by-2031-propelled-by-13-13-cagr-verified-market-res",
    "time_published": "20240809T141500",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Lewes, Delaware, Aug. 09, 2024 ( GLOBE NEWSWIRE ) -- The Global Metabolomics Market Size is projected to grow at a CAGR of 13.13% from 2024 to 2031, according to a new report published by Verified Market Research\u00ae.",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/46f2fcd1-639c-4bbb-aad2-19c0609724a5/metabolomics-market-size-and-forecast-768x432.jpg",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      }
    ],
    "overall_sentiment_score": 0.252202,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "A",
        "relevance_score": "0.028089",
        "ticker_sentiment_score": "0.105579",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RSSS",
        "relevance_score": "0.028089",
        "ticker_sentiment_score": "0.16831",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SHMZF",
        "relevance_score": "0.028089",
        "ticker_sentiment_score": "0.105579",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.028089",
        "ticker_sentiment_score": "0.105579",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BRKR",
        "relevance_score": "0.028089",
        "ticker_sentiment_score": "0.105579",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BIO",
        "relevance_score": "0.028089",
        "ticker_sentiment_score": "0.105579",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WAT",
        "relevance_score": "0.028089",
        "ticker_sentiment_score": "0.105579",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.028089",
        "ticker_sentiment_score": "0.105579",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Apoptosis Assays Market Projected to Expand at a CAGR of 8.5%, Elevating to a Valuation of USD 11.3 billion by 2034 | Analysis by Transparency Market Research Inc.",
    "url": "https://www.benzinga.com/pressreleases/24/08/g40330745/apoptosis-assays-market-projected-to-expand-at-a-cagr-of-8-5-elevating-to-a-valuation-of-usd-11-3-",
    "time_published": "20240813T074700",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, Transparency Market Research Inc. -, Aug. 13, 2024 ( GLOBE NEWSWIRE ) -- The global apoptosis assay market ( \uc138\ud3ec\uc0ac\uba78 \ubd84\uc11d \uc2dc\uc7a5 ) was projected to attain US$ 4.6 billion in 2023. It is likely to garner an 8.5% CAGR from 2024 to 2034, and by 2034, the market is ...",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.538269"
      }
    ],
    "overall_sentiment_score": 0.02183,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "GOOG",
        "relevance_score": "0.038843",
        "ticker_sentiment_score": "0.053799",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TECH",
        "relevance_score": "0.038843",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.038843",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.077593",
        "ticker_sentiment_score": "0.052609",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BIO",
        "relevance_score": "0.038843",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.116161",
        "ticker_sentiment_score": "0.05042",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.038843",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Rheumatology Therapeutics Market Size is Anticipated to Surpass Revenue of USD 65.1 Billion by 2034 at a Grow CAGR of 2.6% | Transparency Market Research Inc.",
    "url": "https://www.benzinga.com/pressreleases/24/08/g40382614/rheumatology-therapeutics-market-size-is-anticipated-to-surpass-revenue-of-usd-65-1-billion-by-203",
    "time_published": "20240814T213000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, Transparency Market Research, Inc.-, Aug. 14, 2024 ( GLOBE NEWSWIRE ) -- As per the report published by Transparency Market Research, the global rheumatology therapeutics market ( \u30ea\u30a6\u30de\u30c1\u6cbb\u7642\u85ac\u5e02\u5834 ) was worth US$ 48.8 Billion in 2023 and is expected to reach US$ ...",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/a8fed192-c91a-4fb3-9f0b-9237251567b2/rheumatology-therapeutics-market.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.138353,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "BMXMF",
        "relevance_score": "0.03798",
        "ticker_sentiment_score": "0.135565",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GOOG",
        "relevance_score": "0.03798",
        "ticker_sentiment_score": "0.051692",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.03798",
        "ticker_sentiment_score": "0.135565",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SMAWF",
        "relevance_score": "0.03798",
        "ticker_sentiment_score": "0.135565",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.03798",
        "ticker_sentiment_score": "0.135565",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.03798",
        "ticker_sentiment_score": "0.135565",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DSRLF",
        "relevance_score": "0.03798",
        "ticker_sentiment_score": "0.135565",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BIO",
        "relevance_score": "0.03798",
        "ticker_sentiment_score": "0.135565",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVS",
        "relevance_score": "0.03798",
        "ticker_sentiment_score": "0.135565",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.113597",
        "ticker_sentiment_score": "0.06894",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.03798",
        "ticker_sentiment_score": "0.135565",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Chlamydia Infection Diagnostics and Therapeutics Market Size is Estimated to Reach 2.3 Billion, Expanding at a CAGR of 6.9 % by 2034 | TMR Research",
    "url": "https://www.benzinga.com/pressreleases/24/08/g40372339/chlamydia-infection-diagnostics-and-therapeutics-market-size-is-estimated-to-reach-2-3-billion-exp",
    "time_published": "20240814T155201",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, Transparency Market Research Inc., Aug. 14, 2024 ( GLOBE NEWSWIRE ) -- As per the report published by Transparency Market Research, the global chlamydia infection diagnostics and therapeutics market ( \ud074\ub77c\ubbf8\ub514\uc544 \uac10\uc5fc \uc9c4\ub2e8 \ubc0f \uce58\ub8cc\uc81c \uc2dc\uc7a5 ) was worth US$ 1.1 Billion in 2023 ...",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/6c7fcd4a-22c9-442c-94f6-e613cdddc87f/chlamydia-infection-diagnostics-and-therapeutics-market.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.147152,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "BMXMF",
        "relevance_score": "0.036587",
        "ticker_sentiment_score": "-0.028254",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GOOG",
        "relevance_score": "0.036587",
        "ticker_sentiment_score": "0.051403",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SMAWF",
        "relevance_score": "0.036587",
        "ticker_sentiment_score": "-0.028254",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BIO",
        "relevance_score": "0.036587",
        "ticker_sentiment_score": "-0.028254",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVS",
        "relevance_score": "0.036587",
        "ticker_sentiment_score": "-0.028254",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.109455",
        "ticker_sentiment_score": "0.045263",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.036587",
        "ticker_sentiment_score": "-0.028254",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.036587",
        "ticker_sentiment_score": "-0.028254",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.036587",
        "ticker_sentiment_score": "-0.028254",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.036587",
        "ticker_sentiment_score": "-0.028254",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DSRLF",
        "relevance_score": "0.036587",
        "ticker_sentiment_score": "-0.028254",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TSOI",
        "relevance_score": "0.036587",
        "ticker_sentiment_score": "0.189473",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "BNXYF",
        "relevance_score": "0.036587",
        "ticker_sentiment_score": "0.189473",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Dental Restorative Market is Projected to Reach US$39 Billion at a CAGR of 6.7% by 2034 | Fact.MR",
    "url": "https://www.benzinga.com/pressreleases/24/08/g40362035/dental-restorative-market-is-projected-to-reach-us-39-billion-at-a-cagr-of-6-7-by-2034-fact-mr",
    "time_published": "20240814T110000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Rockville, MD, Aug. 14, 2024 ( GLOBE NEWSWIRE ) -- Revenue from the global dental restorative market is projected to reach US$ 20.32 billion in 2024, according to an updated study published by Fact.MR, a market research and competitive intelligence provider.",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/5f05dbc8-ad12-4894-a4bb-6f2f4b62320f/dental-restorative-market.jpg",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.295215,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ZBH",
        "relevance_score": "0.039548",
        "ticker_sentiment_score": "0.054909",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZIMV",
        "relevance_score": "0.079",
        "ticker_sentiment_score": "0.164723",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MITSF",
        "relevance_score": "0.039548",
        "ticker_sentiment_score": "0.054909",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SAUHF",
        "relevance_score": "0.039548",
        "ticker_sentiment_score": "0.054909",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MITUF",
        "relevance_score": "0.039548",
        "ticker_sentiment_score": "0.054909",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "XRAY",
        "relevance_score": "0.039548",
        "ticker_sentiment_score": "0.054909",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MMM",
        "relevance_score": "0.039548",
        "ticker_sentiment_score": "0.054909",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.039548",
        "ticker_sentiment_score": "0.054909",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Danaher  ( DHR )  Benefits From Business Strength Amid Risks",
    "url": "https://www.zacks.com/stock/news/2323187/danaher-dhr-benefits-from-business-strength-amid-risks",
    "time_published": "20240816T152800",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Danaher (DHR) benefits from strength in the clinical diagnostics business, Abcam buyout and pro-investor policies. However, softness in its Instrument unit is concerning.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/58/4678.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.769861"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.241737,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "PDD",
        "relevance_score": "0.303175",
        "ticker_sentiment_score": "-0.022419",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MMM",
        "relevance_score": "0.154455",
        "ticker_sentiment_score": "-0.064942",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.504646",
        "ticker_sentiment_score": "0.389344",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "FSS",
        "relevance_score": "0.373751",
        "ticker_sentiment_score": "-0.026288",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "3M  ( MMM )  Rises 21% in a Month: Is the Stock Worth Buying?",
    "url": "https://www.zacks.com/stock/news/2323883/3m-mmm-rises-21-in-a-month-is-the-stock-worth-buying",
    "time_published": "20240819T152100",
    "authors": [
      "Avisekh Bhattacharjee"
    ],
    "summary": "3M's (MMM) strong prospects, driven by strength across its businesses and restructuring actions, make it an attractive pick for investors.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/84/473.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.999365"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.310843"
      }
    ],
    "overall_sentiment_score": 0.44172,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "PDD",
        "relevance_score": "0.115509",
        "ticker_sentiment_score": "0.236377",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "HON",
        "relevance_score": "0.115509",
        "ticker_sentiment_score": "0.020364",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.115509",
        "ticker_sentiment_score": "0.236377",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Intelligent Product Solutions Announces that Brad Carlson Joins as VP of Technology and Business Development",
    "url": "https://www.globenewswire.com/news-release/2024/08/20/2932935/0/en/Intelligent-Product-Solutions-Announces-that-Brad-Carlson-Joins-as-VP-of-Technology-and-Business-Development.html",
    "time_published": "20240820T135000",
    "authors": [
      "Intelligent Product Solutions"
    ],
    "summary": "Intelligent Product Solutions (IPS) announced today that Brad Carlson joined the company as Vice President of Technology and Business Development.",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/64868e5d-8996-49bf-a532-733564dbffc6",
    "source": "GlobeNewswire",
    "category_within_source": "n/a",
    "source_domain": "www.globenewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.360215"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.261376,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GOOG",
        "relevance_score": "0.105604",
        "ticker_sentiment_score": "0.056008",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FORD",
        "relevance_score": "0.209365",
        "ticker_sentiment_score": "0.139922",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "VZ",
        "relevance_score": "0.105604",
        "ticker_sentiment_score": "0.056008",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVST",
        "relevance_score": "0.105604",
        "ticker_sentiment_score": "0.045208",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZBRA",
        "relevance_score": "0.209365",
        "ticker_sentiment_score": "0.07516",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.105604",
        "ticker_sentiment_score": "0.045208",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Why Is Danaher  ( DHR )  Up 2% Since Last Earnings Report?",
    "url": "https://www.zacks.com/stock/news/2325829/why-is-danaher-dhr-up-2-since-last-earnings-report",
    "time_published": "20240822T153037",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Danaher (DHR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default147.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.838487"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.054688,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.499254",
        "ticker_sentiment_score": "0.041179",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Laboratory Consumables Market Size Poised for Growth with Surpassing USD 301.2 Billion by 2031 at a 5.1% CAGR: Transparency Market Research",
    "url": "https://www.benzinga.com/pressreleases/24/08/g40510671/laboratory-consumables-market-size-poised-for-growth-with-surpassing-usd-301-2-billion-by-2031-at-",
    "time_published": "20240822T152005",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, Transparency Market Research, Inc., Aug. 22, 2024 ( GLOBE NEWSWIRE ) -- As per the report published by Transparency Market Research, the global laboratory consumables market ( \uc2e4\ud5d8\uc2e4 \uc18c\ubaa8\ud488 \uc2dc\uc7a5 ) was worth US$ 191.2 Billion in 2022 and is expected to reach US$ 301.2 ...",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/7eec8c9b-40ba-43bd-b830-1186c07a2820/laboratory-consumables-market-.jpg",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.225286,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "A",
        "relevance_score": "0.035661",
        "ticker_sentiment_score": "-0.035718",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GOOG",
        "relevance_score": "0.035661",
        "ticker_sentiment_score": "0.048332",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.035661",
        "ticker_sentiment_score": "-0.035718",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "EKDHF",
        "relevance_score": "0.035661",
        "ticker_sentiment_score": "-0.035718",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GLW",
        "relevance_score": "0.035661",
        "ticker_sentiment_score": "-0.035718",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NTOIF",
        "relevance_score": "0.035661",
        "ticker_sentiment_score": "0.103297",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.035661",
        "ticker_sentiment_score": "-0.035718",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.106699",
        "ticker_sentiment_score": "0.065222",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.035661",
        "ticker_sentiment_score": "-0.035718",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Laboratory Equipment Services Market Size & Share to Surpass USD 22.8 Billion by 2031, at a CAGR 8.4% - Transparency Market Research, Inc.",
    "url": "https://www.benzinga.com/pressreleases/24/08/g40501619/laboratory-equipment-services-market-size-share-to-surpass-usd-22-8-billion-by-2031-at-a-cagr-8-4-",
    "time_published": "20240822T090800",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, Transparency Market Research Inc. -, Aug. 22, 2024 ( GLOBE NEWSWIRE ) -- As per the report published by Transparency Market Research, the global laboratory equipment services market ( \uc2e4\ud5d8\uc2e4 \uc7a5\ube44 \uc11c\ube44\uc2a4 \uc2dc\uc7a5 ) was worth USD 10.9 Bn in 2022 and is expected to reach USD ...",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/f3af479e-5009-40f8-b689-bfda2feab51f/laboratory-equipment-services-market.jpg",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.259245,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "A",
        "relevance_score": "0.039548",
        "ticker_sentiment_score": "0.064627",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GOOG",
        "relevance_score": "0.039548",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.039548",
        "ticker_sentiment_score": "0.064627",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.039548",
        "ticker_sentiment_score": "0.064627",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BIO",
        "relevance_score": "0.039548",
        "ticker_sentiment_score": "0.064627",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WAT",
        "relevance_score": "0.039548",
        "ticker_sentiment_score": "0.064627",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.118257",
        "ticker_sentiment_score": "0.066736",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.039548",
        "ticker_sentiment_score": "0.064627",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "$1000 Invested In This Stock 10 Years Ago Would Be Worth $5,200 Today - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/news/24/08/40555384/1000-invested-in-this-stock-10-years-ago-would-be-worth-5-200-today",
    "time_published": "20240826T150021",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Danaher DHR has outperformed the market over the past 10 years by 7.18% on an annualized basis producing an average annual return of 18.0%. Currently, Danaher has a market capitalization of $195.04 billion.",
    "banner_image": "https://www.benzinga.com/files/images/story/2024/1724684418_0.png",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.238974,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.95919",
        "ticker_sentiment_score": "0.384695",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "HTHIY or DHR: Which Is the Better Value Stock Right Now?",
    "url": "https://www.zacks.com/stock/news/2327794/hthiy-or-dhr-which-is-the-better-value-stock-right-now",
    "time_published": "20240827T154007",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "HTHIY vs. DHR: Which Stock Is the Better Value Option?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default4.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.890401"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.481935,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "HTHIF",
        "relevance_score": "0.194242",
        "ticker_sentiment_score": "0.328279",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.674691",
        "ticker_sentiment_score": "0.592083",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "CVRx Announces Appointment of Two New Board Members",
    "url": "https://www.globenewswire.com/news-release/2024/09/03/2939682/0/en/CVRx-Announces-Appointment-of-Two-New-Board-Members.html",
    "time_published": "20240903T123000",
    "authors": [
      "CVRx",
      "Inc."
    ],
    "summary": "Kevin Ballinger and Mitch Hill appointed as new independent Board members Kevin Ballinger and Mitch Hill appointed as new independent Board members ...",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/04c4feba-7841-4ac8-8ca5-6c03be383a0e",
    "source": "GlobeNewswire",
    "category_within_source": "n/a",
    "source_domain": "www.globenewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "IPO",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.275124,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "SILK",
        "relevance_score": "0.068502",
        "ticker_sentiment_score": "0.058309",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BSX",
        "relevance_score": "0.068502",
        "ticker_sentiment_score": "0.058309",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CVRX",
        "relevance_score": "0.452639",
        "ticker_sentiment_score": "0.392903",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "NARI",
        "relevance_score": "0.068502",
        "ticker_sentiment_score": "0.107357",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.068502",
        "ticker_sentiment_score": "0.058309",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "JNJ",
        "relevance_score": "0.068502",
        "ticker_sentiment_score": "0.058309",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Smart Money Is Betting Big In DHR Options - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/options/24/09/40734430/smart-money-is-betting-big-in-dhr-options",
    "time_published": "20240905T153215",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Whales with a lot of money to spend have taken a noticeably bearish stance on Danaher. Looking at options history for Danaher DHR we detected 14 trades. If we consider the specifics of each trade, it is accurate to state that 14% of the investors opened trades with bullish expectations and 35% ...",
    "banner_image": "https://www.benzinga.com/files/images/story/2024/1725550332_0.png",
    "source": "Benzinga",
    "category_within_source": "Markets",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.157316,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "VLTO",
        "relevance_score": "0.096671",
        "ticker_sentiment_score": "0.033585",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WFC",
        "relevance_score": "0.096671",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.66878",
        "ticker_sentiment_score": "0.110721",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "$1000 Invested In Danaher 10 Years Ago Would Be Worth This Much Today - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/news/24/09/40753991/1000-invested-in-danaher-10-years-ago-would-be-worth-this-much-today",
    "time_published": "20240906T173023",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Danaher DHR has outperformed the market over the past 10 years by 7.37% on an annualized basis producing an average annual return of 17.83%. Currently, Danaher has a market capitalization of $191.18 billion.",
    "banner_image": "https://www.benzinga.com/files/images/story/2024/1725643820_0.png",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.238974,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.95919",
        "ticker_sentiment_score": "0.384695",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Unpacking the Latest Options Trading Trends in Danaher - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/options/24/09/40777521/unpacking-the-latest-options-trading-trends-in-danaher",
    "time_published": "20240909T161549",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Financial giants have made a conspicuous bearish move on Danaher. Our analysis of options history for Danaher DHR revealed 13 unusual trades. Delving into the details, we found 38% of traders were bullish, while 53% showed bearish tendencies.",
    "banner_image": "https://www.benzinga.com/files/images/story/2024/1725898546_0.png",
    "source": "Benzinga",
    "category_within_source": "Markets",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.413559"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.154531,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "VLTO",
        "relevance_score": "0.093653",
        "ticker_sentiment_score": "0.033338",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WFC",
        "relevance_score": "0.093653",
        "ticker_sentiment_score": "-0.116105",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.653386",
        "ticker_sentiment_score": "0.033025",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "OraSure Technologies Elects Jack Kenny to the Board of Directors",
    "url": "https://www.globenewswire.com/news-release/2024/09/09/2942700/11732/en/OraSure-Technologies-Elects-Jack-Kenny-to-the-Board-of-Directors.html",
    "time_published": "20240909T110500",
    "authors": [
      "OraSure Technologies",
      "Inc."
    ],
    "summary": "BETHLEHEM, Pa., Sept. 09, 2024 ( GLOBE NEWSWIRE ) -- OraSure Technologies, Inc. ( NASDAQ: OSUR ) , a leader in point-of-care and home diagnostic tests and sample management solutions today announced the election of Jack Kenny to its Board of Directors, effective September 9, 2024.",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/65692861-ef8b-490e-b730-7449593e438f",
    "source": "GlobeNewswire",
    "category_within_source": "n/a",
    "source_domain": "www.globenewswire.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.184211,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "CURN",
        "relevance_score": "0.03178",
        "ticker_sentiment_score": "0.065428",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DGX",
        "relevance_score": "0.03178",
        "ticker_sentiment_score": "-0.11803",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "OSUR",
        "relevance_score": "0.157896",
        "ticker_sentiment_score": "0.100848",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.03178",
        "ticker_sentiment_score": "-0.11803",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.03178",
        "ticker_sentiment_score": "-0.11803",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "OraSure Technologies Elects Jack Kenny to the Board of Directors - OraSure Technologies  ( NASDAQ:OSUR ) ",
    "url": "https://www.benzinga.com/pressreleases/24/09/g40769799/orasure-technologies-elects-jack-kenny-to-the-board-of-directors",
    "time_published": "20240909T110500",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "BETHLEHEM, Pa., Sept. 09, 2024 ( GLOBE NEWSWIRE ) -- OraSure Technologies, Inc. OSUR, a leader in point-of-care and home diagnostic tests and sample management solutions today announced the election of Jack Kenny to its Board of Directors, effective September 9, 2024.",
    "banner_image": "https://ml.globenewswire.com/media/65692861-ef8b-490e-b730-7449593e438f/small/orasure-technologies-inc-logo.jpg",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.191137,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "CURN",
        "relevance_score": "0.030759",
        "ticker_sentiment_score": "0.066193",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DGX",
        "relevance_score": "0.030759",
        "ticker_sentiment_score": "-0.117506",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "OSUR",
        "relevance_score": "0.182967",
        "ticker_sentiment_score": "0.11163",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.030759",
        "ticker_sentiment_score": "-0.117506",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.030759",
        "ticker_sentiment_score": "-0.117506",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Here's Why It is Appropriate to Retain Danaher Stock For Now",
    "url": "https://www.zacks.com/stock/news/2334153/heres-why-it-is-appropriate-to-retain-danaher-stock-for-now",
    "time_published": "20240910T160000",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "DHR benefits from solid momentum across its Diagnostics segment. However, increasing expenses remain a concern.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default285.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.650727"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.769861"
      }
    ],
    "overall_sentiment_score": 0.274618,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "PH",
        "relevance_score": "0.178459",
        "ticker_sentiment_score": "0.123652",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "VGR",
        "relevance_score": "0.119532",
        "ticker_sentiment_score": "0.086927",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.401331",
        "ticker_sentiment_score": "0.432343",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "FSS",
        "relevance_score": "0.236396",
        "ticker_sentiment_score": "0.217804",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Dental Biomaterials Market Size and Share Projected to Surpass USD 13.0 Billion by 2031 at 6.8% CAGR - Report by Transparency Market Research, Inc.",
    "url": "https://www.benzinga.com/pressreleases/24/09/g40810538/dental-biomaterials-market-size-and-share-projected-to-surpass-usd-13-0-billion-by-2031-at-6-8-cag",
    "time_published": "20240911T104400",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, Transparency Market Research Inc. -, Sept. 11, 2024 ( GLOBE NEWSWIRE ) -- Dental biomaterials ( \u6b6f\u79d1\u7528\u751f\u4f53\u6750\u6599\u5e02\u5834 ) were estimated to have a market value of US$ 6.6 billion in 2021.",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/f82dac67-447c-46b8-9b85-f670640d7514/dental-biomaterials-market.jpg",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.284663,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GOOG",
        "relevance_score": "0.03463",
        "ticker_sentiment_score": "0.052876",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HSIC",
        "relevance_score": "0.03463",
        "ticker_sentiment_score": "0.129145",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SAUHF",
        "relevance_score": "0.03463",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.103628",
        "ticker_sentiment_score": "0.10464",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.03463",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "3M Stock Trades Near 52-Week High: How Should Investors Play?",
    "url": "https://www.zacks.com/stock/news/2337392/3m-stock-trades-near-52-week-high-how-should-investors-play",
    "time_published": "20240917T160800",
    "authors": [
      "Avisekh Bhattacharjee"
    ],
    "summary": "MMM is making strides in electronics, automotive and aerospace, and transportation markets, which makes the stock worth a watch amid certain headwinds.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/d9/573.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.999998"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.576289"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.294014,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ITT",
        "relevance_score": "0.090816",
        "ticker_sentiment_score": "0.197342",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MMM",
        "relevance_score": "0.090816",
        "ticker_sentiment_score": "0.197342",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "HON",
        "relevance_score": "0.090816",
        "ticker_sentiment_score": "0.116712",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.090816",
        "ticker_sentiment_score": "0.197342",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Cell Expansion Market Size to Reach USD 40.1 billion, Advancing at a CAGR of 12.1% by 2034: Exclusive Report by Transparency Market Research, Inc.",
    "url": "https://www.benzinga.com/pressreleases/24/09/g40894909/cell-expansion-market-size-to-reach-usd-40-1-billion-advancing-at-a-cagr-of-12-1-by-2034-exclusive",
    "time_published": "20240917T105000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, Transparency Market Research Inc. -, Sept. 17, 2024 ( GLOBE NEWSWIRE ) -- The global cell expansion market ( \uc138\ud3ec \ud655\uc7a5 \uc2dc\uc7a5 ) is estimated to flourish at a CAGR of 12.1% from 2024 to 2034.",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/894a5c35-33ef-4501-b171-428f591834e1/cell-expansion-market.jpg",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.37897,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GOOG",
        "relevance_score": "0.033236",
        "ticker_sentiment_score": "0.05064",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TECH",
        "relevance_score": "0.033236",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GLW",
        "relevance_score": "0.066414",
        "ticker_sentiment_score": "0.388359",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "SUVPF",
        "relevance_score": "0.033236",
        "ticker_sentiment_score": "0.051638",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.033236",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "STMM",
        "relevance_score": "0.066414",
        "ticker_sentiment_score": "0.102194",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.099476",
        "ticker_sentiment_score": "0.227224",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.099476",
        "ticker_sentiment_score": "0.076662",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.033236",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "3 Large-Cap Value Funds Shine After the Fed's Rate Cut",
    "url": "https://www.zacks.com/stock/news/2338314/3-large-cap-value-funds-shine-after-the-feds-rate-cut",
    "time_published": "20240919T113000",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Invest in large-cap value mutual funds such as DAGVX, ACSTX and OFVIX that provide stability and growth following the Fed's recent rate cut.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/09/344.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.2"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.2"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.2"
      },
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.576289"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.2"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.955357"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.2"
      }
    ],
    "overall_sentiment_score": 0.364035,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MPC",
        "relevance_score": "0.064104",
        "ticker_sentiment_score": "0.049022",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MO",
        "relevance_score": "0.064104",
        "ticker_sentiment_score": "0.049022",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BAC",
        "relevance_score": "0.064104",
        "ticker_sentiment_score": "0.050023",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WFC",
        "relevance_score": "0.064104",
        "ticker_sentiment_score": "0.050023",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BLDR",
        "relevance_score": "0.064104",
        "ticker_sentiment_score": "0.049022",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BRK-A",
        "relevance_score": "0.064104",
        "ticker_sentiment_score": "0.044018",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "IVZ",
        "relevance_score": "0.127795",
        "ticker_sentiment_score": "0.144766",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PM",
        "relevance_score": "0.064104",
        "ticker_sentiment_score": "0.050023",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.064104",
        "ticker_sentiment_score": "0.044018",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Danaher Unusual Options Activity - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/options/24/09/40990666/danaher-unusual-options-activity",
    "time_published": "20240923T200126",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Investors with a lot of money to spend have taken a bullish stance on Danaher DHR. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.",
    "banner_image": "https://www.benzinga.com/files/images/story/2024/1727121683_0.png",
    "source": "Benzinga",
    "category_within_source": "Markets",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.316726"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.191488,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "VLTO",
        "relevance_score": "0.078354",
        "ticker_sentiment_score": "0.032389",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WFC",
        "relevance_score": "0.078354",
        "ticker_sentiment_score": "0.081569",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.623976",
        "ticker_sentiment_score": "0.207218",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Spotlight on Danaher: Analyzing the Surge in Options Activity - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/options/24/09/41056330/spotlight-on-danaher-analyzing-the-surge-in-options-activity",
    "time_published": "20240926T201657",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Whales with a lot of money to spend have taken a noticeably bearish stance on Danaher. Looking at options history for Danaher DHR we detected 38 trades. If we consider the specifics of each trade, it is accurate to state that 28% of the investors opened trades with bullish expectations and 57% ...",
    "banner_image": "https://www.benzinga.com/files/images/story/2024/1727381814_0.png",
    "source": "Benzinga",
    "category_within_source": "Markets",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.197044,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "VLTO",
        "relevance_score": "0.097062",
        "ticker_sentiment_score": "0.033619",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.670742",
        "ticker_sentiment_score": "0.285893",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "$1000 Invested In Danaher 10 Years Ago Would Be Worth This Much Today - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/news/24/09/41071084/1000-invested-in-danaher-10-years-ago-would-be-worth-this-much-today",
    "time_published": "20240927T163032",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Danaher DHR has outperformed the market over the past 10 years by 7.27% on an annualized basis producing an average annual return of 18.66%. Currently, Danaher has a market capitalization of $199.90 billion.",
    "banner_image": "https://www.benzinga.com/files/images/story/2024/1727454629_0.png",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.238974,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.95919",
        "ticker_sentiment_score": "0.384695",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "The Zacks Analyst Blog Highlights McDonald's, Danaher, S&P Global, Twin Disc and Cato",
    "url": "https://www.zacks.com/stock/news/2344540/the-zacks-analyst-blog-highlights-mcdonalds-danaher-sp-global-twin-disc-and-cato",
    "time_published": "20241002T111500",
    "authors": [
      "Zacks Investment Research"
    ],
    "summary": "McDonald's, Danaher, S&P Global, Twin Disc and Cato are included in this Analyst Blog.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/f6/355.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Economy - Fiscal",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.576289"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.207199,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "MDNDF",
        "relevance_score": "0.161982",
        "ticker_sentiment_score": "0.068205",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CATO",
        "relevance_score": "0.121856",
        "ticker_sentiment_score": "0.047683",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "III",
        "relevance_score": "0.081414",
        "ticker_sentiment_score": "0.308528",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "SPGI",
        "relevance_score": "0.201691",
        "ticker_sentiment_score": "0.158367",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.121856",
        "ticker_sentiment_score": "0.047683",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MCD",
        "relevance_score": "0.121856",
        "ticker_sentiment_score": "0.047683",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TWIN",
        "relevance_score": "0.121856",
        "ticker_sentiment_score": "0.047683",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Treponema Pallidum Tests Market is Projected to Reach US$ 360 Million by 2034, According to New Report by Fact.MR",
    "url": "https://www.benzinga.com/pressreleases/24/10/g41159943/treponema-pallidum-tests-market-is-projected-to-reach-us-360-million-by-2034-according-to-new-repo",
    "time_published": "20241003T100000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Rockville, MD, Oct. 03, 2024 ( GLOBE NEWSWIRE ) -- According to a new industry report released by Fact.MR, the global Treponema pallidum tests market is estimated at US$ 204.6 million in 2024 and is forecasted to reach US$ 360 million by the end of 2034.",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/0fab68df-3ac5-4f04-91b5-d7652a07325d/treponema-pallidum-test-market.jpg",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.538269"
      }
    ],
    "overall_sentiment_score": 0.332711,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DSRLF",
        "relevance_score": "0.036146",
        "ticker_sentiment_score": "0.075365",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BIO",
        "relevance_score": "0.036146",
        "ticker_sentiment_score": "0.075365",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HOLX",
        "relevance_score": "0.036146",
        "ticker_sentiment_score": "0.075365",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.036146",
        "ticker_sentiment_score": "0.075365",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.036146",
        "ticker_sentiment_score": "0.075365",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Looking Into Danaher's Recent Short Interest - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/short-sellers/24/10/41190250/looking-into-danahers-recent-short-interest",
    "time_published": "20241004T174527",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Danaher's DHR short percent of float has risen 5.83% since its last report. The company recently reported that it has 7.01 million shares sold short, which is 1.09% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.86 days to cover their ...",
    "banner_image": "https://www.benzinga.com/files/images/story/2024/1728063924_0.png",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.289997,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.212115",
        "ticker_sentiment_score": "0.151778",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "3M Surges 45.6% in Six Months: How Should You Play the Stock?",
    "url": "https://www.zacks.com/stock/news/2347615/3m-surges-456-in-six-months-how-should-you-play-the-stock",
    "time_published": "20241008T140200",
    "authors": [
      "Avisekh Bhattacharjee"
    ],
    "summary": "MMM is strategically positioned, leveraging its strong foothold in several key end markets amid certain challenges.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/84/473.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.99999"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.857896"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.308256,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "ITT",
        "relevance_score": "0.085936",
        "ticker_sentiment_score": "0.208936",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "HON",
        "relevance_score": "0.085936",
        "ticker_sentiment_score": "0.208936",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.085936",
        "ticker_sentiment_score": "0.050305",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Cell Culture Market to Surpass Market Valuation of USD 74.52 Billion by 2031 | SkyQuest Technology",
    "url": "https://www.benzinga.com/pressreleases/24/10/g41229428/cell-culture-market-to-surpass-market-valuation-of-usd-74-52-billion-by-2031-skyquest-technology",
    "time_published": "20241008T134500",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Westford, USA, Oct. 08, 2024 ( GLOBE NEWSWIRE ) -- SkyQuest projects that the Global Cell Culture Market will reach a value of USD 74.52 Billion by 2031, with a CAGR of 13.4% during the forecast period ( 2024-2031 ) .",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.254779,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "A",
        "relevance_score": "0.038345",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GLW",
        "relevance_score": "0.038345",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SUVPF",
        "relevance_score": "0.038345",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "STMM",
        "relevance_score": "0.038345",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.038345",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "FUJIF",
        "relevance_score": "0.038345",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GNGBY",
        "relevance_score": "0.038345",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.038345",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Antibody Production Market Expected to Reach USD 30.7 Billion by 2031, Growing at a CAGR of 7.8% from 2023 to 2031: Transparency Market Research, Inc.",
    "url": "https://www.benzinga.com/pressreleases/24/10/g41225152/antibody-production-market-expected-to-reach-usd-30-7-billion-by-2031-growing-at-a-cagr-of-7-8-fro",
    "time_published": "20241008T113500",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Wilmington, Delaware, United States, Transparency Market Research Inc. -, Oct. 08, 2024 ( GLOBE NEWSWIRE ) -- As per the report published by Transparency Market Research, the global antibody production market ( \ud56d\uccb4 \uc0dd\uc0b0 \uc2dc\uc7a5 ) was worth US$ 15.6 Bn in 2022 and is expected to reach US$ 30.7 Bn by the ...",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/1b62091b-db5a-4562-a02e-260e1580bb96/antibody-production-market.jpg",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": -0.014503,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "GOOG",
        "relevance_score": "0.029008",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GRFS",
        "relevance_score": "0.029008",
        "ticker_sentiment_score": "0.048621",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WMGTF",
        "relevance_score": "0.08687",
        "ticker_sentiment_score": "0.060902",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PFE",
        "relevance_score": "0.029008",
        "ticker_sentiment_score": "0.25347",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.029008",
        "ticker_sentiment_score": "0.048621",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.029008",
        "ticker_sentiment_score": "0.048621",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Blood Screening Market Growth at USD 6.33 Billion by 2031 | SkyQuest Technology",
    "url": "https://www.benzinga.com/pressreleases/24/10/g41250900/blood-screening-market-growth-at-usd-6-33-billion-by-2031-skyquest-technology",
    "time_published": "20241009T133248",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Westford, USA, Oct. 09, 2024 ( GLOBE NEWSWIRE ) -- Global Blood Screening Market size was valued at USD 3.30 Billion in 2023 to USD 6.33 Billion by 2031, at a CAGR of 8.50% during the forecast period ( 2024-2031 ) . Blood screening is the process of screening donated blood.",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.210588,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BMXMF",
        "relevance_score": "0.033799",
        "ticker_sentiment_score": "-0.001881",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NTRA",
        "relevance_score": "0.033799",
        "ticker_sentiment_score": "-0.001881",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HOLX",
        "relevance_score": "0.033799",
        "ticker_sentiment_score": "-0.001881",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.033799",
        "ticker_sentiment_score": "-0.001881",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SSMXF",
        "relevance_score": "0.033799",
        "ticker_sentiment_score": "-0.001881",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.033799",
        "ticker_sentiment_score": "-0.001881",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.033799",
        "ticker_sentiment_score": "-0.001881",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BIO",
        "relevance_score": "0.033799",
        "ticker_sentiment_score": "-0.001881",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GRFS",
        "relevance_score": "0.067536",
        "ticker_sentiment_score": "-0.002005",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SEMHF",
        "relevance_score": "0.033799",
        "ticker_sentiment_score": "-0.001881",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "HAE",
        "relevance_score": "0.033799",
        "ticker_sentiment_score": "-0.001881",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.033799",
        "ticker_sentiment_score": "-0.001881",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Danaher to Benefit From Business Strength Amid Headwinds",
    "url": "https://www.zacks.com/stock/news/2349212/danaher-to-benefit-from-business-strength-amid-headwinds",
    "time_published": "20241011T132000",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "DHR stands to benefit from strength in the clinical diagnostics business, Abcam buyout and shareholder-friendly policies. Softness in the Instrument unit remains a concern.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/58/4678.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.158519"
      }
    ],
    "overall_sentiment_score": 0.222879,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "A",
        "relevance_score": "0.087503",
        "ticker_sentiment_score": "0.03322",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MTD",
        "relevance_score": "0.173958",
        "ticker_sentiment_score": "0.045546",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.620664",
        "ticker_sentiment_score": "0.473251",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.173958",
        "ticker_sentiment_score": "0.045546",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Here's How Much You Would Have Made Owning Danaher Stock In The Last 10 Years - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/news/24/10/41320316/heres-how-much-you-would-have-made-owning-danaher-stock-in-the-last-10-years",
    "time_published": "20241014T200021",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Danaher DHR has outperformed the market over the past 10 years by 6.5% on an annualized basis producing an average annual return of 18.16%. Currently, Danaher has a market capitalization of $196.21 billion.",
    "banner_image": "https://www.benzinga.com/files/images/story/2024/1728936018_0.png",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.238974,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.95919",
        "ticker_sentiment_score": "0.384695",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "This Is What Whales Are Betting On Danaher - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/options/24/10/41364317/this-is-what-whales-are-betting-on-danaher",
    "time_published": "20241016T171601",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Deep-pocketed investors have adopted a bearish approach towards Danaher DHR, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.",
    "banner_image": "https://www.benzinga.com/files/images/story/2024/1729098958_0.png",
    "source": "Benzinga",
    "category_within_source": "Markets",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.962106"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.178752,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "EVR",
        "relevance_score": "0.076602",
        "ticker_sentiment_score": "0.022544",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "VLTO",
        "relevance_score": "0.076602",
        "ticker_sentiment_score": "0.032315",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.751437",
        "ticker_sentiment_score": "0.252473",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Honeywell International Inc.  ( HON )  Reports Next Week: Wall Street Expects Earnings Growth",
    "url": "https://www.zacks.com/stock/news/2352382/honeywell-international-inc-hon-reports-next-week-wall-street-expects-earnings-growth",
    "time_published": "20241017T140129",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Honeywell International (HON) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default284.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      },
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.140489,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "HON",
        "relevance_score": "0.260189",
        "ticker_sentiment_score": "0.053436",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.175221",
        "ticker_sentiment_score": "0.018603",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Exploring Analyst Estimates for Danaher  ( DHR )  Q3 Earnings, Beyond Revenue and EPS",
    "url": "https://www.zacks.com/stock/news/2352127/exploring-analyst-estimates-for-danaher-dhr-q3-earnings-beyond-revenue-and-eps",
    "time_published": "20241017T131524",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Danaher (DHR), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2024.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default272.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.967321"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.180246,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.474958",
        "ticker_sentiment_score": "0.151251",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Rapid Medical Diagnostic Kits Market to Surpass $26 Billion with 4% CAGR by 2034 | Fact.MR Analysis",
    "url": "https://www.benzinga.com/pressreleases/24/10/g41376663/rapid-medical-diagnostic-kits-market-to-surpass-26-billion-with-4-cagr-by-2034-fact-mr-analysis",
    "time_published": "20241017T110000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Rockville, MD, Oct. 17, 2024 ( GLOBE NEWSWIRE ) -- Fact.MR, a market research and competitive intelligence provider, reveals in its updated research report that the global rapid medical diagnostic kit market is approximated at a size of US$ 17.6 billion in 2024 and is forecasted to increase to ...",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/71926703-cfde-4fde-85d1-dc027551f7e3/rapid-medical-diagnostic-kit-market.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.358256,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BMXMF",
        "relevance_score": "0.03448",
        "ticker_sentiment_score": "0.091218",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TRIB",
        "relevance_score": "0.03448",
        "ticker_sentiment_score": "0.091218",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.03448",
        "ticker_sentiment_score": "0.091218",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.03448",
        "ticker_sentiment_score": "0.091218",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ZTS",
        "relevance_score": "0.03448",
        "ticker_sentiment_score": "0.091218",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BIO",
        "relevance_score": "0.03448",
        "ticker_sentiment_score": "0.091218",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CAH",
        "relevance_score": "0.03448",
        "ticker_sentiment_score": "0.091218",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.03448",
        "ticker_sentiment_score": "0.091218",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Danaher Gears Up to Report Q3 Earnings: What's in the Cards?",
    "url": "https://www.zacks.com/stock/news/2353294/danaher-gears-up-to-report-q3-earnings-whats-in-the-cards",
    "time_published": "20241018T154600",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "DHR's Q3 results are likely to be affected by weakness in the Biotechnology and Life Sciences segment.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default186.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.999953"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.124956,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "IR",
        "relevance_score": "0.116914",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MMM",
        "relevance_score": "0.116914",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "CR",
        "relevance_score": "0.174587",
        "ticker_sentiment_score": "0.055824",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.581383",
        "ticker_sentiment_score": "0.354783",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Hedge Fund Billionaire Daniel Loeb Bets On Trump Win, Singles Out This Recent Buy As Having 'Significant Upside Potential' - SPDR S&P 500  ( ARCA:SPY ) ",
    "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41397978/hedge-fund-billionaire-daniel-loeb-bets-on-trump-win-singles-out-this-recent-buy-as",
    "time_published": "20241018T092255",
    "authors": [
      "Shanthi Rexaline"
    ],
    "summary": "Another billionaire investor is rooting for Republican presidential candidate Donald Trump's victory in the Nov. 5 election and has accordingly positioned his portfolio. The call comes on the heels of former hedge fund manager Stanley Druckenmiller's similar prediction.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/10/18/Trumps-Lack-of-Policy-Detail.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Markets",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Economy - Monetary",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "0.25"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.25"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.928769"
      },
      {
        "topic": "Energy & Transportation",
        "relevance_score": "0.25"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.25"
      }
    ],
    "overall_sentiment_score": 0.215055,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "AAP",
        "relevance_score": "0.128135",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MSFT",
        "relevance_score": "0.128135",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GOOG",
        "relevance_score": "0.128135",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "PCG",
        "relevance_score": "0.128135",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "VST",
        "relevance_score": "0.128135",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BBWI",
        "relevance_score": "0.128135",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.128135",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Danaher's Q3 Earnings Boosted By Bioprocessing Order Growth, Analyst Maintain Stock Rating - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41465140/danahers-q3-earnings-boosted-by-bioprocessing-order-growth-analyst-maintain-stock-r",
    "time_published": "20241022T192758",
    "authors": [
      "Vandana Singh"
    ],
    "summary": "On Tuesday, Danaher Corp DHR reported third-quarter sales of $5.79 billion, up 3% year-over-year, beating the consensus of $5.59 billion. Guidance: Danaher reaffirms that in fiscal year 2024, non-GAAP core revenue will be down in the low single digits year over year.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/10/22/West-Bangal--India---April-20--2022--Dan.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.796627"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.168928,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GS",
        "relevance_score": "0.118064",
        "ticker_sentiment_score": "0.178266",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.447528",
        "ticker_sentiment_score": "-0.157916",
        "ticker_sentiment_label": "Somewhat-Bearish"
      }
    ]
  },
  {
    "title": "Danaher Q3 Earnings Surpass Estimates, Diagnostics Sales Up Y/Y",
    "url": "https://www.zacks.com/stock/news/2355223/danaher-q3-earnings-surpass-estimates-diagnostics-sales-up-yy",
    "time_published": "20241022T170700",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "DHR's third-quarter earnings and sales surpass estimates, benefiting from the solid performance of its Life Sciences and Diagnostics segments.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/58/4678.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.96136"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.080167,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "PH",
        "relevance_score": "0.174167",
        "ticker_sentiment_score": "0.121557",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ALLE",
        "relevance_score": "0.116631",
        "ticker_sentiment_score": "0.093928",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.49084",
        "ticker_sentiment_score": "-0.138323",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "MKL",
        "relevance_score": "0.174167",
        "ticker_sentiment_score": "0.164997",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "A Closer Look at Danaher's Options Market Dynamics - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/options/24/10/41459671/a-closer-look-at-danahers-options-market-dynamics",
    "time_published": "20241022T154533",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Deep-pocketed investors have adopted a bearish approach towards Danaher DHR, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.",
    "banner_image": "https://www.benzinga.com/files/images/story/2024/1729611930_0.png",
    "source": "Benzinga",
    "category_within_source": "Markets",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.929393"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.134419,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "EVR",
        "relevance_score": "0.078354",
        "ticker_sentiment_score": "0.001029",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "VLTO",
        "relevance_score": "0.078354",
        "ticker_sentiment_score": "0.032389",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.76213",
        "ticker_sentiment_score": "0.186918",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Week Opens With Markets on a Pullback Mode",
    "url": "https://www.zacks.com/stock/news/2355065/week-opens-with-markets-on-a-pullback-mode",
    "time_published": "20241022T145500",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Following a week or two of seemingly higher and higher all-time closing highs, we see something of a pullback in stock market activity in the first two trading days of this week.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/fb/468.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.977154"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.928139"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.19936,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "VZ",
        "relevance_score": "0.2035",
        "ticker_sentiment_score": "-0.061992",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GM",
        "relevance_score": "0.136499",
        "ticker_sentiment_score": "0.190668",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.136499",
        "ticker_sentiment_score": "0.265715",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Stock Markets Taper on High Valuations, Upcoming Election",
    "url": "https://www.zacks.com/stock/news/2355038/stock-markets-taper-on-high-valuations-upcoming-election",
    "time_published": "20241022T142100",
    "authors": [
      "Mark Vickery"
    ],
    "summary": "In two weeks we potentially could see a number of prominent news items which could change the trajectory of stock market enthusiasm.",
    "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/e1/31054.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.977154"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.333333"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.99489"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.333333"
      }
    ],
    "overall_sentiment_score": 0.187502,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "VZ",
        "relevance_score": "0.189175",
        "ticker_sentiment_score": "0.076318",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "GM",
        "relevance_score": "0.126784",
        "ticker_sentiment_score": "0.059307",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.126784",
        "ticker_sentiment_score": "0.137279",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Life Science Giant Danaher Q3 Earnings: Revenue And EPS Beat, Sticks To Annual Guidance - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/news/earnings/24/10/41449367/life-science-giant-danaher-q3-earnings-revenue-and-eps-beat-sticks-to-annual-guidance",
    "time_published": "20241022T120210",
    "authors": [
      "Vandana Singh"
    ],
    "summary": "On Tuesday, Danaher Corp DHR reported third-quarter sales of $5.79 billion, up 3% year-over-year, beating the consensus of $5.59 billion. Non-GAAP core revenue increased by 0.5%, compared to the expectations of a decline in the low-single digits.",
    "banner_image": "https://cdn.benzinga.com/files/images/story/2024/10/22/xrdDAFySnxfpTI2-j4953240827673953644-t23.jpeg?width=1200&height=800&fit=crop",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999921"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      }
    ],
    "overall_sentiment_score": 0.23996,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.655824",
        "ticker_sentiment_score": "-0.196697",
        "ticker_sentiment_label": "Somewhat-Bearish"
      }
    ]
  },
  {
    "title": "Danaher  ( DHR )  Tops Q3 Earnings and Revenue Estimates",
    "url": "https://www.zacks.com/stock/news/2354508/danaher-dhr-tops-q3-earnings-and-revenue-estimates",
    "time_published": "20241022T111003",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Danaher (DHR) delivered earnings and revenue surprises of 9.62% and 3.65%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default119.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.999992"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.266143"
      }
    ],
    "overall_sentiment_score": 0.162323,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.406745",
        "ticker_sentiment_score": "0.166389",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Immunoassay Market to Surpass Market Valuation of USD 54.27 Billion by 2031 | SkyQuest Technology",
    "url": "https://www.benzinga.com/pressreleases/24/10/g41514552/immunoassay-market-to-surpass-market-valuation-of-usd-54-27-billion-by-2031-skyquest-technology",
    "time_published": "20241024T120000",
    "authors": [],
    "summary": "Westford, USA, Oct. 24, 2024 ( GLOBE NEWSWIRE ) -- SkyQuest projects that the Global Immunoassay Market will reach a value of USD 54.27 Billion by 2031, with a CAGR of 5.59% during the forecast period ( 2024-2031 ) .",
    "banner_image": null,
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      }
    ],
    "overall_sentiment_score": 0.194543,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BMXMF",
        "relevance_score": "0.036926",
        "ticker_sentiment_score": "0.017056",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "A",
        "relevance_score": "0.036926",
        "ticker_sentiment_score": "0.017056",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SSMXF",
        "relevance_score": "0.036926",
        "ticker_sentiment_score": "0.017056",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BIO",
        "relevance_score": "0.036926",
        "ticker_sentiment_score": "0.017056",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SEMHF",
        "relevance_score": "0.036926",
        "ticker_sentiment_score": "0.017056",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.036926",
        "ticker_sentiment_score": "0.017056",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ENZ",
        "relevance_score": "0.036926",
        "ticker_sentiment_score": "0.017056",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TECH",
        "relevance_score": "0.036926",
        "ticker_sentiment_score": "0.017056",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.036926",
        "ticker_sentiment_score": "0.017056",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.036926",
        "ticker_sentiment_score": "0.017056",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.036926",
        "ticker_sentiment_score": "0.017056",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DSRLF",
        "relevance_score": "0.036926",
        "ticker_sentiment_score": "0.017056",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "QGEN",
        "relevance_score": "0.036926",
        "ticker_sentiment_score": "0.017056",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SZIHF",
        "relevance_score": "0.036926",
        "ticker_sentiment_score": "0.017056",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "QDEL",
        "relevance_score": "0.036926",
        "ticker_sentiment_score": "0.017056",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TOSCF",
        "relevance_score": "0.073773",
        "ticker_sentiment_score": "0.018113",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Want to Grow a Passive Income Snowball? Buy These 7 Elite Dividend Growth Stocks.",
    "url": "https://www.fool.com/investing/2024/10/26/want-to-grow-a-passive-income-snowball-buy-these-7/",
    "time_published": "20241026T101500",
    "authors": [
      "George Budwell"
    ],
    "summary": "These seven companies are transforming steady profits into rising passive income streams for investors.",
    "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F795258%2Fpassive-income.jpg&op=resize&w=700",
    "source": "Motley Fool",
    "category_within_source": "n/a",
    "source_domain": "www.fool.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.2"
      },
      {
        "topic": "Technology",
        "relevance_score": "0.2"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.2"
      },
      {
        "topic": "Retail & Wholesale",
        "relevance_score": "0.2"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.503496"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.2"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.999892"
      }
    ],
    "overall_sentiment_score": 0.423656,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "LIN",
        "relevance_score": "0.154125",
        "ticker_sentiment_score": "0.218389",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "MSFT",
        "relevance_score": "0.154125",
        "ticker_sentiment_score": "0.11947",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TJX",
        "relevance_score": "0.154125",
        "ticker_sentiment_score": "0.213784",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "AXP",
        "relevance_score": "0.204503",
        "ticker_sentiment_score": "0.339809",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TXN",
        "relevance_score": "0.154125",
        "ticker_sentiment_score": "0.259636",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "UNH",
        "relevance_score": "0.154125",
        "ticker_sentiment_score": "0.196403",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.103109",
        "ticker_sentiment_score": "0.204149",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "If You Invested $1000 In This Stock 10 Years Ago, You Would Have $4,600 Today - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/news/24/10/41579223/if-you-invested-1000-in-this-stock-10-years-ago-you-would-have-4-600-today",
    "time_published": "20241028T153020",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Danaher DHR has outperformed the market over the past 10 years by 5.16% on an annualized basis producing an average annual return of 16.37%. Currently, Danaher has a market capitalization of $176.82 billion.",
    "banner_image": "https://www.benzinga.com/files/images/story/2024/1730129417_0.png",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.238974,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.95919",
        "ticker_sentiment_score": "0.384695",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  },
  {
    "title": "Danaher  ( DHR )  Reliance on International Sales: What Investors Need to Know",
    "url": "https://www.zacks.com/stock/news/2358488/danaher-dhr-reliance-on-international-sales-what-investors-need-to-know",
    "time_published": "20241028T131510",
    "authors": [
      "Zacks Equity Research"
    ],
    "summary": "Examine Danaher's (DHR) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.",
    "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default65.jpg",
    "source": "Zacks Commentary",
    "category_within_source": "n/a",
    "source_domain": "www.zacks.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "1.0"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.171604,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.06697",
        "ticker_sentiment_score": "0.077147",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "A Look Into Danaher Inc's Price Over Earnings - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/news/24/11/41694868/a-look-into-danaher-incs-price-over-earnings",
    "time_published": "20241101T200551",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "In the current market session, Danaher Inc. DHR share price is at $242.91, after a 0.09% spike. Moreover, over the past month, the stock decreased by 8.25%, but in the past year, went up by 26.72%.",
    "banner_image": "https://www.benzinga.com/files/images/story/2024/1730491548_0.png",
    "source": "Benzinga",
    "category_within_source": "Markets",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.094612,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.499789",
        "ticker_sentiment_score": "0.30863",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Peering Into Danaher's Recent Short Interest - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/short-sellers/24/11/41716435/peering-into-danahers-recent-short-interest",
    "time_published": "20241104T151715",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Danaher's DHR short percent of float has fallen 5.68% since its last report. The company recently reported that it has 5.32 million shares sold short, which is 0.83% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.63 days to cover their ...",
    "banner_image": "https://www.benzinga.com/files/images/story/2024/1730733432_0.png",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.365926"
      }
    ],
    "overall_sentiment_score": 0.264538,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.212115",
        "ticker_sentiment_score": "0.081887",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Inquiry Into Danaher's Competitor Dynamics In Life Sciences Tools & Services Industry - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/news/24/11/41716008/inquiry-into-danahers-competitor-dynamics-in-life-sciences-tools-amp-services-industry",
    "time_published": "20241104T150345",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "In the fast-paced and highly competitive business world of today, conducting thorough company analysis is essential for investors and industry observers. In this article, we will conduct an extensive industry comparison, evaluating Danaher DHR in relation to its major competitors in the Life ...",
    "banner_image": "https://www.benzinga.com/files/images/story/2024/1730732622_0.png",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.875462"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.503496"
      }
    ],
    "overall_sentiment_score": 0.235392,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "VLTO",
        "relevance_score": "0.067727",
        "ticker_sentiment_score": "0.032057",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.503424",
        "ticker_sentiment_score": "0.292764",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Standard BioTools Appoints Alex Kim as Chief Financial Officer",
    "url": "https://www.globenewswire.com/news-release/2024/11/07/2976600/0/en/Standard-BioTools-Appoints-Alex-Kim-as-Chief-Financial-Officer.html",
    "time_published": "20241107T130000",
    "authors": [
      "Standard BioTools Inc."
    ],
    "summary": "SOUTH SAN FRANCISCO, Calif., Nov. 07, 2024 ( GLOBE NEWSWIRE ) -- Standard BioTools Inc. ( \"Standard BioTools\" or the \"Company\" ) ( Nasdaq: LAB ) today announced the appointment of Alex Kim as Chief Financial Officer, effective November 11, 2024.",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/122934c3-b763-4386-89d1-3047d0704c17",
    "source": "GlobeNewswire",
    "category_within_source": "n/a",
    "source_domain": "www.globenewswire.com",
    "topics": [
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.245964,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "LAB",
        "relevance_score": "0.784319",
        "ticker_sentiment_score": "0.42869",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.075874",
        "ticker_sentiment_score": "0.03363",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SLGC",
        "relevance_score": "0.075874",
        "ticker_sentiment_score": "0.196192",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Standard BioTools Appoints Alex Kim as Chief Financial Officer - Standard BioTools  ( NASDAQ:LAB ) ",
    "url": "https://www.benzinga.com/pressreleases/24/11/g41805136/standard-biotools-appoints-alex-kim-as-chief-financial-officer",
    "time_published": "20241107T130000",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "SOUTH SAN FRANCISCO, Calif., Nov. 07, 2024 ( GLOBE NEWSWIRE ) -- Standard BioTools Inc. ( \"Standard BioTools\" or the \"Company\" ) LAB today announced the appointment of Alex Kim as Chief Financial Officer, effective November 11, 2024.",
    "banner_image": "https://ml.globenewswire.com/media/122934c3-b763-4386-89d1-3047d0704c17/small/sbt-new-august-2022-logo.png",
    "source": "Benzinga",
    "category_within_source": "News",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Mergers & Acquisitions",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.250561,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "LAB",
        "relevance_score": "0.781928",
        "ticker_sentiment_score": "0.398695",
        "ticker_sentiment_label": "Bullish"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.070105",
        "ticker_sentiment_score": "0.033339",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SLGC",
        "relevance_score": "0.070105",
        "ticker_sentiment_score": "0.193631",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Cell Line Development Market to Surpass Market Valuation of USD 15.88 Billion by 2031 | SkyQuest Technology",
    "url": "https://www.benzinga.com/pressreleases/24/11/g41931687/cell-line-development-market-to-surpass-market-valuation-of-usd-15-88-billion-by-2031-skyquest-tec",
    "time_published": "20241113T082646",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Westford, USA, Nov. 13, 2024 ( GLOBE NEWSWIRE ) -- SkyQuest projects that the Global Cell Line Development Market will reach a value of USD 15.88 Billion by 2031, with a CAGR of 12.12% during the forecast period ( 2024-2031 ) .",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.214378"
      },
      {
        "topic": "Manufacturing",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.37262,
    "overall_sentiment_label": "Bullish",
    "ticker_sentiment": [
      {
        "ticker": "GLW",
        "relevance_score": "0.051886",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SUVPF",
        "relevance_score": "0.051886",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "WUXAY",
        "relevance_score": "0.051886",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.051886",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.051886",
        "ticker_sentiment_score": "0.0",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "What the Options Market Tells Us About Danaher - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/options/24/11/42017898/what-the-options-market-tells-us-about-danaher",
    "time_published": "20241115T201712",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Investors with a lot of money to spend have taken a bearish stance on Danaher DHR. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.",
    "banner_image": "https://www.benzinga.com/files/images/story/2024/1731701829_0.png",
    "source": "Benzinga",
    "category_within_source": "Markets",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "0.5"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.990999"
      },
      {
        "topic": "Earnings",
        "relevance_score": "0.310843"
      },
      {
        "topic": "Finance",
        "relevance_score": "0.5"
      }
    ],
    "overall_sentiment_score": 0.143038,
    "overall_sentiment_label": "Neutral",
    "ticker_sentiment": [
      {
        "ticker": "VLTO",
        "relevance_score": "0.07031",
        "ticker_sentiment_score": "0.032111",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BCS",
        "relevance_score": "0.07031",
        "ticker_sentiment_score": "0.039223",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.841981",
        "ticker_sentiment_score": "0.196339",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "What the Options Market Tells Us About Danaher - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/options/24/11/42096973/what-the-options-market-tells-us-about-danaher",
    "time_published": "20241120T190110",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Investors with a lot of money to spend have taken a bullish stance on Danaher DHR. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",
    "banner_image": "https://www.benzinga.com/files/images/story/2024/1732129237_0.png",
    "source": "Benzinga",
    "category_within_source": "Markets",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.158519"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.316726"
      }
    ],
    "overall_sentiment_score": 0.185596,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "VLTO",
        "relevance_score": "0.076602",
        "ticker_sentiment_score": "0.032315",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.709804",
        "ticker_sentiment_score": "0.261268",
        "ticker_sentiment_label": "Somewhat-Bullish"
      }
    ]
  },
  {
    "title": "Cell Counting Market is expected to generate a revenue of USD 16.5 Billion by 2031, Globally, at 6.20% CAGR: Verified Market Research\u00ae",
    "url": "https://www.benzinga.com/pressreleases/24/11/g42166496/cell-counting-market-is-expected-to-generate-a-revenue-of-usd-16-5-billion-by-2031-globally-at-6-2",
    "time_published": "20241125T151500",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Lewes, Delaware, Nov. 25, 2024 ( GLOBE NEWSWIRE ) -- The Global Cell Counting Market Size is projected to grow at a CAGR of 6.20% from 2024 to 2031, according to a new report published by Verified Market Research\u00ae.",
    "banner_image": "https://ml.globenewswire.com/Resource/Download/4d4e92b6-a3bd-49ef-a14b-8c6a97bc1a35/global-cell-counting-market-size-and-forecast-1024x576.jpg",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.161647"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.161647"
      }
    ],
    "overall_sentiment_score": 0.290559,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "A",
        "relevance_score": "0.022368",
        "ticker_sentiment_score": "0.040417",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "ABT",
        "relevance_score": "0.022368",
        "ticker_sentiment_score": "0.040417",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SSMXF",
        "relevance_score": "0.022368",
        "ticker_sentiment_score": "0.040417",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "SUVPF",
        "relevance_score": "0.022368",
        "ticker_sentiment_score": "0.040417",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BDX",
        "relevance_score": "0.022368",
        "ticker_sentiment_score": "0.040417",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "RSSS",
        "relevance_score": "0.022368",
        "ticker_sentiment_score": "0.164405",
        "ticker_sentiment_label": "Somewhat-Bullish"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.022368",
        "ticker_sentiment_score": "0.040417",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BIO",
        "relevance_score": "0.022368",
        "ticker_sentiment_score": "0.040417",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "OCPNF",
        "relevance_score": "0.022368",
        "ticker_sentiment_score": "0.040417",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.022368",
        "ticker_sentiment_score": "0.040417",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Blood Culture Tests Market is Slated to Evolve at an Impressive 12.3% CAGR through 2031 | SkyQuest Technology",
    "url": "https://www.benzinga.com/pressreleases/24/11/g42241660/blood-culture-tests-market-is-slated-to-evolve-at-an-impressive-12-3-cagr-through-2031-skyquest-te",
    "time_published": "20241129T113306",
    "authors": [
      "Globe Newswire"
    ],
    "summary": "Westford, USA, Nov. 29, 2024 ( GLOBE NEWSWIRE ) -- SkyQuest projects that the blood culture tests market size will attain a value of USD 17.50 billion by 2031, with a CAGR of 12.3% over the forecast period ( 2024-2031 ) .",
    "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
    "source": "Benzinga",
    "category_within_source": "General",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Earnings",
        "relevance_score": "0.108179"
      },
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      }
    ],
    "overall_sentiment_score": 0.155931,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "BMXMF",
        "relevance_score": "0.048425",
        "ticker_sentiment_score": "-0.032542",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "NVS",
        "relevance_score": "0.048425",
        "ticker_sentiment_score": "-0.032542",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "BAYZF",
        "relevance_score": "0.048425",
        "ticker_sentiment_score": "-0.032542",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "DHR",
        "relevance_score": "0.048425",
        "ticker_sentiment_score": "-0.032542",
        "ticker_sentiment_label": "Neutral"
      },
      {
        "ticker": "TMO",
        "relevance_score": "0.048425",
        "ticker_sentiment_score": "-0.032542",
        "ticker_sentiment_label": "Neutral"
      }
    ]
  },
  {
    "title": "Here's How Much You Would Have Made Owning Danaher Stock In The Last 10 Years - Danaher  ( NYSE:DHR ) ",
    "url": "https://www.benzinga.com/insights/news/24/12/42669134/heres-how-much-you-would-have-made-owning-danaher-stock-in-the-last-10-years",
    "time_published": "20241224T140015",
    "authors": [
      "Benzinga Insights"
    ],
    "summary": "Danaher DHR has outperformed the market over the past 10 years by 3.64% on an annualized basis producing an average annual return of 14.74%. Currently, Danaher has a market capitalization of $164.51 billion.",
    "banner_image": "https://www.benzinga.com/files/images/story/2024/1735048812_0.png",
    "source": "Benzinga",
    "category_within_source": "Trading",
    "source_domain": "www.benzinga.com",
    "topics": [
      {
        "topic": "Life Sciences",
        "relevance_score": "1.0"
      },
      {
        "topic": "Financial Markets",
        "relevance_score": "0.108179"
      }
    ],
    "overall_sentiment_score": 0.238974,
    "overall_sentiment_label": "Somewhat-Bullish",
    "ticker_sentiment": [
      {
        "ticker": "DHR",
        "relevance_score": "0.95919",
        "ticker_sentiment_score": "0.384695",
        "ticker_sentiment_label": "Bullish"
      }
    ]
  }
]